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Abstract 
 
Stereotactic radiation therapy such as SRS and SBRT utilise multiple beams 
delivery with a small radiation field and high dose gradients. A quality 
assurance tool with high stability and linearity of radiation response that can 
map a 2D dose read out in real time and with a high spatial resolution is needed 
to accurately verify two-dimensional (2D) pre-treatment dose distributions. 
This thesis describes two 2D monolithic diode arrays based on different silicon 
substrates called MagicPlate-512 (MP512) designed and developed by the 
Centre for Medical Radiation Physics to verify small field dosimetry. The first 
substrate is based on bulk p-type silicon known as MP512-Bulk and the other 
is based on the high resistivity of a thin epitaxial layer known as MP512-EPI. 
MP512 allows real time 2D dose mapping with a high spatial and temporal 
resolution. Both detector arrays consist of 512 0.5x0.5 mm2 active pixels with 
a 2 mm pitch that covers an area of 52x52 mm2. The angular response of 
MP512-Bulk as well as its correction factor were investigated for various field 
sizes and photon energies. It showed a maximum variation of relative angular 
response normalised to an incidence beam angle zero at a beam angle of 90° of 
approximately 18.5±0.5% and 15.5±0.5% for 6 MV and 10 MV photon beams. 
These results indicate that the angular response is sensitive to the energy, 
whereas the variation of angular response is less affected by field size. The 
packaging and intrinsic asymmetry of the monolithic silicon detector array 
structure are the major elements that affect the angular dependence of an 
MP512-Bulk. A comparison of the cross-plane profiles measured by the 
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corrected MP512-Bulk and EBT3 shows an agreement within ±2% for all field 
sizes, which proves that its correction factor and procedures can be applied to 
small field sizes.  
A full dosimetric characterisation of an MP512-EPI was carried out in terms of 
the radiation hardness, percentage depth dose, dose linearity, dose per pulse 
dependence, output factors for small field sizes, segmental dose linearity 
measurement, and the angular response for 6 MV and 10 MV photon beams; it 
was also studied for the dose rate dependence of 6 MV photon and 6 MeV 
electron beams. The results were then compared to a number of cylindrical 
ionisation chamber (Farmer and Wellhoefer CC13), PTW Markus chamber, 
gafchromic EBT3 film, MOSkin detector, and MP512-Bulk detector. The 
MP512-EPI had excellent full dosimetric characterisation and very stable 
response for a high irradiation gamma dose of 60 kGy with a sensitivity 
degradation of 0.3%/10 kGy. 
The ability of MP512-EPI to measure 2D dose distributions was evaluated 
using small IMRT and VMAT fields and a combination of homogeneous and 
inhomogeneous insertions and a CMRP cylindrical phantom, and then 
compared to EBT3 dose measurements and treatment planning system (TPS) 
dose calculations. A Pinnacle3 version 14 TPS was used to optimise and 
calculate all the plans using an adaptive convolution superposition algorithm. 
A comparison of the dose distribution measured by MP512-EPI, EBT3 film 
and TPS dose calculation in a homogeneous phantom revealed a gamma pass 
rate of 97.11%±1.62 (1SD) and 99.72%±0.55 (1SD) for 2% /2 mm and 
3%/3mm criteria for all plans. The similar results demonstrated in the 
heterogeneous phantom, a reconstructed MP512-EPI dose compared to EBT3 
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film and TPS dose calculation revealed a gamma pass rate of 97.58%±1.07 
(1SD) and 99.60%±0.41 (1SD) for 2%/2mm and 3%/3mm criteria, 
respectively. Whereas the reconstructed MP512-EPI doses compared to the 
measured EBT3 films dose and TPS dose calculation revealed a gamma pass 
rate of less than 85% for criteria of 1%1 mm for both phantoms. The 
reconstructed MP512-EPI doses at smaller gantry angular increments showed 
slightly improved passing rate criteria of 2%/2mm for gamma and a VMAT 
plan delivery within ±2% (1SD). 
This MP512-EPI detector will be used for 3D dose reconstruction in 
conjunction with rotating phantoms and it will be evaluated in terms of 3D 
gamma analysis and dose volume histogram (DVH). Future work will be 
devoted to the development of a Quadro MP512-EPI detector with four tiled 
MP512-EPI that will enable a sensitive area of 10×10 cm2 to maintain the same 
spatial and temporal resolutions. 
  
 
vii 
Acknowledgements 
 
This thesis would not have completed without the support, guidance, and 
assistance of my committee members, and my friends and family. 
I express deep gratitude to my advisor, Distinguished Professor Anatoly 
Rosenfeld for his guidance, patience, and care, as well as the discussions and 
motivation over the past several years; Professor Rosenfeld helped me to 
expand my experience and background in medical physics, especially radiation 
detectors. I would also like to thank Dr Marco Petasecca for his support, advice, 
and the opportunities to do excellent research on the innovation detector. I am 
also grateful for his assistance with the practical experiments and data 
acquisition system. 
I also thank Associate Professor Martin Carolan, and Dean Wilkinson and Kym 
Nitschke from the Illawarra Cancer Care Centre (ICCC) at Wollongong 
Hospital for their support and guidance in the use of treatment machines and 
treatment planning. I am also grateful to Dr Justin Davies for his support during 
gamma irradiation of detectors on Co-60 source at the GATRI facility, 
ANSTO, Australia.  
I would like to acknowledge Matthew K. Newall, Mitchell Duncan, and 
Antony Espinoza for their help and support with the data acquisition software 
for this work. Special thanks go to Morakot Choetkiertikul and Todsaporn 
Fuangrod for their great advice and support in the MATLAB. Many thanks also 
to my colleagues Maegan Gargett, Claudiu Porumb, and Sarah Alnaghy for 
helping and supporting me during my research. I would like to acknowledge 
 
viii 
Craig Davis and his colleagues from the engineering workshop for their 
excellent work on the detector holders. I deeply appreciate my good friend 
Kananana Utitsarn for her willing support and help, and for providing me with 
a great atmosphere; I would have been a slow and lonely experimenter without 
her assistance.  
I want to thank my parents and older sisters for their continuous love, 
encouragement, and support during this study.   
Finally, this work would not have been possible without financial assistance 
from the faculty of Medicine at Ramathibodi Hospital, Mahidol University, 
Thailand. 
 
 
 
 
 
  
 
ix 
Contents 
 
Declaration .................................................................................................. iii 
Abstract ....................................................................................................... iv 
Acknowledgements .................................................................................... vii 
Contents ...................................................................................................... ix 
List of figures ............................................................................................ xiv 
List of tables ............................................................................................ xxiii 
Peer reviewed journal papers and conference proceedings ..................... xxiv 
List of abbreviation ................................................................................ xxvii 
Chapter 1: Introduction ................................................................................ 1 
1.1 Introduction ............................................................................................ 1 
1.2 Objective of the study ............................................................................ 2 
1.3 Outline of the thesis ............................................................................... 2 
Chapter 2: Literature Review ....................................................................... 4 
2.1. Stereotactic Body Radiotherapy (SBRT) .............................................. 4 
2.1.1. Overview ........................................................................................ 4 
2.1.2. SBRT equipment ............................................................................ 8 
2.2. Critique of QA .................................................................................... 12 
2.2.1. Small field: Overview and definition of field size ....................... 13 
2.2.2. Detector size, spatial resolution, and density ............................... 14 
2.2.3. Ideal detector for small field dosimetry ....................................... 16 
 
x 
2.3. The quality assurance currently available and its limitations ............. 17 
2.3.1. Point dose ..................................................................................... 19 
2.3.2. 1D array dosimetry ....................................................................... 24 
2.3.3. 2D dosimetry ................................................................................ 24 
2.3.4. 3D dosimetry ................................................................................ 31 
2.4. Bulk Epitaxial Silicon diodes. ............................................................. 41 
Chapter 3: Angular dependence and the correction factor ..................... 46 
3.1. Introduction ......................................................................................... 46 
3.2. Material ............................................................................................... 47 
3.2.1. MagicPlate-512 (MP512-Bulk) design and fabrication ............... 47 
3.2.2. Data acquisition system (DAQ) ................................................... 48 
3.2.3. CMRP Cylindrical phantom ......................................................... 51 
3.3. Methods ............................................................................................... 52 
3.3.1. Equalisation and calibration factors ............................................. 52 
3.3.2. Angular response .......................................................................... 53 
3.3.3. Gafchromic EBT3 film measurement .......................................... 54 
3.3.4. Angular correction factors............................................................ 58 
3.3.5. Validating the angular response correction factor for a small field
 ................................................................................................................ 59 
3.4. Results ................................................................................................. 60 
3.4.1. Angular response .......................................................................... 60 
3.4.2. Validating the angular response correction factor for a small field
 ................................................................................................................ 63 
3.5. Conclusions ......................................................................................... 73 
Chapter 4: the characteristics of a 2D monolithic epitaxial detector array 
as a quality assurance dosimeter for small field ........................................ 75 
4.1. Introduction ......................................................................................... 75 
 
xi 
4.2. Materials and Methods ........................................................................ 76 
4.2.1. MP512-EPI design and fabrication .............................................. 76 
4.2.2. Data acquisition system (DAQ) ................................................... 77 
4.2.3. Electrical characterisation: Current-Voltage (IV) characteristic. . 78 
4.2.4. Radiation hardness. ...................................................................... 80 
4.2.5. Percentage depth dose (PDD) ...................................................... 82 
4.2.6. Dose linearity ............................................................................... 83 
4.2.7. Dose rate (MU/min) dependence ................................................. 83 
4.2.8. Dose per pulse (DPP) dependence ............................................... 84 
4.2.9. Output factor for small field size ................................................. 86 
4.2.10. Angular response ........................................................................ 87 
4.2.11. Segment linearity ....................................................................... 87 
4.2.12. Long-term reproducibility .......................................................... 88 
4.2.13. Measuring the cross plane profiles ............................................. 88 
4.3. Results ................................................................................................. 89 
4.3.1. I-V Characteristics ....................................................................... 89 
4.3.2. Radiation hardness ....................................................................... 93 
4.3.3. Percentage depth dose (PDD) measurement ................................ 94 
4.3.4. Dose linearity ............................................................................... 95 
4.3.5. Dose rate (MU/min) dependence ................................................. 96 
4.3.6. Dose per pulse (DPP) dependence ............................................... 97 
4.3.7. Output factor for small field size ................................................. 98 
4.3.8. Angular response .......................................................................... 99 
4.3.9. Segment linearity ....................................................................... 100 
4.3.10. Long-term reproducibility ........................................................ 101 
4.3.11. Measuring the cross plane profiles ........................................... 103 
4.4. Conclusions ....................................................................................... 105 
Chapter 5: clinical implementation of a 2D monolithic epitaxial detector 
array for a small intensity modulated field ............................................. 109 
5.1. Introduction ....................................................................................... 109 
 
xii 
5.2. Materials and Methods ...................................................................... 110 
5.2.1. Two-dimensional monolithic epitaxial detector array (MP512-EPI)
 .............................................................................................................. 110 
5.2.2. Data acquisition system (DAQ) and inclinometer ..................... 110 
5.2.3. CMRP cylindrical phantom and insertions ................................ 114 
5.2.4. Computed tomography (CT) scan .............................................. 116 
5.2.5. Clinical planning and optimisation ............................................ 118 
5.2.6. Gafchromic EBT3 film .............................................................. 121 
5.2.7. Verifying the clinical delivery ................................................... 122 
5.2.8. The correction factor .................................................................. 124 
5.2.9. Gamma analysis ......................................................................... 128 
5.3. Results ............................................................................................... 130 
5.3.1. The couch attenuation effect ...................................................... 130 
5.3.2. Inclinometer verification ............................................................ 130 
5.3.3. Clinical verification .................................................................... 131 
5.4. Conclusions ....................................................................................... 142 
Chapter 6: 3D dose reconstruction using MP512 EPI ............................ 144 
6.1. Introduction ....................................................................................... 144 
6.2. Theoretical background of 3D dose reconstruction .......................... 145 
6.3. Data measurement for commissioning and the factor involved in 3D 
dose reconstruction................................................................................... 147 
6.3.1. Percentage depth dose (PDD) measurement and off-axis ratio 
(OAR) ................................................................................................... 147 
6.3.2. Measuring the tissue maximum ratio (TMR) ............................. 149 
6.3.3. Electron density of the CMRP phantom .................................... 151 
6.3.4. Equivalent square field calculation ............................................ 153 
6.3.5. Verifying the dose reconstruction for a small static field .......... 155 
6.4. Results ............................................................................................... 156 
6.4.1. PDDs curve and off-axis ratio (OAR) ........................................ 156 
 
xiii 
6.4.2. Tissue maximum ratio (TMR) data ............................................ 158 
6.4.3. Verifying the dose reconstruction for a small static field…..….160 
6.5. Conclusions ....................................................................................... 162 
Chapter 7: Conclusion and future work .................................................. 164 
7.1 The angular dependence study ........................................................... 164 
7.2 The dosimetric characteristics of MP512-EPI ................................... 165 
7.3. 2D and 3D dose reconstruction ......................................................... 166 
7.4. Future work ....................................................................................... 167 
Bibliography ........................................................................................... 169 
Appendix A:  Autodesk drawing .......................................................... 198 
A.1. MP512 holder for solid water phantom ....................................... 198 
A.2. Inhomogeneous holder for CMRP phantom ................................ 199 
Appendix B:  Matlab Scripts ................................................................. 201 
B.1. Mapping function script ............................................................... 201 
B.1. Angular correction script .............................................................. 202 
B.2. Gamma analysis............................................................................ 206 
 
xiv 
List of figures 
 
Figure 2.1: CyberKnife Treatment components . ....................................................... 9 
Figure 2.2: Gantry-based systems (a) Novalis machine and (b) Built in micro multileaf.
 .................................................................................................................................... 10 
Figure 2. 3:  Colours of dose washes for IMRT and VMAT plans for pulmonary SBRT 
using LINAC base. ..................................................................................................... 11 
Figure 2.4: A schematic configuration for Tomotherapy systems ............................ 12 
Figure 2.5: The effect of penumbra overlapping on the full width of half maximum 
(FWHM) achieve from small field collimator setting………………………………14 
Figure 2.6:  The volume averaging effect ( a)  a schematic diagram of a detector inside a 
broad and narrow beam (b) a comparison of output factors and dose profiles measured by 
various detectors......................................................................................................... 15 
Figure 2.7: The ionisation chamber used in small dosimetry: (a) Pinpoint (PTW31013) 
and (b) CC01 and CC04 (Wellhofer) ......................................................................... 20 
Figure 2. 8:  A schematic of p- n junction of silicon diode and the commercial p- type 
silicon diode detector use in small field dosimetry (IBA Dosimetry). ...................... 21 
Figure 2. 9:  A single crystal diamond detector ( SCDD)  and its configuration ( PTW-
Freiburg) ..................................................................................................................... 23 
Figure 2. 10:  The general shape detector within the phantom for a commercial semi- 3D 
dosimetry system ........................................................................................................ 33 
Figure 2.11: A detector used for patient verification during treatment; (a) downstream of 
the patient, and (b) upstream of the patient. ............................................................... 38 
Figure 3. 1:  A schematic of the cross section of an MP512 detector component and its 
packaging (not to scale). ............................................................................................ 48 
 
xv 
Figure 3.2: The general operation schematic of ASIC ship (a) Dual switched integral 
architecture and (b) Integration Timing ..................................................................... 50 
Figure 3.3: Magic Suite interface (a) Map response display and (b) Histogram response 
display. ....................................................................................................................... 50 
Figure 3.4: Flow chart of data acquisition (DAQ). ................................................... 51 
Figure 3. 5:  PMMA cylindrical phantom ( a)  Lateral view of phantom and ( b)  MP512 
inside the phantom. .................................................................................................... 52 
Figure 3. 6:  The experiment setup; ( a)  The MP512 embedded inside the phantom, ( b) 
Schematic diagram of angular response measurement (not to scale). ....................... 54 
Figure 3.7: The structure of EBT3 film .................................................................... 55 
Figure 3.8: The calibration curve of EBT3 film using a red channel........................ 57 
Figure 3. 9:  The experiment setup of EBT3 films using MP512 packaging to fit the 
PMMA holder ............................................................................................................ 57 
Figure 3. 10:  A comparison of the central pixel response between MP512 and EBT3 for 
6 MV (a) Field size 3x3 cm2, (b) Field size 10x10 cm2. ............................................ 61 
Figure 3. 11:  Angular dependence of the averaged four central pixels of the MP512 
detector array shown as a function of incident gantry angle for (a) 6 MV and (b) 10 MV 
photons. ...................................................................................................................... 62 
Figure 3. 12:  Angular dependence of the averaged four central pixels of the MP512 
detector array shown as a function of incident gantry angle for an open field size of 10x10 
cm2 for 6 MV and 10 MV photons. ........................................................................... 63 
Figure 3. 13:  Dose profiles of EBT3 films and MP512 measured with and without a 
correction factor of open field size 2x2 cm2 for 6 MV photon as a function of distance 
(mm) and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° ........................ 65 
 
xvi 
Figure 3. 14:  Dose profiles of EBT3 films and MP512 measured with and without a 
correction factor of open field size 3x3 cm2 for 6 MV photon as a function of distance 
(mm) and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° ........................ 66 
Figure 3.15: Dose profiles EBT3 films and MP512 measured with and without a 
correction factor of open field size 4x4 cm2 for 6 MV photon as a function of distance 
(mm) and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° ........................ 67 
Figure 3.16: Dose profiles of EBT3 films and MP512 measured with and without a 
correction factor of open field size 2x2 cm2 for 10 MV photon as a function of distance 
(mm) and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° ........................ 68 
Figure 3.17: Dose profiles of EBT3 films and MP512 measured with and without a 
correction factor of open field size 3x3 cm2 for 10 MV photon as a function of distance 
(mm) and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° ........................ 69 
Figure 3.18: Dose profiles of EBT3 films and MP512 measured with and without a 
correction factor of open field size 4x4 cm2 for 10 MV photon as a function of distance 
(mm) and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° ........................ 70 
Figure 3.19: Dose profiles of EBT3 films and MP512 measured with and without a 
correction factor of open field size 1x1 cm2 for 6 MV photon as a function of distance 
(mm) and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° ........................ 71 
Figure 3.20: Dose profiles of EBT3 films and MP512 measured with and without a 
correction factor of open field size 1x1 cm2 for 10 MV photon as a function of distance 
(mm) and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° ........................ 72 
Figure 4.1: Schematic of the MP512-EPI fabrication and packaging (not to scale). 77 
Figure 4.2: MP512-EPI wire-bonded onto a PCB and the connector pins. .............. 77 
Figure 4.3: I-V characteristic measurement setup. .................................................... 78 
Figure 4.4: LabVIEW software interface. ................................................................. 79 
 
xvii 
Figure 4.5: Location of selected diodes on the MP512-EPI (yellow highlight). ...... 80 
Figure 4.6: Schematic of I-V test for MP512-EPI. ................................................... 80 
Figure 4.7: Schematic of the setup for measuring radiation degradation. ................ 82 
Figure 4.8: The dose rate time-sequence of 6 MV photons for Varian Clinac IX. ... 84 
Figure 4.9: A schematic of the gantry angle orientation for measuring dose per pulse.
 .................................................................................................................................... 86 
Figure 4.10: The MP512-EPI in the output factors measurement setup. .................. 87 
Figure 4.11: Leakage current measured in the reverse direction on selected channels of 
MP512-EPI comparison before and after irradiation. ................................................ 92 
Figure 4.12: The results of I-V characteristic comparison of each channel for (a) Prior 
irradiation, and (b) After 20 kGy irradiation. ............................................................. 93 
Figure 4.13: The relative sensitivity of MP512-Bulk and MP512-EPI as a function of the 
accumulated dose for Co-60 gamma source, normalised to a zero dose response. ... 94 
Figure 4.14: Percentage depth dose measurement of MP512 compared to the Markus and 
CC13 ionisation chambers for (a) 6 MV and (b) 10 MV photon beams.................... 95 
Figure 4.15: The average response of four central pixels of MP512-EPI as a function of 
the accumulated dose (MU). ...................................................................................... 96 
Figure 4.16: Variation of MP512-EPI response as a function of the dose rate (MU/min) 
for 6 MV photon and 6 MeV electron beams. ........................................................... 97 
Figure 4.17: Sensitivity response of MP512-Bulk and MP512-EPI detectors as a function 
of dose per pulse for 6 MV photon beam. These responses were normalised to a dose per 
pulse of 2.8x10-4 Gy/pulse at the source to a surface distance of 100 cm. ................ 98 
Figure 4.18: The output factors measured by MP512-EPI and normalised to a 10x10cm2 
field radiation compared to those measured by MP512-Bulk, MOSkin and EBT3 film for 
(a) 6 MV and (b) 10 MV photon beams. .................................................................... 99 
 
xviii 
Figure 4.19: A comparison of the average response of four central pixels between 6 and 
10 MV photon beams for MP512-EPI. .................................................................... 100 
Figure 4.20: A comparison of the average response of four central pixels between 
MP512-EPI and MP512-Bulk for (a) 6 MV and (b) 10 MV photon beams. ........... 100 
Figure 4.21: The response of MP512-EPI as a function of a segmental monitor unit (MU) 
normalised to 1x50 MU. .......................................................................................... 101 
Figure 4.22: The response of MP512-EPI from the central pixel during segmental beam 
irradiation as a function of acquisition time ............................................................. 102 
Figure 4.23: The average response of four central pixels of MP512-EPI as a function of 
time (months) normalised to the first acquisition after pre-irradiation of 60 kGy. The 
standard deviation is smaller than the marked symbol. ........................................... 103 
Figure 4.24: Cross plane profiles measured by MP512-EPI and EBT3 film for 6 MV 
photon beams; (a) field size 1x1 cm2, (b) 2x2 cm2, (c) 3x3 cm2 and (d) 4x4 cm2. .. 104 
Figure 4.25: Cross-plane profiles measured by MP512-EPI and EBT3 film for 10 MV 
photon beams ........................................................................................................... 105 
Figure 5.1: The CMRP phantom with the MP512-EPI inserted in the coronal plane and 
associated device, DAQ, and inclinometer. ............................................................. 112 
Figure 5.2: The function block diagram of ADIS16209 inclinometer. ................... 112 
Figure 5.3: Schematic diagram of data acquisition system (DAQ) synchronised with the 
inclinometer.............................................................................................................. 113 
Figure 5.4: The software interface Magic Suite; (a) the inclinometer indicator and (b) the 
angle (degrees) as a function of time. ...................................................................... 113 
Figure 5.5: Inclinometer settings function .............................................................. 114 
Figure 5.6: The homogeneous holder and MP512-EPI packaging. ........................ 115 
Figure 5.7: The inhomogeneous holder; (a) without and (b) with MP512-EPI. ..... 116 
 
xix 
Figure 5.8: The inhomogeneous insertion; (a) The upper and lower part of the insert, and 
(b) schematic cross-section of the inhomogeneous insertion with a tumor inside (not to 
scale). ....................................................................................................................... 116 
Figure 5.9: MP512-EPI and phantom setup for CT scan (b) the lead marker used  for 
reference points. ....................................................................................................... 117 
Figure 5.10: The CT images for the homogeneous holder (a) with MP512-EPI, and (b) 
without MP512-EPI. ................................................................................................ 118 
Figure 5.11: CT images of the inhomogeneous holder; (a) without MP512-EPI and (b) 
with MP512-EPI and with a tumour. ....................................................................... 118 
Figure 5.12: Pinnacle3 version 14 TPS screenshots of the dose distribution cross-sections 
through the iso-centre of the CMRP cylindrical phantom for axial, sagittal and coronal 
plane; (a) IMRT plan and (b) VMAT plan............................................................... 120 
Figure 5.13: EBT3 film cutting pieces using for patient verification; (a) Homogeneity 
holder and (b) Inhomogeneity holder. ...................................................................... 122 
Figure 5.14: A schematic diagram of the clinically validated process. .................. 123 
Figure 5.15: A schematic diagram of MP512-EPI dose reconstructed for VMAT 
delivery. .................................................................................................................... 125 
Figure 5.16: Photographs of the Varian Exact image-guide (IGRT) couch and 
construction cross-section [225]. ............................................................................. 127 
Figure 5.17: The setup used for the couch attenuation effect; (a) MP512-EPI face up and 
(b) MP512-face down. ............................................................................................. 128 
Figure 5.18: Schematic diagram of gamma evaluation [231]. ................................ 129 
Figure 5.19: Comparison of the gantry angle measured by the inclinometer and extracted 
from Dynalog files over full arc (360°) delivery. .................................................... 131 
 
xx 
Figure 5.20: A comparison of planar dose reconstruction of MP512-EPI and EBT3 film 
dose measurement for (a) IMRT and (b) VMAT plans delivery. ............................ 134 
Figure 5.21: A comparison of Superior-Inferior dose profiles measured with EBT3 films 
and reconstructed from MP512-EPI measurements with and without angular correction, 
to deliver an IMRT plan to a homogeneous phantom as a function of distance from the 
centre;. ...................................................................................................................... 135 
Figure 5.22: A comparison of Left-Right dose  profiles measured with EBT3 films and 
reconstructed from MP512 measurements with and without angular correction to deliver 
an IMRT plan to a homogeneous phantom as a function of distance (mm) from the centre
 .................................................................................................................................. 136 
Figure 5.23: A comparison of Superior-Inferior dose profiles measured with EBT3 films 
and reconstructed from MP512 measurements with and without angular correction, to 
deliver a VMAT plan to a homogeneous phantom as a function of distance (mm) from 
the centre .................................................................................................................. 137 
Figure 5.24: A comparison of Left-Right dose profiles measured with EBT3 films and 
reconstructed from MP512 measurements with and without angular correction to deliver 
a VMAT plan to a homogeneous phantom as a function of distance (mm) from the centre
 .................................................................................................................................. 138 
Figure 5.25: A comparison of planar dose reconstruction of MP512-EPI and EBT3 film 
dose measurement to deliver VMAT plans. ............................................................. 139 
Figure 5.26: A comparison of Superior-Inferior dose profiles measured with EBT3 films 
and reconstructed from MP512 measurements with an angular correction for a VMAT 
plan delivered to an inhomogeneous phantom as a function of distance (mm) from the 
centre ........................................................................................................................ 140 
 
xxi 
Figure 5.27: A comparison of Left-Right dose profiles measured with EBT3 films and 
reconstructed from MP512 measurements with angular correction for a VMAT plan 
delivered as a function of distance (mm) from the centre ........................................ 141 
Figure 6.1: OCTAVIUS® 4D system; (a) the component of OCTAVIUS® 4D system and 
(b) the phantom rotates synchronised with the treatment gantry. ............................ 146 
Figure 6.2: Geometry used for PDDs measured by MP512-EPI at an SSD of 85 cm for 6 
MV photon beams. ................................................................................................... 149 
Figure 6.3: Geometry used for TMR measured by MP512-EPI at SAD of 100 cm for 6 
MV photon beams. ................................................................................................... 150 
Figure 6.4: The NCT to mass and electron density calibration curve normalised to water.
 .................................................................................................................................. 153 
Figure 6.5: The relative field size equivalent using the polar coordinates. ............ 155 
Figure 6.6: Summary of the 3D dose reconstruction based on the algorithm by Allgaier 
et al. .......................................................................................................................... 156 
Figure 6.7: Central-axis percentage depth dose (PDD) curves measured by MP512-EPI 
at an SSD of 85 cm and normalised to a dose at Dmax for 6 MV photon beams ranging 
from 1x1 cm2 to 10x10 cm2. .................................................................................... 157 
Figure 6.8: The off-axis ratio (MP13j, 10,r)measured by MP512-EPI for different size fields 
at a depth of 10 cm and SSD of 85 cm. .................................................................... 157 
Figure 6.9: The off-axis ratio of field size 3 cmx3 cm for 6 MV photon beams measured 
by MP512-EPI at SSD 85 cm .................................................................................. 158 
Figure 6.10: The tissue maximum ratio curves for different size fields as measured by 
MP512-EPI, Markus, CC01, and SFD. .................................................................... 159 
 
xxii 
Figure 6.11: The cross beam profiles reconstructed along the central axis (MP13,j) of a 
3x3 cm2 open field for 6 MV photon beams were compared to those obtained from TPS 
at a physical depth of (a) 1.5 cm, (b) 5 cm, (c) 10 cm, (d) 20 cm and (e) 25 cm. .... 161 
 
 
 
  
 
xxiii 
List of tables 
Table 2.1: A summary of dosimeters used for megavoltage photon beam dosimetry ... 18 
Table 2.2: Specifications of a commercial 2D detector array ]115][116][55.[ .............. 29 
Table 2.3 : Summary of commercial semi-3D dosimeter specifications  ] 139][144][148.[
 ......................................................................................................................................... 37 
Table 3.1 : The difference in FWHM and penumbra width  ) 20 %- 80 (%between MP512 
and EBT3 films for various field sizes. ........................................................................... 64 
Table 4.1 : The FWHM and penumbra width measured by MP512- EPI and gafchromic 
EBT3 films .................................................................................................................... 104 
Table  5 . 1: Treatment delivery parameters for homogeneous and inhomogeneous 
phantoms. ........................................................................ Error! Bookmark not defined. 
Table 5.2 : Summary of the gamma passing rate of IMRT and VMAT plan delivery to 
CMRP homogeneous phantom ..................................................................................... 133 
Table 5.3 : Gamma passing rate of IMRT and VMAT for a CMRP inhomogeneous 
phantom ......................................................................................................................... 139 
Table 6.1: Characteristic of phantom materials ]264][265.[ ........................................ 153 
Table 6.2 : The relative errors )Dmax (of the tissue maximum ration )TMR (measured by 
the MP512-EPI, Markus, CC01 and SFD. .................................................................... 159 
Table 6.3 : The different agreement of cross beam profiles between the reconstructed and 
TPS for different physical depths. ................................................................................. 160 
  
 
xxiv 
Peer reviewed journal papers and 
conference proceedings 
 
1. N. Stansook, M. Petasecca, K. Utitsarn, M. Newall, P. Metcafe, M. Carolan, M. Lerch, 
A.B. Rosenfeld, “The angular dependence of a two dimensional monolithic detector array 
for dosimetry in small fields,” Journal of Physics:Conf.Series MMND&ITRO2016. 777, 
012020 (2017). 
 
2. K. Utitsarn, Z.A. Alrowaili, N. Stansook, M. Lerch, P. Metcafe, M. Carolan, A.B. 
Rosenfeld, “Optimisation of output factor measurements using the MagicPlate 512 silicon 
dosimeter array in small megavoltage photon fields” Journal of Physics:Conf.Series 
MMND&ITRO2016. 777, 012022 (2017).  
 
3. N. Stansook, K. Utitsarn, M. Petasecca, M. Newall, M. Duncan, K. Nitschke, M. 
Carolan, P. Metcafe, M. Lerch, A.B. Rosenfeld, “Angular dependence of a 2D monolithic 
array dosimeter and correction required for small field dosimetry” Poster presentation at 
Engineering and Physical Sciences in Medicine (EPSM) conference 2016, 6-10 
November 2016, Sydney, Australia. 
 
4. K. Utitsarn, N. Stansook, Z.A. Alrowaili, M. Lerch, P. Metcafe, M. Carolan, A.B. 
Rosenfeld, “Beam Perturbation characteristic of 2D monolithic silicon Diode MagicPlate 
512 (MP512)” Poster presentation at Engineering and Physical Sciences in Medicine 
(EPSM) conference 2016, 6-10 November 2016, Sydney, Australia. 
 
xxv 
 
5. N. Stansook, M. Petasecca, K. Utitsarn, M. Carolan, P. Metcafe, M. Lerch, A.B. 
Rosenfeld, “Validation of the influence of M512 substrate resistivity on sensitivity 
degradation of radiation” Poster presentation at European Society for Radiotherapy and 
Oncology (ESTRO36) conference 2017, 5-9 May 2017, Vienna, Austria. 
 
6. K. Utitsarn, N. Stansook, Z.A. Alrowaili, M. Lerch, P. Metcafe, M. Carolan, A.B. 
Rosenfeld, “The effect of air gaps on Magic Plate (MP512) for small field dosimetry” 
Poster presentation at European Society for Radiotherapy and Oncology (ESTRO36) 
conference 2017, 5-9 May 2017, Vienna, Austria. 
 
7. N. Stansook, M. Petasecca, K. Utitsarn, P. Metcafe, M. Carolan, M. Lerch, A.B. 
Rosenfeld, “The characteristic of 2D monolithic epitaxial detector array as a quality 
assurance dosimeter for small field” Oral presentation at Innovation in radiation 
applications (IRA) conference 2017, 20-22 April 2017, Wollongong, Australia.  
 
8. K. Utitsarn, N. Stansook, M. Lerch, P. Metcafe, M. Carolan, A.B. Rosenfeld, “A real 
time QA system with variable spatial resolution for volumetric modulated arc therapy” 
Poster presentation at Innovation in radiation applications (IRA) conference 2017, 20-22 
April 2017, Wollongong, Australia.  
 
9. N. Stansook, K. Utitsarn, M. Petasecca, M. Newall, M. Duncan, K. Nitschke, M. 
Carolan, P. Metcafe, M. Lerch, A.B. Rosenfeld, “Technical Note: Angular dependence 
of a 2D monolithic silicon diode array for small field dosimetry” Med. Phys., pp. 1–29, 
2017., DOI: 10.1002/mp12377. 
 
xxvi 
 
10. K. Utitsarn, Z.A. Alrowaili, N. Stansook, M. Petasecca, M. Carolan, V.L. 
Perevertaylo, M. Lerch, A.B. Rosenfeld, “Technical Note: Impact of a monolithic silicon 
detector operating in transmission mode on clinical photon beams” Physica Medica., 
volume 43, pp. 114-119, 2017., https://doi.org/10.1016/j.ejmp.2017.10.017 
  
 
xxvii 
List of abbreviation 
 
1D One dimensional 
2D Two dimensional 
3D Three dimensional 
4D Four dimensional 
AAPM American Association of Physicists in 
Medicine 
ADC Analog to digital converter 
ASTRO the American Society of Therapeutic 
Radiology and Oncology 
BED biologically effective dose 
BEV Beam eye view 
CBCT Cone beam computed tomography 
CMRP Centre for Medical Radiation Physics 
CP control point  
CT Computed tomography 
DAQ Data acquisition system 
DICOM Digital Imaging and Communications in 
Medicine 
Dmax Maximum dose 
DMG Dose magnifying glass 
EBRT external beam radiation therapy 
EPID Electronic Portal Imaging Devices 
 
xxviii 
EPI Epitaxial 
eV Electron volt 
FPGA Field programmable gate array 
FWHM Full Width of Half Maximum 
GTV Gross tumour volume 
HU Hounsfield units 
IC Ionization chamber 
ICCC Illawarra Cancer Care centre 
ICRU The International Commission of 
Radiation Units and Measurements 
IGRT Inage guide radiotherapy 
IMRT Intensity modulated radiation therapy 
KV Kilovoltage 
Linac Linear accelerator 
MLC Multi-leaf collimator 
MP Magic plate 
MRI Magnetic resonance imaging 
MU Monitor unit 
MV megavoltage 
MVCT Megavoltage computed tomography 
OF Output factor 
PCB Print circuit board 
PDD percentage depth dose 
PMMA Polyemethyl methacrylate 
PTV Planning target volume 
 
xxix 
QA quality assurance 
RTP Radiation treatment planning 
SABR stereotactic ablative radiotherapy 
SAD source to axis distance 
SBRT stereotactic body radiotherapy 
SRS stereotactic radiosurgery 
SSD Source to surface distance 
TERMA Total energy imparted or released in the 
medium  
TG Task group 
TMR Tissue Maximum Ratio 
TPS Treatment planning system 
USB Universal serial bus 
VMAT Volumetric modulated arc therapy 
WED Water equivalent depth 
UOW University of Wollongong 
   
 
 
 
 
Chapter 1  
Introduction 
 
1.1 Introduction 
Since external beam radiation therapy (EBRT) is now an effective option in cancer 
treatment, new equipment and techniques have been developed to provide high quality 
therapy. The treatment must deliver the highest conformal dose to a tumour while sparing 
healthy tissue; the methods used to minimise complications are stereotactic localisation 
techniques such as stereotactic radiosurgery (SRS), stereotactic body radiotherapy 
(SBRT) or stereotactic ablative radiotherapy (SABR). While stereotactic radiation 
therapy provides much better radiobiological effectiveness than conventional photon 
therapies [1]. This technique is so complex that quality assurance devices are becoming 
more of an issue. More than 150 accidents with stereotactic radiotherapy have been 
reported, of which almost 62% stemmed from the quality assurance (QA) process [2][3]. 
The complicated treatment field due to a small field size and intensity modulated 
dosimetry means that point dose measurement cannot verify pre-treatment plans, and 
therefore planar dose (2D) and three-dimensional (3D) dosimetry is needed to verify the 
full plan delivery, including the penumbra or low dose region. Moreover, QA devices 
require small active volumes with high spatial resolution, water equivalence, dose rate 
and energy independence, and linear dose responses to achieve sufficient accuracy [4]. 
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This thesis focuses on the development and characterisation of a two-dimensional (2D) 
monolithic diode array MagicPlate-512 that is based on epitaxial silicon; it is an efficient 
and accurate quality assurance tool for small field intensity modulated radiotherapy. 
 
1.2 Objective of the study 
The objective is to examine the feasibility of using a 2D monolithic detector array 
(MP512) based on epitaxial (MP512-EPI) and bulk (MP512-Bulk) silicon substrate as a 
2D and 3D QA dosimeter for small field dosimetry in SRS and SBRT. The detector arrays 
were designed and developed by the Centre for Medical Radiation Physics (CMRP) at 
the University of Wollongong. For this purpose the full characterisation of a 2D 
monolithic detector array (MP512-EPI) and the small IMRT and VMAT plans were 
highlighted and validated. The parameters measured with MP512 were investigated and 
extended for use with an adaptive 3D dose reconstruction to verify it for patient pre-
treatment.  
 
1.3 Outline of the thesis 
The general background and project goals are introduced in Chapter 1 while Chapter 2 
describes and summarises the literature review of small field dosimetry.  This review 
focused on stereotactic body radiotherapy (SBRT), the technique used to locate tumours, 
SBRT equipment, and a critique of QA in small fields.  This chapter also discusses the 
benefits and drawbacks of current QA tools.  Chapter 3 focuses on the intrinsic 
directional dependence of 2D monolithic diode arrays based on a bulk silicon substrate 
(MP512-Bulk) .  It also studies the effects that photon energy and field sizes have on the 
angular response; the various field sizes were delivered using 6 MV and 10 MV photon 
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beams. This chapter also introduces a developing angular correction factor to improve the 
accuracy of MP512 measurements, and its verification procedures using the small static 
fields employed in SRS and SBRT.  Chapter 4 explores the full dosimetric 
characterisation of MP512-EPI for external radiotherapy using a Varian Clinac iX (linear 
accelerator). Characterization is studied in terms of radiation hardness, percentage depth 
dose (PDD), dose rate (MU/min) dependence, the dose per pulse response, dose linearity, 
as well as the angular response and segmental dose linearity.  This chapter also presents 
an electrical characterization of IV characteristics of detector before and after irradiation. 
Chapter 5 explores the validation of using MP512-EPI for quality assurance in an SBRT 
plan in combination with a cylindrical PMMA phantom developed by the Centre for 
Medical Radiation Physics ( CMRP) , at the University of Wollongong.  Patient pre-
treatment verifications for homogeneous and heterogeneous phantoms were examined for 
IMRT and VMAT. The MP512-EPI measurements were reconstructed using the angular 
correction factor to mitigate the effect of angular dependence before comparing it to 
EBT3 film dose measurements and TPS dose calculation. This chapter also examines how 
the treatment couch influences the patient dose verification where an actual gantry was 
performed.  Chapter 6 describes a method for reconstructing a 3D dose to verify patient 
pre- treatment using companies with 2D monolithic arrays and cylindrical PMMA 
phantoms.  The MP512- EPI measured the significant parameters using a 3D algorithm 
such as the off-axis ratio (OAR), and the PDD and tissue maximum ratio (TMR). Chapter 
7 summarises the study outcomes, including the advantages and disadvantages of the 
MP512 detector.  
 
 
 
 
Chapter 2  
Literature Review 
 
 
Since external beam radiation therapy (EBRT) is now an effective option for treating 
cancer, new equipment and techniques have been developed to provide high quality 
treatment for patients. It is desirable that the treatment method can deliver the highest 
conformal dose to a tumour while sparing normal tissue and minimising complications. 
Over the past decade, stereotactic radiosurgery (SRS) and stereotactic body radiotherapy 
(SBRT), or stereotactic ablative radiotherapy (SABR) has been increasingly used in the 
field of external radiation field because they are much better than conventional external 
beam therapy.  
This chapter focuses on SBRT/SABR because it is used for small field dosimetry 
and this technique requires effective quality assurance (QA). There is also a discussion 
of current QA tools and their limitations, as well as the problem of small field dosimetric 
verification.  
2.1. Stereotactic Body Radiotherapy (SBRT) /SABR 
2.1.1. Overview 
Stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy (SABR) is 
defined by the American Society of Therapeutic Radiology and Oncology (ASTRO) as 
an external beam radiation therapy method for delivering very precise high dose radiation 
per fraction to an extracranial tumour target, using one to five fractions [5]. Since the 
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SBRT target has a small margin, the prescribed dose is specified at an approximately 80% 
isodose lower than a conventional technique, while the heterogeneous dose and hot spots 
within PTV have been accepted under clinical consideration [6]. In a fractionated 
regimen, SBRT/SABR offers better outcomes in terms of a biologically effective dose 
(BED) relative to conventional external beam radiotherapy [1], and whereas a 
conventional technique delivers doses of 1.8 to 2.0 Gy per fraction and total doses of 60-
70 Gy, SBRT applies a lower dosage using a hypo-fractionated scheme of five or less 
fractions between 10 to 20 Gy per fraction. Moreover, the small number of radiation 
fractions make SBRT more comfortable and convenient for the cancer patient.  
The general concept of SBRT was developed from single fraction intracranial 
radiosurgery. In 1951, Lars Leksell [7] introduced the term radiosurgery where he 
delivered a single high dose fraction to a small intracranial lesion using a rigid metal 
frame for localised targets. The extracranial stereotactic frame and three-dimensional 
coordinate system for spinal lesion was developed by Hamilton et al. in 1995 [8]. This 
technique works on the principle of a rigid immobilisation of the brain by screwing a 
frame to the spinous processes, and although it is accurate within 2 mm, it is also time 
consuming and inconvenient. At the same time, Lax et al. constructed a stereotactic body 
frame with a vacuum bag that immobilises the body from caudal to tarsal with non-
invasive patient fixations [9]. The author found that patients could be placed in the same 
position within 5-8 mm.  Since body lesions are more complicated and difficult to 
irradiate than brain lesions due to organ movement, extracranial lesions can be displaced 
during and between fractions of irradiation by internal organ motions such as breathing, 
gastrointestinal peristalsis, and cardiac contraction. This means that the relative position 
of a tumour and the external marker is not reliable enough to ensure accurate radiation, 
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which is why improved image-guidance and software are crucial to allow for accurate 
delivery of SBRT.  
Treatment machines have recently been improved with a collimator that provides more 
accurate dose conformation for stereotactic plans and very efficient image-guidance for 
more accurate localisation. This technology has led to increased confidence in 
implementing SBRT in multi-centres around the world. In fact SBRT is now an effective 
treatment for curative and palliative indications [2][10], with the  three most frequent sites 
for treatment being spine, lung, and liver.  
2.1.1.1. SBRT for spinal tumours 
Spinal SBRT is a more challenging technique than traditional external beam radiation 
because it delivers a higher dose of radiation to spinal tumours without exceeding the 
cord tolerance. The spinal cord is a critical organ for spine irradiation because a high dose 
of radiation to the spinal cord can induce myelitis [6]. The spinal cord dose is limited to 
10 Gy in 10% of the spinal cord, defined as 6 mm maximum above and below a planned 
target volume according to radiation therapy protocol oncology group number 0631 
(RTOG0631) [7]. A typical regimen of conventional external beam therapy for spine 
metastasis is 30 Gy in 10 fractions whereas radiosurgery irradiates with a target dose of 
8 to 25 Gy in one to five fractions [8]. The selected dose per fraction depends on factors 
such as the dimension and location of lesions, a patient’s histological status, previous 
treatment, and which device is available. Tumour(s) on the spine are either extradural 
(vertebra bodies or in paraspinous regions) or intradural (extramedullary or 
intramedullary) [2], most of which are spinal metastases (up to 40%) that commonly 
occur at vertebral bodies in about 35% of cases [9][10]. Radiosurgery for spinal 
metastases is focused on the reduction of pain, improving sensory and motor function, 
and controlling the growth rate of local tumours [10].  
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2.1.1.2. SBRT for lung tumours 
Lung SBRT/SABR is treatment offered to patients who are high-risk for surgery due to 
the location or size of the tumour(s) and their health. Lung SBRT is commonly used for 
early stage non-small cell lung cancer (NSCLC), oligometastasis, and the early stage of 
small cell lung cancer [13][14]. The single biggest problem with treating lungs is 
respiratory motion where tumours can move from 3-5 cm [15]; respiratory motion 
therefore limits the treatment outcomes due to the intra-fraction motion due to errors 
generated acquiring the images, planning the treatment, and delivering the radiation. The 
effects of respiratory motion can be minimised using a vacuum bag to immobilise and 
limit abdominal compression and movement, by respiratory gating to treat each specific 
respiratory phase or track the tumour in real time with MLC tracking as the tumour moves 
[16][17]. 4D CT scanning is proving to be a major technique for accurately delineating a 
tumour using physiologic movement for a specific phase of the respiratory cycle [18]. 
Treatment with lung SBRT is normally carried out with a non-opposing beam, with non-
coplanar multiple beams (7-11 beams) or a combination of arc delivery and online image-
guided radiation therapy (IGRT) to accurately locate the position of a tumour. The dose 
delivery limit to a lung with a volume of 10% (V10) is less than 20 Gy of the total dose of 
60 Gy (20 Gy/Fx) following the RTOG protocol number 0236, 0813 and 0631 [19] [20].  
2.1.1.3. SBRT for liver tumours 
The common SBRTs used for livers are primary hepatocellular carcinoma (HCC) and 
liver metastases [1]. SBRT is primarily used to maintain the systemic cytoreduction 
response of a liver as well providing systemic therapy to reduce the tumor without 
resorting to surgery. The margin of gross tumor volume (GTV) plus up to 5 mm for radial 
and 10 mm for the superior-inferior can be treated as the planning target volume (PTV), 
where the normal dose delivery is 14-26 Gy for one fraction or 30-36 Gy in three fractions 
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[21][22]. The VMAT or non-coplanar multiple static beams delivered using photon 
energies of up to 15 MV depends on the size of the patient’s body. The dose used to treat 
liver cancer that a patient can tolerate is based on the dose a normal liver can receive, so 
the accumulated dose must less than 15 Gy (an overall treatment dose) for a liver with a 
volume 700 mL. To reduce respiratory motion and target the liver precisely, SBRT 
delivery must utilise custom body immobilisation with radiopaque markers or combine 
with 3-5 gold fiducials implanted around or within the tumour tissue. Moreover, 
respiratory motion can be minimised by abdominal compression, breath holding 
techniques, and respiratory gating.   
2.1.2. SBRT equipment 
There are at present many commercial delivery treatments which can deliver a steep dose 
gradient to a tumour lesion while sparing the critical organ; they include a compact 
imaging system that provides extreme accuracy and precision for localised targets. These 
treatment delivery methods are classified into three groups (2.1.2.1, 2.1.2.2, and 2.1.2.3, 
below), according to the capability of the image and delivery application system [23].  
2.1.2.1. Irradiation with micro-stationary fields by cylindrical collimator 
Stereotactic radiation is delivered with a micro cylindrical collimator and a robotic system 
(CyberKnife®, Accuray, Inc., CA, USA) (Figure 2.1). A 6 MV linear accelerator is 
mounted on a robotic arm that can rotate with six degrees of freedom, and the delivery 
system and verification of the set-up position for the patient operates through two 
orthogonal kV images and two 3D camera arrays [24]. The circular fields can emit non-
coplanar and non-isocentric beams at large angles around the patient, this enables high 
doses to be delivered directly onto a target while avoiding normal tissue; the average 
delivery per plan is 100-300 beams [25]. To treat a target at an accurate sub-millimetre 
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level, a specialised tracking systems such as XsightTM spinal tracking, SynchronyTM, and 
XsightTM Lung are used [26].  
 
Figure 2.1: CyberKnife Treatment components [27]. 
2.1.2.2. Irradiation with stationary fields shaped by a multileaf collimator (MLC) with 
gantry-based systems  
The most common equipment used to deliver radiation for stereotactic tumours are linear 
accelerators (LINAC) with intensity-modulated radiation. This machine normally uses a 
2.5 mm to 5 mm leaf-width MLC attached to a conventional LINAC such as ClinacIX 
(Varian Medical System, CA, USA) and Elekta (Stockholm, Sweden). While a LINAC 
such as the Novalis system (BrainLAB, Inc., Munich, Germany) can be dedicated with a 
built-in micromultileaf (Figure 2.2), all treatment machines are equipped with image-
guidance to verify pre-treatment targets, where the image information can originate from 
an orthogonal x-ray or a cone beam CT. These treatment machines deliver a series of 
small segment radiation or sub-beams by modulated intensity photon fluence by changing 
the shape and speed of the MLC to produce a steep dose reduction at the targets. This 
delivery technique is known as Intensity Modulated radiotherapy (IMRT), and with 
SBRT, a patient is usually treated with four to twelve IMRT beams [28][13][29].  
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(a) (b) 
Figure 2.2:  Gantry-based systems (a)  Novalis machine [30]  and (b)  Built in micro 
multileaf [31]. 
2.1.2.3. Irradiation with a circular approach from a moving source or table (Arc 
treatment) 
Arc treatment is a delivery radiation system where a circular method is used to rotate the 
source (linear accelerators base) or move the table (TomoTherapy Hi-Art System). 
Volumetric Modulated Arc Therapy (VMAT) is a common technique that delivers a dose 
to patients with a rotating gantry of linear accelerators (LINAC) such as RapidArc® 
(Varian Medical Systems, CA, USA) that surrounds a patient’s body with a stable couch. 
The dose is modulated by changing the speed of the gantry, and the dose rate and multileaf 
(MLC) shapes, while the gantry is rotating [32][33]. The colours of the dose washes for 
the IMRT and VMAT plans for SBRT are shown in Figure 2.3.  
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Figure 2.3: Colours of dose washes for IMRT and VMAT plans for pulmonary SBRT 
using LINAC base [33]. 
Tomotherapy Hi-ART (TomoTherapy, Inc., Madison, WI) is a CT-based delivery 
technology that can provide information from megavoltage computed tomography 
(MVCT) images. This imaging system enables high set up accuracy and will determine 
and correct patient position before delivering radiation; it can also modulate the intensity 
of the dose distribution via a binary multileaf (MLC) mounted on a slip-ring gantry 
(Figure 2.4). A helical fan beam emits radiation at 3600 around a patient with a source to 
axis distance (SAD) of 85 cm, while the table moves into the gantry in a superior-inferior 
position and the selected pitch depends on the size of the target [34][35]. The precise table 
index and movement have a significant effect on the accuracy of the dose delivered. 
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Figure 2.4: A schematic configuration for 
Tomotherapy systems [36]. 
2.2. Critique of QA 
SBRT delivers a very high dose per fraction and provides a steep dose gradient in a small 
field which usually places the margin of the boundary tumours in close proximity to the 
organ at risk (OAR). Therefore, this technique requires effective quality assurance in the 
overall process, from patient immobilisation, target delineation, the treatment planning 
system (TPS), and throughout delivery. The American Association of Physicists in 
Medicine (AAPM) has given practical guidelines (task group 101: TG101) for SBRT 
quality assurance procedures for medical physicists, oncologists, and therapists [6]. There 
are two primary dosimetric verifications in the entire quality control of small field 
delivery treatment; the first part is the accuracy of beam data measurement used for 
calculating and optimising the dose distribution such as the percentage depth dose (PDD), 
the tissue maximum ratio (TMR), output factors, and the off-axis ratio (OAR); the second 
is a patient-specific quality assurance phase that verifies the accuracy of dose distribution 
from the planning system to the dose delivered to patients.  
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2.2.1. Small field: Overview and definition of field size  
The charge particle equilibrium (CPE) is where the number and energies of photons or 
particles entering a volume of interest are the same as those leaving the volume. A CPE 
is a significant situation condition used in conventional dosimetry, according to Technical 
report series No.938 and ICRU 1980 [37]. The most critical issue of small field dosimetry 
is a lack of CPE where the dimensions of the collimator field are less than the lateral 
range of secondary electrons and the source of partial radiation is obscured by the 
collimator. Variations in the range of secondary electrons depends on the photon energy 
and spectrum because the electron range increases as the photon energy increases; the 
approximate range of secondary electrons for a 6 MV photon beam is normally 16 mm 
[38]. Moreover, the density and composition of the medium have a significant impact on 
the penumbra and effective beam size, and the range of electrons in a low density medium 
such as air is longer than the range of electrons in water [39]. This phenomenon can be 
defined as a small field where the dimensions of the beam are smaller than the range of 
secondary or charge particles at the central axis of radiation beam [40]. According to these 
theoretical and clinical data measurements, fields that are smaller than 4×4 cm2 are small 
field sizes whereas conventional fields are defined with sizes ranging from 4×4 cm2 to 
40×40 cm2 [38]. Figure 2.5 shows the effect of overlapping penumbra on the full width 
of half maximum (FWHM) achieve form small field collimator setting [38].  
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Figure 2.5: The effect of penumbra overlapping on the full width of half 
maximum (FWHM) achieve from small field collimator setting [38]. 
2.2.2. Detector size, spatial resolution, and density  
The use of small fields in stereotactic radiosurgery combined with intensity-modulated 
delivery creates a challenging scenario for accurate dosimetry because the two most 
significant concerns for small field dosimetry are the averaging effects of detector volume 
and the spatial resolution of detectors [41] [42]. Laub W.U. et al. found a significant 
difference in the absolute dose measurements when using the different size detectors for 
IMRT fields; they were up to 6% between a 0.6 cm3 Farmer chamber and a 0.015 cm3 
pinpoint chamber. The same results appeared in other reports, where a drop in the output 
factors for small field occurred in a central beam due to a partial source combined with 
electronic disequilibrium and decreasing scatter. These effects caused the under response 
signal of the detector to respond and a blurred penumbra due to a too large detector 
(Figure 2.6) [42][4][43]. Inaccurate output factors and broadened penumbra 
measurements are basic parameters for a treatment planning system, so inaccurate 
monitor unit calculations and planning optimisation resulted in an incorrect dose being 
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delivered to a patient [43][44]. To avoid the effects of volume a detector should be small 
enough to measure the uniform dose region of a small field, therefore its maximum size 
should not be greater than half the full width of half the maximum (FWHM) of the beam 
profile, and furthermore, the spatial resolution of the device should be the same size as 
the calculation grid used in the treatment planning system (less than or equal to 2 mm) 
for end-to-end testing [6].  
The density perturbation effect stems from detector measurements in small field 
dosimetry; it can be explained using Fano’s theorem that states the effect of particles 
emitted per unit mass [46] is the difference in mass density compared to the influence of 
water and the uniformity of the fluence of charged particles in the medium. A low-density 
detector such as an ionisation chamber can produce fewer electrons than water, so 
electrons with a longer range can exit the cavity and lead to a lower dose in the detector. 
However, a detector of high Z material such as a diode emits higher number of secondary 
 
 
Figure 2.6:  The volume averaging effect (a) a schematic diagram of a detector inside 
a broad and narrow beam [ 38]  ( b)  a comparison of output factors and dose profiles 
measured by various detectors [45]. 
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electrons in the detector than water material measurement due to a shorter electron range 
where most electrons are absorbed in the medium and fewer in the exit cavity.  
2.2.3. Ideal detector for small field dosimetry 
Since small field dosimetry is complicated it is difficult to find a perfect detector. An 
ideal detector for small field dosimetry should have the following attributes:  
(i).      A stability response within 0.1 % for short-term measurements of large 
doses and multiple beam irradiation, as well as long term stability that does 
not require frequent recalibration.  
(ii).      It should have a linear response to a clinical dose range of 1-1000 cGy.   
(iii). A stable response independent of dose-rate measurements because 
treatment machines such as LINAC can change the dose rate (MU/min) during 
VMAT delivery.  
(iv). Since the dose per pulse varies depending on the distance measured and 
the medium, the detector should be stable when measuring in a typical dose 
per pulse range of 0.2-0.4 mGy per pulse.  
(v).     An ideal detector should respond to a wide photon energy range and not be 
affected by attenuation of low energy photons and low electrons.  
(vi).    Volume averaging by a large detector can cause penumbra boarding, so 
small spatial resolutions are needed in small dosimetry where a high dose 
gradient is presented.   
(vii). A high temporal resolution to accurately verify the time-resolved 
dosimetry for 4D IMRT and VMAT delivery in combination with respiratory 
gating or a tumour tracking system. A high temporal resolution detector can 
reduce the burling effect of an integrated gantry and moving MLC.   
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(viii). It should be water equivalent to avoid any extreme electron perturbation 
from its composition and density due to the ratio of the mass energy absorption 
coefficient and the stopping power of water and the detector medium.  
(ix). It should respond isotropic ally to the direction of the radiation beams 
while the gantries rotate around the detector.   
There is no ideal detector that IPEM could recommend other than the detector used to 
measure in small dosimetry [47].  
2.3. The quality assurance currently available and its 
limitations  
In recent years many commercial QA tools have been used in radiotherapy. The following 
examples are devices currently available for measuring relative dose parameters such as 
beam profiles, PDD, output factors including patient pre-treatment and in-vivo 
verification. This section will give a general description of detectors including their 
specific configurations, functions, and limitations. The detectors will be classified into 
four categories based on their basic dose measurements.  
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Table 2.1: A summary of dosimeters used for megavoltage photon beam dosimetry 
Dosimeter Applications Advantages Limitation 
Ionisation chamber Absolute and relative 
dosimetry 
measurement, 
QA testing, 
commissioning 
measurement 
(1D, 2D and semi-3D) 
 
High level of accuracy 
and reproducibility, 
dose rate and energy 
independence 
Volume averaging 
effect  
Silicon diode Relative and in-vivo 
dosimetry 
measurement 
(1D, 2D and semi-3D) 
High sensitivity and 
good spatial resolution 
Sensitive to low dose 
(High Z), directional 
dependence and 
response sensitivity 
depend on accumulated 
dose 
 
Diamond detector Relative dosimetry 
(1D) 
High sensitivity and 
spatial resolution, 
tissue equivalent, less 
dependence on dose 
per pulse and dose rate 
 
Cost expensive, high Z 
of electrode increases 
electron scattering 
Scintillating fibre Relative dosimetry 
measurement, 
intracavitary therapy 
(1D) 
High sensitivity and 
spatial resolution, 
tissue equivalent, wide 
dose range 
measurement, flexible 
 
Cherenkov effect (high 
noise within system) 
Radiochromic films Relative dosimetry 
measurement (2D) 
High sensitivity and 
spatial resolution, 
tissue equivalent, 
energy and dose rate 
independent and 
directional independent 
 
Not real-time read-out, 
scanner system and 
film batch dependent 
Gel dosimeter  Relative dosimetry 
measurements (1D, 2D 
and 3D) 
High sensitivity and 
spatial resolution, near 
tissue equivalent, 
actual 3D dosimetry 
Not real-time read-out 
and sensitive to the 
preparation (chemical 
proportion) and read-
out procedure (image 
artefact) 
 
Flat panel electronic 
portal imaging device 
(EPID) 
Relative dosimetry 
measurements (2D and 
semi-3D) 
High sensitivity and 
spatial resolution, dose 
rate independent, no 
extra phantom 
requirement 
High Z, signal is 
nonlinear to dose 
measurement, suffer 
from radiation 
backscatter (supporting 
arm), ghosting and 
image lag effect 
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2.3.1. Point dose  
2.3.1.1. Ionisation chamber  
Ionisation chambers (IC) are commonly used in EBRT due to their directional 
independence (cylindrical shape), dose linearity, dose rate and energy independence (kV 
energy range), and sensitivity to stability [48][49]. An IC can measure an absolute or 
relative dose, and it can verify output factors and point dose in the central axis of beams. 
The major components of an IC are its air or liquid filled cavity and the chamber electrode 
(anode and cathode). An IC measures the current in proportion to the electron-ion pair 
generating from the interacting ionisation proceeding from the medium in the cavity. A 
voltage must be supplied to the detector electrode to make the pairs of electron ions move 
across the detector which created a current through the IC. The appropriate voltage 
depends on the size of the chamber; this means a large chamber must supply up to 400 
Volts. The numbers of electrons depend on the energy deposited within the volume (EX: 
1 MeV produce 30000 ion pairs), the distance between electrodes, and the voltage supply 
and the density of the detector (either gas or liquid). ICs come in various sizes as defined 
by the average sensitive volume; a standard IC volume of 0.6 cm3 is generally used as a 
reference chamber and an IC volume of 0.13- 0.14 cm3 is generally used for beam 
scanning [50][37]. However, the volume averaging effect of a large IC can underestimate 
the dose in the central and broadening penumbra in the steep dose region of a small field 
[51][42]. To minimise this effect, the PTW31016 PinPoint (0.016 cm3), 
Wellhofer/Scanditronix compact ionisation chamber, model CC01 (0.01 cm3) and CC04 
(0.04 cm3), were introduced into radiosurgery and small field (Figure 2.7) [52][53]. The 
preferred chamber size should be compromise between its sensitivity and its signal to 
noise ratio response. Since CC01 and PinPoint have a small volume the anode is made 
from a high-Z material to maintain appropriate signal to noise ratio so the response of 
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both detectors depends mainly on the low energy photons [54]. Apart from which the 
polarity, cable, and stem effects of small ICs is of more concern that an IC with a large 
volume, particularly when they must perform in the regions of homogeneity or where the 
dose across the detector is less than 5- 10% [48].   
  
(a) (b) 
Figure 2.7:  The ionisation chamber used in small field dosimetry:  ( a) Pinpoint 
(PTW31013)[55] and (b) CC01 and CC04 (Wellhofer)[56].   
2.3.1.2. Single-Point silicon diode 
The p-n junctions are commonly used in a semiconductor detector because the built in 
electrical field is greater than 103 V/cm and it can be operated in a passive mode (without 
external bias supply) [57]. There are two types of diodes based on bulk silicon wafers, n-
types and p-types. A p-n junction is obtained by doping the opposite impure material onto 
a silicon substrate, so a p-type is doped with boron and an n-type is doped with 
phosphorus. The basic operating principals of a silicon diode are similar to those within 
an ionisation chamber, where the electrometer detects the diode current emanating from 
electron-hole pair diffusion. Radiation energy that exceeds 3.6 eV produces an electron-
hole pair within the silicon, while the excess minority carriers within the diffused lengths 
of p-side (electrons) and n-side (holes) diffuse to the opposite side of the depleted region 
(p-n junction) and are collected by the anode and cathode (Figure 2.8) [58]. A silicon 
diode has a higher response per volume than other detectors, for instance, with the same 
volume the sensitivity of a diode is approximately 18000 times greater than the ionisation 
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chambers [59]. These characteristics of diodes enables detector to be manufactured in 
sizes less than 3 mm, such as SFD stereotactic, and PFD photon (IBA Dosimetry), both 
of which have a diameter with an active area of 0.6 mm and 2 mm, respectively [56]. The 
diode used in small field dosimetry is shown in Figure 2.8. While diodes are generally 
used in relative dosimetry such as scanning beam profiles, depth doses, and measuring 
MLC penumbra, they can perform within phantom or in-vivo dosimetry such as MOSkin, 
which is one type of Metal Oxide semiconductor field-effect transistors (MOSFET). 
MOSkin was designed by CMRP and using drop in technology for MOSFET chip 
packaging in a tissue equivalent kapton tail making MOSkin suitable for small field 
dosimetry, especially measuring surface doses in real time at water equivalent depth 
(WED) 0.07mm [60]. However, silicon diodes should not be used for measurements of 
absolute dose because while their response is almost MeV photon energy range 
independent , their sensitivity increases if low energy photons are present due to their 
high atomic number; these diodes still induce a perturbation effect and provide directional 
dependence due to their high-Z material and asymmetrical orientation of the sensitive 
volume [61]. The sensitivity of a diode also depends on the accumulated dose, and the 
temperature and dose rate [62][63][64][65].   
  
(a) (b) 
Figure 2.8:  A schematic of p- n junction of silicon diode and the commercial p- type 
silicon diode detectors for use in small field dosimetry (IBA Dosimetry) [56][58].  
Chapter 2: Literature Review 
 
22 
2.3.1.3. Diamond Detector 
A diamond detector is an outstanding QA detector for small field dosimetry because its 
atomic number is almost tissue equivalent to Z = 6 (Zeff of tissue approximately 7.42) 
[66][67], and it has a small sensitive volume ranging from 0.004 to 6 mm3 that provides 
an excellent high spatial resolution suitable for measuring in the penumbra region of small 
fields. Traditionally, a diamond detector uses a naturally grown diamond plate or dice 
with a specific contact system embeds in a cylindrical PMMA capsule which made a 
detector difficult to reproduce in the same sensitive volume. Recently, the synthetic 
diamond detector has been developed based on chemical vapour deposition (CVD) by 
embedding the CVD intrinsic layer on a highly conductive boron-dropped CVD diamond 
film and grown on high-pressure high temperature single crystal substrate (HPHT) [68], 
[69].  A diamond detector can also act like an ionisation  chamber (TM60003 diamond) 
or as a solid state diode (T60019 microDiamond) (Figure 2.9) [55][70] because its basic 
operating principles are similar to an ionisation  chamber and a diode detector. Similar to 
silicon diode ionizing radiation interact with the diamond to create electron-hole pairs 
which migrate towards the anode and cathode respectively and generate a signal current 
that is measured by the electrometer. A microDiamond detector is a synthetic single 
crystal which operating in the photovoltaic regime that can be operated at zero voltage so 
no external voltage is required. These detectors are almost independent on energy of 
photon beams because they provide a constant of the mass stopping power detector to 
water ratio [71]. Diamond detectors will also indicate radiation hardness and long term 
stability, as well as directional and temperature independence; they also less dependent 
on varying the dose per pulse and the dose rate (MU/min) [72][73]. A micro-Diamond 
can also measure an insignificant signal variation of absolute dose to water when 
measuring a large field size of 40×40 cm2 or a small field size of 0.5×0.5 cm2 [74]. These 
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advantages mean that a diamond detector can be used in PDD, output factors, and 
measuring beam profiles for conventional and small field sizes (SRS and SBRT fields) in 
all photon energy ranges, including electron energy [75]–[77].  However, diamond 
detectors are is more expensive than diode and ionisation chamber detectors. The 
composition and density of detector material such as the high-Z of an electrode or silver 
conductive glue increases electron scattering so the dose absorbed by the detector’s 
sensitive volume also increases [66].  
 
 
(a) (b) 
Figure 2.9:  A single crystal diamond detector (SCDD) and its configuration (PTW-
Freiburg) [78]. 
2.3.1.4. Single Scintillating fibre  
Scintillation detectors have been developed and used in radiotherapy for past 15 years. 
Common scintillation dosimeters using in radiotherapy are organic scintillators; they have 
a low atomic number and are almost tissue-equivalent to plastic scintillators [79][80]. 
When irradiated photons or particles interact with the scintillating medium they stimulate 
atoms into excited states and fall back to a ground state emitting photons into visible light. 
The transfer of light through fibre optic is collected and converted into an electronic signal 
by a photodetector [81]. Scintillators can read signals in real-time and have a linear 
response to a broad dose range of photon and electron energy. The fibres in a scintillator 
are flexible and small enough to enable it to measure a dose in intra-cavitary 
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brachytherapy and intra-operative therapy. Scintillators have a high spatial resolution 
(approximately 1 mm diameter), there is less degradation of the radiation dose and dose 
rate, and they are energy and temperature independent [79], [80]. However, Cherenkov 
in the fibre guide is the significant effect of inducing noise within the system [82], and 
scintillators that combine with a silicon photomultiplier (SiPM) tend to show a higher 
noise [83]. 
2.3.2. 1D array dosimetry 
A point dose detector cannot distribute the entire planned dose or the beam profile in a 
single irradiation, which is why a 1D array is usually based on an ionisation chamber or 
diodes which fabricate the detector in a linear direction such as CA 24 scanditronix 
Welhofer and an LDA-99 that provide a resolution of 2 cm and 0.5 cm, respectively. 1D 
arrays are generally used for data commissioning and measuring a dynamic wedge 
[84][85]. In 2010, Wong et al. introduced an innovative 1D diode array called a Dose 
Magnifying Glass (DMG), which implanted 128 phosphor n+ on a p-type silicon wafer 
with a high spatial resolution of 0.2 mm; this detector array was designed by CMRP for 
use as a QA verification tool in SRT delivery [86].  
2.3.3. 2D dosimetry 
Point dose verification is no longer adequate for stereotactic RT once the beam shape has 
been modulated, particularly for delivering a high conformal dose. 2D dosimetry was 
developed to evaluate the full dose distribution measurement for IMRT and VMAT plans 
dose delivery. There are several 2D detectors available, such as radiochromic film, IC, 
and silicon diode arrays with EPID. 
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2.3.3.1. Film dosimetry 
The film dosimetry process is based on changing its optical density (OD), which is 
proportional to the dose of irradiation that interacts with the film. The scanner measures 
the dose using the light transmitted through the darkening films. Silver halide (AgH) film 
or radiographic film was the first type of film dosimetry used to verify a relative dose in 
the megavoltage energy range. Radiographic films have successfully validated two-
dimensional IMRT dose distributions by providing a permanent two-dimensional dose 
distribution mapping with a high spatial resolution. However, they have many drawbacks 
due to their varying sensitivity within each batch of film batch, a film process that 
produces chemical, and artefacts caused by the densitometer (scanner) [87][88]. The 
emulsion of radiographic film is based on high Z material, response of which depends 
mainly on low photon energy (<1MeV) [48]. In 1980, radiochromic films were introduced 
and widely used for dosimetry in radiotherapy because film processing is not required 
and they are almost tissue equivalent. Gafchromic EBT3 film is the last generation of 
radiochromic film used in radiotherapy due to its high sensitivity for radiotherapy dose 
between 0.01 and 8 Gy [89]. EBT3 films has a uniformly thin active layer that is 
sandwiched between symmetrical thicknesses of matte polyester [90]. Gafchromic films 
has become a standard tool for verifying small field dosimetry because their high spatial 
resolution provides two-dimensional (2D) dose mapping with sub-millimetre accuracy, 
and they are energy and dose rate independent, as well as angular independent and tissue 
equivalent [91][92][93][94]. However, radiochromic films cannot be read out in real-time 
because they require at least 24 hours to stabilise [90], and they are dependent on film 
scanning orientation, scanner uniformity, and the temperature of scanner bed, and that 
makes film dosimetry depend on the read-out procedure adopted [95]. In addition, the 
accuracy also depend on the colour channels and scanner resolution [94], [96]. 
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Radiochromic films can be used for measuring relative dose distributions and the relative 
outputs in a small field such as the stereotactic field (4 to 30 mm2) provide on a Novalis 
Trilogy [96], [97]; they are not recommended for measuring an absolute dose and 
verifying monitor unit outputs [98].  
2.3.3.2. Array detectors  
Detector arrays are increasingly used in patient-specific verification for delivering IMRT 
and VMAT plans because they provide a two-dimensional dose distribution in real-time 
and are easy to setup. The two main commercial detector arrays are, 1) an ionisation 
chamber-based detector and 2) silicon diode based detector. Table 2.2 is a summary of 
the current commercial detector arrays.  
(i). Ionisation chamber (IC) array 
Amerio et al. introduced the initial design of pixel-segmented ionisation chambers array 
(PXC) for verifying 2D doses distributed in complex shaped field delivery [99][100]. This 
device contains independent cylindrical ionisation  chambers with sensitive volumes of 
0.07 cm3, i.e., 1024 IC that cover a 24×24 cm2 area at 0.75 cm spacing between them. 
This PXC has excellent long and short term stability, as well as integral dose 
independence and linear to dose measurements. Moreover, the output factor measured by 
this device agrees within 0.4 % compared to a Farmer IC; this detector array has evolved 
into an ImRT MatriXX (IBA Dosimetry, Bartlett, TN), which uses a combination with 
specific software. The ImRT MatriXX has fabricated 1020 parallel plate ionisation 
chambers with volumes of 0.08 cm3 and pitches of 0.76 cm that cover an active area of 
24×24 cm2 [101][102]. These detector arrays performed very well in terms of field size 
and independent SSD distance for 6 MV and 18 MV photon beams, they also had good 
long and short term reproducibility, and an independent dose rate between 0.02 to 20 
Gy/min and dose linearity [103]. Although the detector arrays had a gamma passing rate 
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of more than 95% for IMRT and VMAT plans with 3%/3mm criteria, their wide 
resolution showed a large discrepancy in the penumbra region (20%-80%) of a 2×2 cm2 
field that was greater than 1 mm, unlike the beam profiles measured with the CC03 
ionisation chamber [102][101][104]. Moreover, this device requires a pre-irradiation dose 
of up to 10 Gy and a 15 minute warm up before it can be used. Another commercial 2D 
detector array base on an ionisation chamber was designed and developed by PTW-
Freiburg; the seven29 PTW model T10024 has 729 air-vented ionisation chambers, each 
with a sensitive volume chamber 0.125 cm3 by 0.5 cm in diameter. These IC chambers 
cover an active area of 27×27 cm2 and have a 1cm spacing between them [105][106]. 
These devices are less dependent on energy and dose rate for a given range of 
radiotherapy energy, but they do have good long and short term reproducibility and 
uniform sensitivity across the arrays. The arrays also have a good agreement between the 
beam profiles and wedge-modulated field measurements, unlike results measured by an 
ionisation  chamber in water [106]. Although the seven29 PTW requires a pre-irradiation 
dose of only 100 MU, it needs more time to warm up before being used and it cools down 
quickly. Moreover, the large spacing of two adjacent chambers and its large diameter 
limits the potential of the seven29 PTW for stereotactic radiotherapy or in a gradient with 
a high steep dose. To mitigate its spatial resolution limitations PTW-Freiburg introduced 
a higher sampling density within an array called Octavius 1500 (OD1500). This new 
prototype has 1405 ionisation  chambers, each of which has a sensitive volume of 0.058 
cm3, arranged in a checkerboard pattern covering an area of 27×27 cm2 [107][108]. The 
OD1500 was designed for a higher range of dose rates with a flattening filter free (FFF) 
beam (up to 48 Gy/min) [108]. This detector arrays have a very stable signal without 
needing pre-irradiation and have excellent dose linearity within ±1% for doses ranging 
from 5 to 1000 MU. The increased spatial sampling frequency of this detector array 
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occurs when two measurements of couch shifting 5 mm merge to show a high agreement 
of dose distributions with a gamma passing rate up to 99.6% and 96.9% for 3%/3mm 
criteria, compare with dose predicted by radiation treatment planning system (RTP) and 
measured by film, respectively. Although the output factors of the OD1500 agreed with 
a field size above 4×4 cm2 within 1%, compared to a Semiflex chamber (CC13) and Si 
diode, the output factors measured for a small field showed more deviations from the 
reference detectors [107]. To meet the standard required of detectors for small field 
dosimetry in SRS and SBRT technique, PTW-Freiburg introduced the first liquid filled 
ionisation chamber array called Octavius 1000SRS (T0036). This detector array has the 
highest spatial resolution of 2.5 mm in the inner area of 5×5 cm2 and 5 mm in the outer 
area [109]. The 1000 SRS detector has 977 liquid filled ionisation chambers with a small 
sensitive volume of 0.003 cm3 and covers an area of 10×10 cm2. This detector has less 
energy dependence, good dose sensitivity linearity, good long and short term stability and 
reproducibility, and has excellent agreement when measuring the output factors in a small 
field down to 1×1 cm2. The gamma passing rate agreement between the detector 
measurement and TPS calculation for IMRT verification is approximately 95.2% for 
3%/3mm criteria, but the liquid filled ionisation chambers depend mainly on the dose rate 
and dose per pulse because of the high incidence of ion-pair recombination. The detector 
array signal dropped more than 3.5% when measuring a dose per pulse that was less than 
1.7×10-4 Gy/min, and the cross calibration procedure must consider the pressure and the 
temperature applied. 
(ii). Silicon diodes array 
The MapCHECK (Sun nuclear crop, Melbourne, FL) is the first commercial of 2D array 
base on arrays of silicon diodes. The first MapCHECK prototype was model 1175 with 
445 n-type diodes fabricating with a resolution of 7.07 mm in the central area of 10x10 
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cm2 and 14.14 mm close by [110]. The MapCHECK2 has improved by increasing the 
number of diode to 1527 and maintaining a resolution of 7.07 mm over an area of 32×26 
cm2 [111]. The n-type diode used to fabricate the detector array was designed to depend 
less on accumulated dose of radiation and small intrinsic build-up of 0.1 gm/cm2 for 
measuring surface doses [112]. MapCHECK2 is better at verifying IMRT than films, with  
excellent gamma passing rates for 6 MV and 18 MV photon beams and allows it to 
calibrate using absolute dose measurements [103][113]. However, detector arrays based 
on silicon diodes still have a high dose per pulse and directional dependence [114], and 
MapCHECK2’s wide resolution is not suitable for measuring the steep dose gradient of 
small fields 
Table 2.2: Specifications of a commercial 2D detector array [115][116][55]. 
 Detector 
type 
Detector size 
(mm) 
Detector 
volume 
(mm3) 
Resolution 
(mm) 
Number 
of 
detector 
Active 
Field 
size(cm2) 
MapCHECK2 
 
n-type diode 
(cubic) 
0.8×0.8×0.03 0.0192 7.07 1527 32×26 
     
ImRT Matrixx 
 
Pixel 
ionisation 
chamber 
(disc shaped) 
4.5 diameter × 
5height 
80 7.62 1020 24.4×24.4 
     
PTW seven29 
 
Plane-parallel 
ionisation 
chamber 
(cubic) 
5.0×5.0×5.0 125 10 729 27×27 
     
OCTAVIUS 
1500 
 
Plane-parallel 
Ionisation 
chamber 
 
4.4×4.4×3.0 58 7.1 1405 27×27 
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OCTAVIUS 
1000SRS 
 
Liquid-filled 
ionisation 
chamber 
(cubic) 
2.3×2.3×0.5 2.6 2.5 in central 
area of 
5.5×5.5 
cm2 
977 10×10 
  5 mm outer 
area 
  
2.3.3.3. Flat panel Electronic Portal Imaging Device (EPID)  
EPIDs were designed and developed to verify patient localisation in radiotherapy and 
then analyse and store the images in a DICOM file format. However, their use as a dose 
verification tool has expanded rapidly over the last decade so they now provide high 
spatial and temporal resolution (approximately 0.7 mm and readout 10 frames/sec), a real 
time 2D mapping image and accurate positioning perpendicular to beam irradiation while 
being mounted and rotating on the gantry arm [117][118]. EPIDs are now used for pre-
treatment verification and measuring directly onto the EPIDs without a phantom or 
patient, and in-vivo dosimetry using transit dosimetry and back projection. EPIDs can be 
based on fluoroscopy (video based), matrix liquid filled ionisation  chambers and 
amorphous silicon (a-Si) systems [119][120][121]. EPID dosimetry is where scintillation 
is used to convert radiation dose to a signal. The radiation generates electrons within the 
Cu plate which create a visible light in the phosphor screen which is then detected and 
integrated into charge captures by the photodiode array implanted onto an a-Si panel. The 
aSi-based systems such as aS500/ aS1000 (Varian system), iView GT (Elekta) and 
OptiVue (Siemens) have become popular and are commonly used to verify portal doses 
because a lower dose can be delivered per portal frame; moreover, their long term stability 
and reproduction over two years, independent dose rate, spatial resolution and image 
quality are much better than other EPIDs. However, the response relationship between 
EPID signal and dose is nonlinear scale the correction factor for effects of the acquisition 
process are need to be consider [122].  In addition, EPID signal to dose conversion must 
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to be calibrated for the various field sizes, beam energies, and distances from a central 
axis due to their high atomic number that increases the photoelectric effect that makes 
EPID signal beam energy and field size dependent [123]. Furthermore, the doses 
measured by EPIDs usually suffer from radiation backscatter due to its extra layers and 
supporting arm. The inadequate accumulation of material above the detector layer also 
indicates the lack of an electronic equivalent in the phosphor scintillator layer 
[124][117][125]. This means the charge trapped within the detector layer has a significant 
influence on the ghosting and image lag effect for EPIDs.  
2.3.4. 3D dosimetry 
The significant issue with measuring 2D dose distribution is interpreting the results 
because although 2D dose measurement can ensure that the dose delivered to a patient is 
the same as the dose from TPS calculation, the patient’s corrected isocentre and the MLC 
positioning error means that the data is only provided at that particular plane of 
measurement. Calculating the advanced algorithms of a treatment planning system create 
a complicated delivery plan which then provide a large amount of sub-field and irregular 
shapes. This then requires a method that can evaluate and verify a large number of dose 
points in three- dimensional (3D) treatment volume. A 3D dose distribution such as dose 
volume histograms (DVH) is needed for dose verification and clinical interpretation, so 
this section will classified 3D dosimetry into three categories; actual 3D dosimetry which 
will measure the dose in its entire volume; semi-3D dosimetry that will measure particular 
dose points within a specially designed phantom, and then use the dose calculation 
method to predict the dose for the entire volume; and virtual 3D dosimetry which will 
calculate the dose using fluence measurements. 
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2.3.3.1. Gel dosimetry 
In recent years measuring the gel dose is the only one of actual 3D dosimetry. Gel 
dosimetry was introduced in 1950 to verify clinical doses [126]. A gel dosimeter monitors 
and analyses the chemical changes in the interaction between radiation and the chemical 
chain using external quantitative readout such as Magnetic resonance imaging (MRI), 
computed tomography (CT) and spectrophotometric. The first generation of gel 
dosimeters was the Fricke solution based on bulk water, ferrous sulphate (Fe2+) and 
gelatin or agarose [126][127]. Although Fricke gels are easy and convenient to prepare 
and the results can be read soon after irradiation, the ion diffusion effect reduces the 
spatial dose information through the gel [128] [129]. Polymer gels dosimeter (PAG) such 
as bis acrylamide nitrogen and gelatin (BANG) is a tissue equivalent material developed 
to reduce diffusion via an infusion of monomers and cross linked servants in a gelatin 
matrix [130][131]. The free radicals of water radiolysis induce a chain polymerisation 
reaction as the monomers are cross linked in proportion to the absorbed dose. The 
polymer gels reveal that 3D dosimeters can provide permanent 3D dose distributions 
within millimetres, while the liquid form can be manufactured in an irregular shape such 
as an anatomical phantom; these gel dosimeters also deliver independent dose rates and 
energy in a clinically relevant range [130][132]. PAG is limited by oxygen which inhibits 
polymerisation [133]. The normoxic polymer gel dosimeter known as MAGIC gel is a 
new PAG which contains oxygen scavengers in the gel matrix to mitigate oxygen 
inhibition. In 2003, a new polymer gel dosimeter called PRESAGETM was introduced; it 
is a plastic radiochromic dosimeter that is not affected by oxygen. It consists of 
polyurethane, leuco-dye leucomalachite green (radiochromic components), hydroxyl 
reactive polyol, and alkyl diisocyanate prepolymer [134], [135]. The changing optical 
density inside the PRESAGETM dosimeter is suitable for readouts with an optical based 
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scanner such as He-Ne laser-based and an optical-CT scanner [136]. Unfortunately gel 
dosimetry is sensitive to the conditional preparation of gel matrices such as the chemical 
compound rate (type and radical initiator concentration), the light and temperature, and 
the amount of time needed to prepare a procedure and then read the results [137], [138]. 
Moreover, the imaging artefacts from the readout system (MRI or CT) such as image 
distortion, and ring and streak artefacts are important factors in determining the accuracy 
of the dose measurements [127].  
2.3.3.2. Semi 3D dosimetry 
Semi-3D dosimetry is where multiple point doses are measured using built-in detector 
arrays in a cylindrical phantom such as ArcCHECK (helical shape) and Delta4 (cross-
plane array). As well as dose measurements using 2D detector arrays (seven29, 1000SRS, 
OC1500) combined with rotating phantom such as OCTAVIUS 4D system (PTW), dose 
measurements are combined with the specific dose calculation algorithm to create a 3D 
dose volume. The following section is a commercial semi -3D dosimeter system.  
   
(a) (b) (c) 
Figure 2.10:  The general shape detector within the phantom for a commercial semi-
3D dosimetry system 
(i). ArcCHECK 
ArcCHECK (Sun Nuclear Corp, Melbourne, FL) is the first semi-3D cylindrical phantom; 
it has 1386 diode detectors in a helical pattern at 1 cm spacing on the surface around the 
PMMA phantom with the equivalent depth of 3.3 g/cm3 [139][140][141]. Each active 
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diode is 0.8×0.8 mm2 and the active area is 21 cm in diameter 21 cm long. This device 
was designed to deliver dynamic volumetric treatment; it is a time-resolved measurement 
that acquires real-time data for each gantry at 50 ms updates using a virtual inclinometer 
algorithm. The semi-3D dose calculation of AcrCHECK is used in combination with 
3DVH (Sun Nuclear) software where the 3D dose reconstruction is calculated by scaling 
the radiation ray traced through the phantom using a particular point dose measurement 
at the entrance and exit detector which is then renormalised using dose distribution 
calculated from TPS. The ArcCHECK has field size dependence and an ionisation 
chamber that compares the over-response when the field size is less than 10×10 cm2 and 
under-response when the field size is larger due to its spiral configuration and the 
thickness of the build-up above the detectors [141][142]. This means a field size 
correction factor must be applied while interpreting the 3D dose distribution. 
Furthermore, calculating the dose of the ArcCHECK system also requires angular 
correction and background correction [143]. Although the ArcCHECK detector is 
arranged in a  spiral pattern to improve its special resolution, a beam eye view (BEV) 
spacing of 1.12 cm at SAD 89.6 cm is too coarse to analyse a small field size and small 
MLC offset [141]. Moreover, since the detectors are arranged into a spiral shape there is 
no detector in the isocentric of the phantom result so the device can only measure the dose 
near the surface and cannot detect the scattered dose.  
(ii). Delta4® 
The Delta4® (ScandiDose AB, Uppsala, Sweden) is a 3D phantom manufactured from 
two orthogonal p-type diode arrays arranged in an asymmetrical “X” shape (+50° and -
40°) within a PMMA cylindrical phantom with a diameter of 22 cm. Each active detector 
is 0.1 cm in diameter, and the 1069 diodes are fabricated at 0.5 cm and 10 cm spacing in 
the centre of 6×6 cm2 and the remaining area of 20×20 cm2, respectively [144][145]. This 
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device can measure a continuous sampling of dose per pulse at approximately 3 ms pulse 
separation and 3 ms pulse width; the data is then stored to synchronise with the linac 
pulses using the inclinometer attached to the treatment gantry. Since there is no 
measurement between pulses there is a high signal to noise ratio so the device can be 
utilised for 4D treatment delivery and segment-by-segment analysis. The Delta4® 
operated combination with Delta4DVH (ScandiDos) software calculates the dose 
measurement at particular points into a semi-3D dose distribution. The 3D dose has 
calculated the dose along the radiation ray path using the dose detected by two diode 
detector arrays. The Delta4 has good short term reproducibility and stability, dose 
linearity, dose rate and dose per pulse independence [144][146], but it does show a 
different angular response to gantry angles of 0° up to ±5% at a parallel detector plane 
angle [146]. To reduce measurement uncertainty due to fluctuating beam outputs and 
density values, the Delta4 the field measurements must be calibrated daily before using it 
for pre-treatment verification [147].  
(iii). OCTAVIUS and 2D array 
The OCTAVIUS 4D® system (PTW, Freiburg, Germany) is a rotating cylindrical 
phantom 32 cm in diameter by 34.3 cm long and is combined with 2D arrays such as 
seven29, 1000SRS and OC1500 [108]. It was designed to deliver a modulated arc by 
eliminating the influence of angular dependence on the accuracy of QA; this phantom can 
rotate with a full angular range of ±360° [148]. The 2D array is always measuring 
perpendicular to each incident beam angle, the rotation of the phantom is synchronised 
with the linac using the inclinometer attached to the treatment gantry. The OCTAVIUS 
4D® is a stand-alone verification system which does not require information from the TPS 
dose distribution for calculations. The 3D dose distribution was reconstructed using the 
summary of doses along the ray trace in each plane and the dose measured at a particular 
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angle and the PDD curves installed in the PTW Verisoft software [149][148]. Since the 
calculation is based on PDD data implementation, the accuracy of the measurement is 
sensitive to the source of the phantom distance.   
 Semi-3D dosimetry does not directly measure a 3D dose distribution of treatment 
delivery and is therefore not allowed to be used as an in-vivo dosimeter. The accuracy of 
3D dose reconstruction relies on the detector’s characteristics and depends on the 
accuracy of the calculation algorithm which calculates the full 3D dose from the limited 
point dose measured within the phantom. The system must be validated before being used 
for the recommended pre-treatment verification. Moreover, the accuracy of the dose 
calculation is associated with the efficiency of the inclinometer because it is also used to 
store data and phantom movements; therefore this inclinometer must be validated before 
being used. 
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Table 2.3: Summary of commercial semi-3D dosimeter specifications [139][144][148]. 
 Detector 
arranging 
Detector 
spacing 
 
Detector 
Volume 
(mm3) 
Detector 
size 
(mm2) 
Number 
of 
detector 
Software 
ArcCHECK 
 
 
Spiral shape 10 mm 0.19 0.64 1386 3DVH 
Delta4 
 
 
 
Bi-planar  5 mm in inner 
(10×10 cm2) 
10 mm in 
peripheral 
0.39 0.78 1069 Delta4DVH 
OCTAVIUS 
4D system 
 
2D plane 
Depend on 2D array combination 
(the summary is shown in Table 2.1) 
VeriSoft 
 
2.3.3.3. Virtual 3D dosimetry 
Virtual 3D dosimetry does not measure dose delivery within the phantom volume or in a 
patient; it uses beam fluence to measure before or after radiation beam entry to calculate 
the 3D dose distribution, as shown in Figure 2.11. Dosimeters are generally attached to 
the machine so they can rotate with the treatment gantry. This kind of dosimeter can 
operate as either before or during treatment delivery.  
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(a) (b) 
Figure 2.11: A detector used for patient verification during treatment; (a) downstream 
of the patient, and (b) upstream of the patient. 
 (i). A portal dose EPID 
Portal dosimetry using EPID is a type of virtual 3D dosimetry that uses the transit dose 
measurement. EPID generally uses the portal image to do a QA by comparing it with the 
image predicted from the TPS but this type of verification cannot interpret the actual 
difference in dose between treatment delivery and TPS dose calculation. EPID measures 
the dose transmitted through a patient and calculates the dose inside the volume using a 
back projection algorithm and the iterative method [150][151]. Commercial software 
EPIdoseTM is designed for use in combination with conventional EPID; so the EPIDose 
algorithm converts the EPID image into a dose by projecting the image to the simulated 
dose plane or extended phantom (CT image), multiplies the output factor correction, and 
then convolves the corrected EPID dose response with a redistribution kernel. A field 
calibration map is then applied to the relative dose to reconstruct the 3D dose distribution 
inside the volume [152].   
Another virtual 3D dosimetry is where the entrance dose measurements use the 
2D arrays dosimeter mounting on the treatment gantry head such as the COMPASS® 
device, Dolphin detector, and the DAVID, and Delta4AT system. The photon fluence 
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measurements are used in conjunction with a unique algorithm to derive the 3D dose 
distribution within a patient’s volume.   
(ii). COMPASS® system 
The COMPASS® system (IBA Dosimetry, Germany) is an independent dose engine that 
uses a collapsed con convolution/superposition algorithm in conjunction with 2D detector 
arrays such as MatriXX, a novel pixel segment IC transmission detector (COMPASS 
device) and wireless IC (Dolphin®) [153][154][155]. COMPASS arrays fabricate 1600 
parallel ionisation  chambers spaced 0.65 cm apart and with a sensitive volume of 0.02 
cm3 [156]. Since this detector measures the fluence dose by being placed between the 
radiation beam and the patient, the transmitted dose and surface dose is of concern. Sankar 
et al. examined how the COMPASS device affected the dose surface and transmission 
using 6 MV photon beams and found a significant difference in the dose at the surface 
depth of 11.9%, with respect to the open beam measurement. However the dose 
transmitted from the device had no effect on the depth beyond dmax in terms of the beam 
profile and PDD curves, and showed a mean transmission factor of 0.967 for field sizes 
ranging from 3×3 cm2 to 20×20 cm2. Similar results were found in the pixel-segmented 
IC detector array Dolphin® transmission device (DTD). A DTD is a wireless device that 
fabricates a small active area detector of 0.24×0.24 cm2 and 1513 air-vented ICs. It gives 
a high resolution of 5 mm at the detector level (gantry head) and 8 mm at the beam 
isocentre (SAD100 cm). It had a maximum surface dose of almost 11% at a 30×30 cm2 
field and 80cm SSD. These results indicate that the influence of this device on the 
transmission dose depends on its field size and the distance between the detector and the 
surface. The surface dose decreased as the field size decreased and the SSD increased. 
Furthermore, the device had less effect on PDDs beyond the maximum depth where 
different doses were compared to an open beam of only 1% [157]. The DTD was a good 
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agreement when used to verify the transmission mode during treatment for 2D and 3D 
dose distribution compared to pre-treatment verification with MatriXX measurements 
and TPS dose calculations [158]. Because the COMPASS® system is independent and 
uses a complicated dose engine algorithm, it needs commissioning data such as beam 
profiles, PDD curves, output factors, and absolute doses to model the calculation 
algorithm [153].  
(iii). DAVID system 
The DAVID system (PTW) is an advanced real-time method of verifying modulated 
treatment during delivery. This device consists of transparent multi-wire ionisation  
chambers placed inside the accessory tray of the linac and aligned parallel to the MLC 
leaf pair [159]; the number of wire chambers depends on the number of MLC leaf pairs. 
The chambers are collected charge in a 2 mm thick volume of air and sandwiched by two 
4 mm thick PMMA covers. This device monitors the shelf dose area product (DAP) with 
an Integral Quality Monitor (IQM) [160][161]. Here, patient doses are monitored at each 
MLC opening along the wire and the measured signal at each moment is determined the 
length of the wire chamber not blocked by the leaf of MLC and integrated during 
treatment delivery [162]. The total signal comes from the secondary electron and the 
primary photon beam within the radiation field, with some secondary electron scattering 
from the nearby chamber and background scattering from the linac head components. The 
signal information is transferred to the control unit via a Bluetooth interface so it cannot 
lose the signal due to its connecting cable problems [159]. The products from the dose 
area is compared to the pre-recoded data. The presence of DAVID in the beam does not 
interfere with the relative dose measured in the phantom, which showed insignificant 
difference in the PDD curves with and without the device for 6 MV and 18 MV photon 
beams. However, since the instrument is 14mm thick, the surface dose is enhanced by a 
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factor of 1.13 and a transmission factor of 0.939 and 0.955 for the 6 MV and 10 MV 
beams, respectively. Therefore, the transmission factor of the DAVID system is 
considered to be a true factor that should be used to calculate the monitor unit (MU) for 
all segments during the documentation process [163].  
(iv). Delta4DT system 
ScandiDos has developed an ultra-thin transmission detector called Delta4 Discover 
(Delta4AT). It has 4040 p-type silicon diodes, each of which is 1 mm in diameter. The 
detectors are arranged parallel to the MLC leaf pair trajectories (X direction) at 2.5 mm 
spacing along the leaf and 5 mm spacing at the beam isocentre. The detector is fabricated 
on a 0.5 mm PCB that relies on a 1.1 mm globe top embedded between two 0.3 mm thick 
carbon fibres. This device has less attenuation and transmission factor closer to 1 and 
provide less surface dose enhancement. It has an attenuation factor of 1% and the surface 
dose only increases by 1 % for a 10×10 cm2 field. However, the scattering from the 
collimator increased the surface dose by almost 9% when field was larger than 30×30 
cm2. This device tracks MLC motion during treatment and also verifies the MU of each 
segment. The Delta4AT has a built-in inclinometer that can verify the gantry and collimator 
rotation, while the integrated laser can verify a patient’s position during beam delivery. 
This device can analyse the 3D dose distribution in a patient by generating a virtual patient 
dose using correlation of signal measured by transmission device with the Delta4 phantom 
dose measurement [164][165].  
2.4. Bulk Epitaxial Silicon diodes. 
SBRT and SRS are complex radiotherapy treatments that involve multiple small segment 
fields and angles irradiating around patients. These techniques require efficient 2D and 3 
D dose verification with high spatial and temporal resolution. Although the ionisation 
Chapter 2: Literature Review 
 
42 
chamber is used as a gold standard and practical radiation detector for external 
radiotherapy, volume averaging has a significant effect in small field dosimetry. A silicon 
diode is an outstanding candidate for use as an efficient dosimeter for sophisticated 
radiotherapy delivery techniques, because their high sensitivity means they can be 
manufactured to a small sensitive volume and still provide a good sensitivity and high 
spatial resolution. As a consequence, CMRP has designed and developed several 
spectacular silicon diode detectors based on p-type wafers that are used as a radiation 
dosimeter. A p-type silicon diode was selected due to its superior characteristics 
compared to n-type diodes in terms of linearity of the response with dose per pulse and 
higher radiation hardness [166][167]. CMRP has developed various silicon detector 
prototypes such as for surface point dose measurements (MOSkin), 1D diode array 
(DMG), 1D orthogonal diode array (DUO) including 2D diode array (MP121 and 
MP512) [60][86][168][169][170]. These detectors have been studied and are useful for 
external beam radiation therapy dosimetry.   
However, the silicon diodes exhibit angular, temperature, and dose per pulse dependence, 
as well as being sensitive to accumulated radiation [171][57]. Marre et al. studied the 
effect of an accumulated dose on several commercial diodes and found the detector lost 
approximately 20-25% sensitivity at an accumulative dose of 1 Mrad for electron and 
photon beams [172]. The degradation of sensitivity from radiation depends mainly on the 
quality of radiation and the type of silicon [173][174]. Radiation can damage the mass 
bulk and surface regions of silicon detector when energy that is greater than the threshold 
energy is imparted, the point defects and clusters within the silicon lattice are created ; 
this increases the leakage current, induces the growth of full depletion voltage and 
degrades detector sensitivity. The effect of increasing of leakage current can be minimised 
by using silicon diodes in a passive mode or no biased application [175].The sensitivity 
Chapter 2: Literature Review 
 
43 
of silicon detectors is proportional to the active volume, and that depends on the area of 
the detector (A) and the diffusion length (L). The diffusion length (L) depends on the 
minority carrier time (τ) as shown by  =  √, where D is the diffusion constant. The 
lifetime of the minority carrier will decrease the concentration of crystal defects increases; 
these defects at a high and deep level create a recombination-generation (RG) centre 
which reduces the lifetime of the minority carrier, decreases detector sensitivity, but 
makes it more sensitive to dose per pulse and temperature [65][176][64]. An RG centre 
can be managed using the oxygen doping technique or specific silicon growing 
technology; with the silicon growing technique, the silicon substrate is doped with impure 
material to modify the transport mechanism in the silicon lattice.  
Brookhaven National Laboratories has developed oxygenated devices known as oxygen-
enriched floating zone (DOFZ) substrates where the oxygen is doped in the substrate to 
form a vacancy-oxygen (V-O) complex in a deep level of the forbidden gap where the 
energy is approximately 0.55 eV. This V-O complex resulted in the creation of the RG 
centre. This technique is perfect for minimising the effect of radiation damage from 
gamma irradiated by Co-60; it only creates point defects with no generating cluster 
defects. However, the detector was still sensitive to degradation due to higher energy 
irradiation. Besides, the process of manufacturing DOFZ makes is difficult to reproduce 
the same macroscopic property and effective doping concentration [177], [178].The same 
concept was used when doping n-type Czochralski silicon with platinum (Pt); Pt-doping 
delivered a short diffusion range of charge carriers approximately 20 µm but this reduced 
the sensitivity of detector in the low dose rate range [58].  
In 2006, Lindstrom et al. studied the thin layer of low resistivity of an n-type silicon 
detector using for tracking charged particles in hadron field and found its sensitivity had 
improved [179]. The epitaxial layer is limited an active depth of detector which is shorter 
Chapter 2: Literature Review 
 
44 
than the diffusion length and keep the active volume constant even after being irradiated 
with high radiation. Santos et al. investigated the effect of clinical electrons with energy 
ranging from 6 MeV to 21 MeV and photons with energy of 6 MV and 18 MV beams 
onto the thin n-type epitaxial layer with a resistivity of 50 Ω cm, which had been grown 
on 300 µm thick n-type silicon substrate. They found excellent characteristics in terms of 
long and short term repeatability, electron PDD measurements, dose linearity for electron 
and photon beams , and measurements of electron beam profiles, however the detector 
also showed electron energy dependence and increasing current leakage current 
[180][181]. Bruzzi et al. investigated the sensitivity of an epitaxial silicon detector to 
radiation damage delivered from a Co-60 gamma source; they found that the n-type 
silicon diodes decreased in sensitivity more than the p-type silicon diodes with an 83% 
and 58% drop, respectively. Their study also showed the effect of epitaxial thickness and 
guard ring distance to active area of the diode on radiation damage. A 50 µm thick 
epitaxial layer provided high constancy and stability of sensitivity, with sensitivity 
reduced by only 7% at a dose of 1.5 kGy and stability within 1.8% at 10 kGy. However, 
the larger guard ring distance of 50 µm resulted in more stable sensitivity at a dose of 1.5 
kGy [182]. These results mean that a p-type epitaxial silicon detector with a thin layer 
and wide guard ring is better for a radiotherapy dosimeter, and moreover, p-type silicon 
is not affected by changes in the absolute value of space charge  by increases in fluence 
[183]. Talamonti et al. investigated the first prototype of 2D arrays when the p-type 
epitaxial layer was used as a dosimetric detector for pre-treatment verification [184]. The 
prototype 2D detector arrays consisted of 21×21 pixels that achieved a resolution of 3 
mm; this resulted in good dose linearity, excellent repeatability and reproducibility, as 
well as less dependence on the dose rate. As a consequence, CMRP developed an IMRT 
patient verification dosimeter based on the epitaxial p-type diodes with silicon epitaxial 
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layer thickness of 50 µm and using drop-in technology for packaging of the diode called 
magic plate 121 (MP121). An MP121 has 11×11 diodes with a sensitive volume of each 
0.5×0.5×0.05 mm3 and 1 cm pitch. The sensitivity was stable within 2.1% after a pre-
irradiation dose of 41.5 kGy and the excellent dosimetric characteristics for photon beam 
irradiation remained. The detector showed good dose linearity and good agreement of 
PDD measurements with CC13, ionisation chamber however the sensitivity of MP512 
decreased as the dose per pulse increased [168]. However the 1 cm pitch of MP121 is too 
coarse for use in small field dosimetry. Therefore, CMRP has designed a novel monolithic 
detector fabricated on epitaxial p-type layer and providing a high spatial resolution of 2 
mm they call MagicPlate512-epitaxial (MP512-EPI), it will be described and investigated 
in this thesis. 
  
 
 
 
 
Chapter 3  
Angular dependence and the correction 
factor 
 
3.1. Introduction 
This chapter focuses on the characterisation of the 2D monolithic p-type detector array 
called MagicPlate-512 (MP512-Bulk) in terms of its intrinsic directional dependence and 
the effects that energy and field size have on its angular response. This chapter also 
presents a procedure for an angular correction factor development to improve the 
accuracy of a dose map measured in a particular plane using small fields, as used in SBRT 
and SRS.  
This MP512-Bulk was designed and developed by the Centre for Medical 
Radiation Physics (CMRP) to investigate dosimetric characteristics in terms of their 
output factor, percentage depth dose, dose linearity and dose per pulse dependence, and 
the uniformity of detector response by Aldosari et al. [170]. The beam profiles and 
penumbra for field sizes less than 4×4 cm2 that are relevant to stereotactic radiation 
therapy were measured and shown to be feasible for small field dosimetry. The Full Width 
of Half Maximum (FWHM) of square radiation fields  measured by  the MP512-Bulk for 
field sizes down to 1×1 cm2 matched within 2% compared to the gafchromic EBT3 film 
data measurements [170], but the critical aspect of a silicon diode is its directional 
dependence due to asymmetry in the detector packages and the high-Z material generates 
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different attenuations of secondary electrons in different directions [185][186]. Variations 
of detector response can be more than 10% due to anisotropy and detector assembly; the 
results have been reported in several studies [70][187][188][189][190]. Paul et al. 
examined the angular dependence of p-type semi-conductor surface diodes with an active 
volume of 1.6×1.6×0.05 mm3 that were mounted on a 0.051 mm thick copper contact pad 
of PCB. They showed that the detector varied in sensitivity between ±12% when 
normalised to a normal incidence of the beam at a range of angles between ±45 degrees 
[61]. The angular dependence of an n-type 2D diode array, MapCHECK (SunNuclear, 
Melbourne, Florida, USA) was evaluated and compared with ionisation chambers, and a 
maximum difference of almost 20% was found at the beam angle of 90 degrees [189]. 
Hosang et al. also investigated the angular dependence of a MapCHECK for verifying 
RapidArc plans and found a significant difference in dose as large as 30.6±6.6% and 
33.4±5.8% for field sizes of 10×10 cm2 and 3×3 cm2, respectively [190]. This 
phenomenon affected the accuracy of angular dependence of the detector used in 
rotational radiotherapy where many modulated irradiation fields surround the patient.  
3.2. Material 
3.2.1. MagicPlate-512 (MP512-Bulk) design and fabrication 
The MP512-Bulk is a monolithic silicon detector array with 512 square diodes, an active 
area of 0. 5×0. 5 mm2 and a pitch of 2 mm; it was fabricated by ion implantation onto a 
470 m thick p-type silicon substrate (Figure 3.1). The MP512-Bulk is wire bonded to a 
500 m thick fibreglass printed circuit board ( PCB)  with plugs for connection to a fast 
readout DAQ system.  The detector and the wire bonding are covered by a thin layer of 
protective epoxy for mechanical robustness. The MP512-Bulk was pre-irradiated with a 
total water equivalent dose of 80 kGy from Co-60 gamma source to stabilise its response; 
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the MP512-Bulk array operates in a passive mode where no bias voltage is applied to the 
diodes. 
The MP512-Bulk detector array was embedded between two 5 mm thick PMMA 
slabs with an air gap above silicon pixels entrance surface.  This packaging arrangement 
(Figure 3.1b) is needed to protect the silicon detector and optimise the detector response 
to small radiation fields by adjusting the air gap to match the detector’s response for small 
radiation fields to radiochromic film [170], [191]. The air gap is 0.5 mm and 1.0 mm for 
6 MV photon beam and 10 MV photon beam, respectively [192].  
 
 
(a) (b) 
Figure 3.1:  A schematic of the cross section of an MP512 detector component and its 
packaging (not to scale).  
3.2.2. Data acquisition system (DAQ) 
The MP512 data acquisition system (DAQ) is based on a 64-channel analogue front-end 
electrometer ASIC chip that provides an analog differential output that is proportional to 
the charge that accumulates in a capacitor during a pre-selected time frame that is set 
electronically through a software interface. The gain adopted in this work was set to span 
a full scale range up to 9.6 pC max with a resolution of 16 bits and an integral linearity 
of approximately 0.006% [193]. The baseline of each current integrator is subtracted 
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using a double sampling approach: this feature is very important for maintaining accuracy 
in a medical instrument which requires a high signal to noise ratio (Figure 3.2). Each chip 
is interfaced to a quad analogue-to-digital converter (ADC), and the ADC output is 
synchronised and the channels de-randomised by a field programmable gate array 
(FPGA). The FPGA also synchronises the sync pulse of the LINAC to acquire a detector 
current only when the electron gun injects electrons into the accelerator (for 
approximately 3.7 µs every 2.7 ms at 600 MU/min on a Varian Clinac iX). The ADC 
system can also acquire the detector array signal by an internal trigger generator with 
frequency up to 10 kHz in case dosimetry on the source of isotopic radiation radiated 
intensity in all directions.  
The data is transferred from FPGA via USB2.0 to a host computer where the in-
house developed program interface (Magic Suite) operates. This program was designed 
to perform real time signal processing where the signal from the detector is manipulated 
immediately and the users can monitor in real time. Moreover, the Magic Suite interface 
was designed to be convenient and easily accessible. The software enables a user to set 
the acquisition parameters such as the integration time (µs) to match the detector, and the 
acquisition length (s) and acquisition frequency (kHz) that synchronises with the radiation 
time and machine, respectively. The program provides instantaneous and integral detector 
response as an output, and this can be visualised using a map and histogram response 
(Figure 3.3). The tool also provides an equalisation function that can be stored and 
calculate the equalisation factor of the detector. Moreover, each acquisition parameter 
and detector signal are recorded as log files that can be used for further offline analysis. 
An overview of DAQ workflow is shown in Figure 3.4. 
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(a) (b) 
Figure 3.2:  The general operation schematic of ASIC ship (a) Dual switched integral 
architecture and (b) Integration Timing [193].  
 
(a) 
 
(b) 
Figure 3.3: Magic Suite interface (a) Map response display and (b) Histogram response 
display. 
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Figure 3.4: Flow chart of data acquisition (DAQ). 
3.2.3. CMRP Cylindrical phantom 
A CMRP cylindrical phantom is shown in Figure 3.5. It was built by CMRP using 
polymethyl methacrylate (PMMA) material, also known as acrylic glass. The physical 
density of PMMA is approximately 1.15-1.19 g/cm3 [194]. The phantom is a 30 cm 
diameter by 40 cm long cylinder [170] , and has a central PMMA insertion slot of 15.5 
×20.5 ×5 cm3, into which the detector array can be inserted.  
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(a) (b) 
Figure 3.5: PMMA cylindrical phantom (a) Lateral view of phantom and (b) MP512 
inside the phantom. 
3.3. Methods 
All the experiments in this chapter were carried out on a Varian Clinac iX (Varian 
Medical System, Palo Alto, CA) at the Illawarra Cancer Centre (ICCC), Wollongong 
hospital.   
3.3.1. Equalisation and calibration factors 
Before taking any measurements the MP512 must be equalised to correct for any sensitive 
non-uniformity in the detector array and ASIC readout chips channels. This equalisation 
factor was carried out by irradiating the MP512 using a 20×20 cm2 square field of 6 MV 
photon beams and 200 MU. The detector was placed into water at a depth of 10 cm and 
full scatter conditions by fixing the source to the isocentre of the detector (SAD) at 100 
cm. This procedure has been investigated and used to obtain equalisation factors that were 
calculated by following Equation (3.1) and (3.2) [168][170]. The equalisation coefficients 
can be stored in the DAQ software interface.  
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                                                           (3.2) 
Where Fi is the correction factor vector, Xi is the pixel response,  is the average response 
of detector and Xeq-1 is the equalized detector response.  
 Each pixel for the calibration factor was calibrated against a 0.6 cm3 Farmer  
NE2571 ionisation chamber that refers to the relative calibration MU/min of the machine 
[50]. The detector was set to a maximum depth of 1.5 cm for 6 MV photon beams with a 
full back scatter of 10 cm solid water phantom and a fixed source to skin distance (SSD) 
of 100 cm. A 10×10 cm2 field was irradiated to the detector delivering 100 MU and a 
dose rate of 600 MU/min. The calibration factor for each pixel is defined by Equation 
(3.3). 
 
 =                                                           (3.3) 
 
Where CFi is the calibration factor, DIC is the ionisation dose (cGy) measurement. The 
detector was calibrated to 1 MU = 1 cGy and RMP512 is its response.  
3.3.2. Angular response 
The angular response is examined by inserting an MP512 into a CMRP cylindrical 
phantom. The detector is in a vertical position and the treatment gantry is horizontal 
(Figure 3.6). The central pixel of the detector array is aligned to the machine’s isocentre; 
a 5×5 mm2 size field is used for fine alignment as the couch is moved in 1 mm steps 
vertically and laterally to identify the maximum response of the central pixel. The 
gantry’s horizontal position is defined as the zero incident beam angle because the beam 
incidence is perpendicular to the detector surface. This setup enabled the angular response 
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of the MP512 detector to be examined from 0 to +180 degrees without any interference 
from the couch. The Linac gantry was rotated clockwise at 15° increments from the 
incidence beam angle 0° to +180°. For a beam with a 10×10 cm2 field the gantry was 
rotated at 1° increments for angles of incidence between 85° to 95° to finer characterise 
the detector around the expected variations of maximum response. The MP512 was 
irradiated five times with 100 MU for each angular position at a dose rate of 600 MU/min, 
while keeping the central pixel at the isocentre (at a depth of 15 cm for PMMA and 85cm 
for SSD). The square beams are defined by the primary collimators (jaws) field sizes of 
1×1 cm2, 2×2 cm2, 3×3 cm2, 4×4 cm2 and 10×10 cm2. The relative angular response is 
the ratio at which the pixel responds at a given angle of irradiation that is normalised to 
the same pixel with a beam incidence of 0 degrees.  
 
(a)  (b) 
Figure 3.6: The experiment setup; (a) The MP512 embedded inside the phantom, (b) 
Schematic diagram of angular response measurement (not to scale). 
3.3.3. Gafchromic EBT3 film measurement 
Gafchromic EBT3 film was used as the reference dosimeter to evaluate and correct the 
angular response of MP512 by assuming that its response has no significant angular 
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dependence. This EBT3 film was designed to minimise its angular response by using two 
30 µm thick active layers stacked with two 125 µm thick matte polyester layers to protect 
them from mechanical damage [195]; this configuration of EBT3 film is shown in Figure 
3.7. The normalisation of the MP512 detector to EBT3 film response helps minimise the 
mechanical tolerances as the LINAC gantry rotates around the phantom and the non-
homogeneous effects of the phantom.    
 
Figure 3.7: The structure of gafchromic EBT3 film [195]. 
Films were calibrated by using 12 pieces from the same film lot, with each having areas 
of 3×3 cm2 ; they were irradiated with 6 MV photons and an open 10×10 cm2 field at dmax 
(1.5 cm) at SSD 100 cm that was placed on a 10 cm thick slab of solid water for back 
scatter equilibrium. The films were exposed to doses from 0.25 Gy to 5 Gy, although one 
film was retained to have its optical density baseline evaluated. A 0.6 cm3 farmer 
ionisation chamber (model 2571) was used to measure the actual dose delivered for a 
given MU setting under the same irradiation conditions. In this study, a Microtex 
ScanMaker i800 was used for films scan procedure. Microtex ScanMarker model i800 is 
the flatbed scanner with a staggered trilinear CCD array and a built-in transparency 
adapter [196]. The set of calibration films were scanned six times at the same position in 
the centre of a scanner with 48 bits of colour depth and spatial resolution of 72 dpi 
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(equivalent to 350 µm size pixels). All the correction image parameters of the scanner 
were set to disable. The last three scans were used to carry out the analysis needed to 
ensure the scanner was thermally stable and the inter-scanning was consistent [89]. Data 
analysis was carried out using the red channel which had been extracted using ImageJ 
V1.48 (National Institute of Health, USA). The mean pixel values were calculated for a 
region of interest (ROI) of 2×2 cm2 at the centre of each film patch to determine the net 
optical density (net OD) according to Equation (3.4); this was then converted to dose by 
fitting it with a fourth degree polynomial function [197][198][199]. The calibration curve 
of EBT3 film is shown in Figure 3.8. The calibrated dose response curve of EBT3 film 
was energy independent on the photon energy from 6 MV to 15 MV, so the same 
calibration curve was used to analyse the 6 MV and 10 MV irradiation [198].  
 
  =   !" −  $%&' =  ()*+ , -./0-1234-.567-12348                           (3.4) 
 
Where Ipre, Ipost, and Ibckg are the optical intensities for pre and post irradiation, as well as 
the transmitted background intensities.   
To calculate the correction factor, samples from the same lot of EBT3 films were 
cut into 7.0×7.4 cm2 patches to fit the PMMA holder used for MP512 packaging (Figure 
3.9). The films were irradiated inside the cylindrical phantom, in the same position as the 
detector array, with 6 MV and 10 MV photon beams and a 10×10 cm2 open field at 
incident beam angles of 0°, 45°, 90°, 135°, and 180°; the films were then analysed by 
following the same procedure for film calibration. A median 3×3 pixels filter was used to 
reduce noise. An ROI with 137×137 pixels matches the active area of an MP512 
corresponding to 5.2×5.2 cm2. MATLAB 2014b (Math Works Inc., Natick, MA) and the 
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polynomial function obtained during the calibration step were used to convert pixels to 
doses. 
 
Figure 3.8:  The calibration curve of gafchromic EBT3 films using a red 
channel. 
 
 
 
 
Figure 3.9: The experiment setup of gafchromic EBT3 films using  
MP512 packaging to fit the PMMA holder. 
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3.3.4. Angular correction factors  
Data collected by the MP512 and EBT3 film with an open 10×10 cm2 field were used to 
determine the correction factor for each detector pixel. Increasing the field size beyond 
10×10 cm2 for angular calibration does not change the field uniformity or electron 
equilibrium within the active area of MP512 that determines the angular response 
calibration when 10×10 cm2 field irradiation is used. The angular dependence of MP512 
was evaluated in an azimuthal direction (along the x-axis) because the rotation was 
longitudinal (y-axis), as shown in Figure 3.6. Because the spatial resolution of the 
detectors is different, the (i,j)-th pixel of the EBT3 dose profiles in the x and y direction 
was aligned with the (i,j)-th pixel of MP512 using a curve function that obtained a second 
order polynomial fit [168]. The response of film at the angular increments 150 needed to 
determine an angular correction of MP512 was achieved by interpolating between the 
values of films irradiated at 0°, 45°, 90°, 135°, and 180°. The calibration matrix 9: is the 
conversion factor from counts to dose; it was calculated from the ratio between the 
response of MP512 in counts for each pixel (i,j) to the dose measured by the EBT3 film 
in each pixel (i,j) as a function of the gantry angle , defined as Equation 3.5 and 
expressed in units of counts/cGy.  
 
9:(<) =  >?
@(A)BCDE
@(A)                                                      (3.5) 
 
Where i is the row index along the x-axis, i.e., the axis perpendicular to the phantom 
rotation, and j is the column index of pixels along the y-direction parallel to the axis of 
rotation. For each column along the y-coordinate the detector and film did not very much. 
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 For the open 10×10 cm2 field, the angular response calibration tensor for MP512 
(:(<)) was calculated by dividing the calibration factor at an arbitrary gantry angle  
by the calibration factor at a gantry angle of 0 (Equation 3.6) 
 
    :(<) = F
@(A)F
@(+)                                                        (3.6) 
 
3.3.5. Validating the angular response correction factor for a small 
field 
The angular response of MP512 was verified by irradiating it with open field sizes of 1×1 
cm2, 2×2 cm2, 3×3 cm2 and 4×4 cm2, and at gantry angles of 0°, 45°, 90°, 135° and 180° 
using 6 MV and 10 MV photons, and by fixing 100 MU and dose rates at 600 MU/min at 
each position. At each pixel (i,j), the dose response  GH:%IJJ%KL(<) measured by the 
MP512 and corrected for angular dependence, was obtained by dividing the measured 
response GH:′ (<) by the calibration tensor :(<) for a 10×10 cm2 field (Equation 3.7). 
The methodology used to measure the MP512 response was similar to that described 
above. 
 
GH:%IJJ%KL =  >?
@
′ (A)
M
@(A)                                                      (3.7) 
 
Where GH:′ (<) is the MP512 response signal (counts) for a particular angle, and :(<) 
is the calibration tensor for the 10×10 cm2 open field. 
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3.4. Results 
3.4.1. Angular response 
Figure 3.10 shows the difference in angular response at the central pixels for MP512 and 
EBT3 film. Figure 3.11 shows the intrinsic detector response between 00 and 1800 as a 
function of the incidence angles collected from the four central pixels with various field 
sizes. These responses are the combined effect of beam attenuation through the silicon 
substrate and the fibreglass supporting the detector crystal. The error bars are calculated 
as one standard deviation (1SD) for the five measurements repeated in a test state, and 
the measurement uncertainty with a maximum variation of ±0.2% at a 95% confidence 
interval. The relative response of MP512 decreased as the incident beam angle increased, 
giving an average change per degree of 0.18±0.03%. The relative angular response of 
MP512 decreased by less than 5% for incident angles between 00 and 600, whereas the 
minimum response (largest deviation) of 18.5±0.5% for 6 MV and 15.5±0.5% for 10 MV 
was achieved at incidence beam angles between 900-95°. The relative angular response 
increased again when it moved towards larger angles, which led to underestimating the 
response of 14.3±0.6% and 9.4±1.8% at 1800 for the 6 MV and 10 MV photon beams, 
respectively. The data in this study was not distributed normally and the sample size per 
group was less than the criteria (n<15), so a non-parametric statistical analysis such as a 
Kruskal-Wallis test and a Mann-Whitney U test were used. A Kruskal-Wallis test is 
commonly used to compare the difference for three or more independent groups, in this 
study, it was carried out to determine the effect of various field sizes (1×1 cm2 to 10×10 
cm2) for the same photon energy. While Mann-Whitney U-test is suitable for comparison 
of the difference between two independent groups, in this study, it used to find out for the 
effect of energy (6 MV and 10 MV) for same field size. There was no significant 
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difference in an angular response with values of p = 0.9985 for 6 MV and p = 0.5359 for 
10 MV, although the angular response for 1×1 cm2 and 10×10 cm2 field size for a 10 MV 
photon beam at incidence angles between 135° to 180° changed by more than 3%, and a 
Mann-Whiney U test showed no significant difference with p = 0.5214. Hence, the 
angular response of MP512 is not sensitive to field size. However, Figure 3.12 shows the 
intrinsic detector response for a 10 ×10 cm2 open field was between 00 and 1800 as a 
function of the incidence angle collected from the four central pixels and the beam energy. 
The relative angular response for higher energy 10 MV photon beams was less than for 6 
MV photon beams. A Mann-Whitney U test to compare the angular response between 6 
MV and 10 MV photon energies revealed a significant difference in the angular response 
as a function of the beam energy with p = 0.04.  
 
 
Figure 3.10:  A comparison of the central pixel response between MP512 and EBT3 
for 6 MV (a) Field size 3×3 cm2, (b) Field size 10×10 cm2. 
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(a) 
 
 
(b) 
Figure 3.11:  Angular dependence of the averaged four central pixels of the MP512 
detector array shown as a function of incident gantry angle for ( a)  6 MV and ( b)  10 
MV photons. 
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Figure 3.12:  Angular dependence of the averaged four central pixels of the MP512 
detector array shown as a function of incident gantry angle for an open field size of 
10×10 cm2 for 6 MV and 10 MV photons. 
3.4.2. Validating the angular response correction factor for a small 
field  
The beam profile comparisons were evaluated using the shape-preserving interpolant 
curve fitting tool in MATLAB which provides 0.01 mm precision that is reflected in a 
Table 3.1. The beam profiles of field sizes from 1×1 cm2 to 4×4 cm2 measured with an 
MP512 at an incidence angle of 0 degrees were compared to EBT3 films; there was 
agreement with the Full Width of Half Maximum (FWHM) and penumbra (20%-80%) 
for 6 MV and 10 MV beams within ±1% and 1 mm for FWHM and penumbra, 
respectively ( 
Table 3.1). When the angular dependence is not corrected the MP512 response to beams 
at incidence angles other than 0 degrees has a dose profile that is similar in shape to EBT3 
film but with a lot of attenuation. This result confirms that underestimating the dose for 
angled beams due to the extracameral silicon surrounding each pixel cannot be avoided 
for a monolithic solid state detector. After correcting the MP512 measured doses using 
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the :(<) factor (Equations 3.6 and 3.7), the agreement between MP512 and EBT3 films 
improved significantly for field sizes of 2×2 cm2, 3×3 cm2, and 4×4 cm2. The dose profiles 
from 2×2 cm2 to 4×4 cm2 measured with the MP512 detector after correction match the 
EBT3 dose profiles for all angles within 2% (Figures 3.13 to 3.18) for 6 and 10 MV 
photon beams. However, with 6 MV photons and a field size of 1×1 cm2 the cross-plane 
depth-dose profiles corresponding to a 900 gantry angle were wrong by almost 6% out 
compared to EBT3 film [Figure 3.19(c)]. This larger error occurred because the partial 
response of MP512 for small a 1×1 cm2 field for beam incident along the detector plane 
is due to secondary electrons generated by photons interacting along the silicon substrate 
about 400 micron thick and attenuating stronger that in a phantom. In case of 10×10 cm2 
field the contribution of electrons generated in silicon is much smaller because the 
response of the detector is mostly due to secondary electrons generated by photons from 
the phantom where their (photon) attenuation is less than in silicon. However, with a 10 
MV photon beam, the discrepancy between MP512 and film after correction was within 
2% for the 1×1 cm2 size field [Figure 3.20(c)] because the scattered electrons have higher 
energy which is not absorbed by the printed circuit board and the silicon substrate.  
Table 3.1: The difference in FWHM and penumbra width (20%-80%) between MP512 
and EBT3 films for various field sizes. 
 
 
6 MV 10 MV 
 FWHM(mm) Penumbra(mm) FWHM(mm) Penumbra(mm) 
FS 
(cm2) EBT3 MP512 
Diff 
(%) EBT3 MP512 
Diff 
(mm) EBT3 MP512 
Diff 
(%) EBT3 MP512 
Diff 
(mm) 
1×1 9.84 10.06 2.31 2.44 2.82 0.38 10.19 10.41 2.18 2.84 3.14 0.30 
2×2 19.85 20.02 0.83 2.85 3.57 0.71 19.86 20.29 2.17 3.43 3.83 0.39 
3×3 29.80 30.33 1.81 3.18 3.69 0.52 29.92 30.37 1.49 4.01 4.25 0.24 
4×4 40.01 40.32 0.79 3.40 3.79 0.39 40.06 40.54 1.19 4.30 4.39 0.09 
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Figure 3.13:  Dose profiles of 2×2 cm2 beam measured with EBT3 films and MP512 
with and without a correction factor for 6 MV photon as a function of distance ( mm) 
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° 
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Figure 3.14:  Dose profiles of 3×3 cm2 beam measured with EBT3 films and MP512 
with and without a correction factor for 6 MV photon as a function of distance ( mm) 
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° 
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Figure 3.15:  Dose profiles of 4×4 cm2 beam measured with EBT3 films and MP512 
with and without a correction factor for 6 MV photon as a function of distance ( mm) 
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° 
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Figure 3.16:  Dose profiles of 2×2 cm2 beam measured with EBT3 films and MP512 
with and without a correction factor for 10 MV photon as a function of distance (mm) 
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° 
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Figure 3.17:  Dose profiles of 3×3 cm2 measured with EBT3 films and MP512 with 
and without a correction factor for 10 MV photon as a function of distance (mm) and 
dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° 
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Figure 3.18:  Dose profiles of 4×4 cm2 beam measured with EBT3 films and MP512 
with and without a correction factor for 10 MV photon as a function of distance (mm) 
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° 
 
Chapter 3: Angular dependence and the correction factor 
 
71 
 
Figure 3.19:  Dose profiles of 1×1 cm2 beam measured with EBT3 films and MP512 
with and without a correction factor for 6 MV photon as a function of distance ( mm) 
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° 
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Figure 3.20:  Dose profiles of 1×1 cm2 beam measured with EBT3 films and MP512 
with and without a correction factor for 10 MV photon as a function of distance (mm) 
and dose (cGy); (a) 0°, (b) 45°, (c) 90°, (d) 135° and (e) 180° 
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3.5. Conclusions 
This study examined how the field size and photon energy affected the angular response 
of MP512, a monolithic detector arrayed with 0.5×0.5 mm2 pixels and a 2 mm pitch; the 
angular response of MP512 was almost independent of the field size. Our results suggest 
that a using a 10×10 cm2 reference field to calculate the correction factor and apply it to 
any field size larger than 1×1 cm2 is feasible. This makes the MP512 a viable option for 
small field dosimetry in intensity modulated SBRT or VMAT where the fields shape is 
modulated. The method used to calculate the angular correction vector is based on 
comparing the EBT3 mapped dose and MP512 detector response to a 10×10 cm2 field 
and beam incidence angles between 0 degrees and 180 degrees. When the developed 
angular correction vector was used the dose profile measured by MP512 and EBT3 film 
for all field sizes at 6 MV and 10 MV photons agreed within 2%, except for the 1×1 cm2 
field at 6 MV where the agreement was within 6%. The angular dose of MP512 decreased 
by increasing the beam incidence angle to 18.5±0.5% and 15.5±0.5% for 6 MV and 10 
MV photon beams, rather than the normal beam incidence (zero degree) where the 
minimum was between 90° to 95°. While the MP512 is a large monolithic 2D array 
detector, its angular response is similar to or less than of the single diodes presented in 
other studies [61], [114], [200], whereas its directional dependence is attributable to the 
intrinsic anisotropic configuration of the MP512 silicon detector where each pixel is 
surrounded laterally by extra-cameral silicon and by a thin fibreglass printed circuit board 
on the back. This packaging creates differences in beam angle dependent attenuation of 
the secondary electrons which causes the pixels to become sensitive to angular 
dependency; and since the silicon surrounding the pixels is denser than water, secondary 
electrons are produced with an energy distribution that differs to that generated in water 
which affect the dose measured by the pixels under different beam angles [186], [201]–
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[203]. For 10 MV photon beams, the scattered electrons have more energy than 6 MV 
photon beams, which leads to a less pronounced angular response by the MP512.  
 The discrepancy between the MP512 and EBT3 films of up to 6% for 6 MV 
beams and a 1×1 cm2 field at an incidence angle of 900 are due to the different radiation 
fractions for a 1×1 cm2 field compared to a 10×10 cm2 field. The partial fraction of 
photons attenuated by 0.47 mm thick and 52 mm long silicon substrate has more influence 
on how the pixels embedded in silicon with depth respond, whereas the response of pixels 
with depth for a 10×10 cm2 field is driven mostly by secondary electrons scattered from 
the PMMA to silicon. With the 1×1 cm2 field and 10 MV photon beams, this effect was 
less pronounced because the scattered electrons had more energy, leading to a smaller 
asymmetry due to PCB and extra-cameral silicon. At field sizes less than 2×2 cm2 for 6 
MV photon beams, when a beam is irradiated parallel to the silicon detector array such 
as at an incident beam angle of 900 a small field correction factor rather than generic one 
for a 10 × 10 cm2 field should be considered to achieve higher accuracy. 
The applicability of MP512 for the developed correction vector was studied using 
the case of arc delivery in VMAT and IMRT for small lesions. Here, the gantry angles 
measured with an inclinometer and synchronised with the MP512 DAQ are the basis of 
the list mode data which, in conjunction with the angular correction vector, will provide 
corrected integral 2D dose mapping in a particular plane [204]. Measurements using 
MP512 will be compared with the EBT3 response for the same VMAT and IMRT 
delivery and TPS prediction and will be discussed in Chapter 5. 
 
 
  
 
 
 
 
Chapter 4  
The characteristics of a 2D monolithic 
epitaxial detector array as a quality 
assurance dosimeter for small field 
 
4.1. Introduction 
After being investigated the MP512-Bulk proved to be an excellent QA dosimeter in a 
small field, but it is sensitive to degradation from accumulative doses of radiation 
[205][63]; this means it requires frequent recalibration to maintain a measurement 
accuracy within 2%. Although epitaxial silicon technology has been introduced into 
conventional radiotherapy, investigations showed it suffered from radiation hardening 
[182][206][207]. To improve the radiation hardness and provide long term recalibration 
of the MP512 detector arrays, the CMRP has modified the MP512 base on epitaxial 
technology so it is now called MP512-EPI.  
This chapter presents a complete dosimetric characterisation of an MP512-EPI by 
describing its design and fabrication, and the experimental techniques and setup. The 
dosimetric characteristics of this detector were investigated in terms of radiation hardness, 
percentage depth dose (PDD), dose per pulse and dose rate (MU/min) dependence, dose 
linearity, segmental dose linearity, long term reproducibility, cross-plane profiles in small 
fields, and directional dependence. MP512-EPI measurements were compared to the 
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Markus ionisation chamber, to gafchromic EBT3 films, and to MOSkin. The result of 
MP512-EPI in term of radiation degradation was compared to MP512-Bulk to understand 
benefit of epitaxial silicon detector technology can be utilized for development of 
radiation hard quality assurance dosimeters. The chapter also presents the detector’s I-V 
characteristic measurements to show the leakage currents as the function of the 
accumulated dose of irradiation.   
4.2. Materials and Methods 
4.2.1. MP512-EPI design and fabrication 
The MP512-EPI (Figure 4.1) detector has flat array planes with 512 phosphorus n+ 
implanted pixels fabricated on a 34.13-35.67 µm thick epitaxial layer with a high 
resistivity of 100 Ohm·cm (Ω·cm) and grown on top of a low resistivity p+ substrate of 
0.001 Ω·cm resistivity and thickness 525±25 µm. This thin epitaxial layer limits the 
thickness of detector’s sensitive volume to less than the length of the minority carrier 
diffusion while maintaining the stability of the detector’s sensitive volume with the dose 
of irradiation. Each sensitive area is 0.5×0.5 mm2 as defined by an n+ phosphorous ion-
implant that covers an area of 52×52 mm2 with a high resolution of 2 mm. The p-stop 
(p+) is implanted between the sensor pixels to minimise the coupling effect due to 
conductive channels being generated between the boron implantations. MP512-EPI is 
wire-bonded onto a 5 mm thick tissue equivalent printed circuit board (PCB) that is 
connected to the readout system via the connector pins (Figure 4.2). The thin layer of 
epoxy covers the entire active area of the detector to protect it from accidental damage 
and dust. The MP512-EPI is sandwiched between two 5 mm thick PMMA slabs, while 
the covering piece provides  an air gap of 0.5 mm for 6 MV photon and 1.2 mm for 10 
MV photon measurements [192]. 
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Figure 4.1: Schematic of the MP512-EPI fabrication and packaging (not to scale). 
 
 
Figure 4.2: MP512-EPI wire-bonded onto a PCB and the 
connector pins. 
4.2.2. Data acquisition system (DAQ) 
The FPGA data acquisition system was used for the measurements, as discussed in 
Chapter 3, Section 3.2.2.  
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4.2.3. Electrical characterisation: Current-Voltage (IV) characteristic. 
The current-voltage (IV) characteristic or radiation hardness characteristics were 
investigated to determine the quality of the p-n junction and the effects of radiation 
damage. Radiation can increase the leakage current of silicon detectors which limits the 
sensitivity of the silicon diode used to optimise the signal/noise ratio. The IV 
characteristic of MP512-EPI was performed before and after irradiation with a high dose 
Co-60 gamma source for a total dose of 60 kGy, and an increment 20 kGy per step dose. 
A Keithley 230 programmable voltage source was applied to the detector bias, and a 
Keithley 199 System DMM/scanner and Keithley 614 electrometer were used to measure 
the reverse current (Figure 4.3). The IV measurements and parameters were controlled 
using software called LabVIEW (Figure 4.4). 
 
 
Figure 4.3: I-V characteristic measurement setup. 
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Figure 4.4: LabVIEW software interface. 
 
The 14 diodes were randomised to cover the central and peripheral area on the MP512-
EPI and to determine how detector geometry affected the leakage current. The location 
of the selected diodes is shown in Figure 4.5 (yellow highlight). A reverse voltage was 
applied to the sensor on the p+ substrate via the bias pins, and the current across the 
junction was measured with an ammeter connected to the n+ region of each diode pixel 
(Figure 4.6). The voltage ranged from 0 to -60 V, in increments of -0.5 V per step. The 
time interval needed to stabilise the current transient measurement was fixed at 1000 
msec. The variable scale was set for a current between 2 kpA to 200 nA. Light disturbance 
can generate a photocurrent so the detector was kept in a dark environment or sealed box, 
as shown in Figure 4.3. The leakage current measurement depended on the temperature 
due to electromagnetic interference, so the selected diodes were measured at room 
temperature of approximately 298 K (24.85 °C).  
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Figure 4.5: Location of selected diodes on the MP512-EPI (yellow highlight). 
 
 
Figure 4.6: Schematic of I-V test for MP512-EPI. 
 
4.2.4. Radiation hardness. 
Silicon diode are sensitive to degradation when the accumulated dose of radiation 
increases [205][63], but the extent of damage to the diode depends on the quality of beam 
radiation. Typically, a higher energy photon beam such as 15 MV can cause more damage 
than 6 MV or 10 MV due to contamination with fast neutrons [208] [209]. Photon 
radiation mostly induces point defects in a lattice of silicon crystal, this leads to traps in 
the forbidden gap of silicon that acts as centres for generation and recombination. The 
length of the minority carrier diffusion decreases which reduces a diode’s sensitivity and 
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dose per pulse response modification [173]. The damage caused by radiation also 
increases the silicon diode detector’s dark current and temperature dependence. In this 
study the MP512-EPI was irradiated with a 2.28 kGy/hr (approximated at the time of 
irradiation) from a Co-60 gamma source that provided a mean energy spectrum of 1.25 
MeV. All the gamma irradiated by Co-60 was held at the Gamma Technology Research 
Irradiator (GATRI), Australia Nuclear Science and Technology Organisation (ANSTO). 
The MP512-Bulk and MP512-EPI were irradiated with a total water equivalent dose of 
40 kGy and dose increments 10 kGy and 60 kGy with dose increments 20 kGy, 
respectively. The 6 MV photon beams (Varian Clinac iX) at the Illawarra Cancer Centre 
(ICCC) were used to investigate the detector’s sensitivity to degradation before and after 
irradiation. The detector array was placed perpendicular to the iso-centre of the radiation 
beam with a solid water phantom of 30×30 cm2 depth of maximum dose (1.5 cm) and 10 
cm phantom slab downstream for full back scattering, by fixing the source to surface 
distance (SSD) at 100 cm (Figure 4.7). All these experiments were carried out with 10×10 
cm2 square filed while delivering 100 MU at a constant dose rate of 600 MU/min. The 
measurements were repeated five times to study the detector’s consistency and data 
acquisition system. The response of MP512-EPI to radiation was normalised to the 
response of the non-irradiated detector (0 kGy).  
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Figure 4.7: Schematic of the setup for measuring radiation 
degradation. 
4.2.5. Percentage depth dose (PDD) 
The percentage depth dose is the radiation beam absorbed at the central axis measured at 
any depth and normalised to the dose at a depth of maximum (dmax). This curve depends 
on the depth of measurement, the beam energy (beam quality), the field size, the source 
to surface distance (SSD), and the detector used in the measurement [210]. The PDD 
curves show a reduction in the depth and dose functions. The PDD curve is an important 
parameter in radiotherapy, and this measurement is needed to ensure the detector is a 
suitable quality assurance dosimeter. The PDD were carried out in a solid water phantom 
with an MP512-EPI. Because the detector array was covered by 0.5 cm thick PMMA the 
PDDs were measured by varying the phantom depth from 0.5 cm to 30 cm. The PDD 
curves were measured with 6 MV and 10 MV photon beams and a 10×10 cm2 square field 
where the SSD was fixed at 100 cm. The detector was irradiated using 100 MU and a 
fixed dose rate at 600 MU/min. The results were compared with MP512-Bulk 
measurements under the same conditions. The PDD curves were also compared with the 
standard PDD data measured by the Wellhofer CC13 ionisation chamber (cavity volume 
is 0.13 cm3, length 5.8 mm and radius 3.0 mm) in water at depths ranging from 1.5 to 30 
Chapter 4: The characteristics of MP512-EPI 
 
83 
cm while the Markus chamber Model N23343 (PTW-Freiburg, Germany) measured the 
solid water phantom at depths ranging from 0.5 cm to 10 cm. The overdose measured by 
the Markus chamber was due to its small guard ring and large separation; this was 
corrected by following the Velkley and Rawlinson Method [211][212][213], [214]. The 
dimensions of the Markus chamber obtained from Chen et al. were used to correct the 
calculations [215]. 
4.2.6. Dose linearity 
The complexity radiotherapy such as VMAT or IMRT usually delivers the dose range 
covers a large variation of MU per segment and fraction. The response of detector arrays 
should have linearity with the dose or MUs increasing. The MP512-EPI was placed at a 
depth of 1.5 cm in a solid water phantom and 10 cm slab behind detector for full back 
scattering condition of 10 cm, fixing SSD at 100 cm. The measurement obtained for both 
6 MV and 10 MV photon beams. The doses were delivered ranging from 1 MU to 500 
MU using a 10×10 cm2 radiation field.  
 
4.2.7. Dose rate (MU/min) dependence 
The advanced technique VMAT and IMRT modulated the dose to deliver a conformal 
dose to a tumour by changing the monitor’s unit rate (MU/min), gantry position, and MLC 
shapes during radiation. The silicon diode sensitivity on dose per pulse dependence is on 
a LINAC that delivers radiation with a pulsed beam and a high instantaneous dose rate 
[65][216]. The characteristics of this new detector must be examined in terms of its dose 
rate (MU/min) dependence. The pulse base frequency of a Varian accelerator for 6 MV 
is 360 Hz, this dose rate delivers a different pulse period and number of pulses per minute, 
as shown in Figure 4.8 [217]. To investigate how the duration between pulses affects 
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detector sensitivity, an MP512-EPI was irradiated with dose rates ranging from 100 to 
600 MU/min and 100 to 400 MU/min for 6 MV photon beams and 6 MeV electron beams, 
respectively. The set up for this experiment followed the reference conditions of a 10×10 
cm2 size field and SSD at 100 cm at Dmax (1.5 cm) and zref (1.2 cm) for 6 MV photon 
beams and 6 MeV electron beams, respectively. By following the TRS-398 protocol, 1 
MU was calibrated to a dose of 1 cGy to deliver a water equivalent material at the 
reference condition [37]. According to this protocol, the dose rate (MU/min) 
measurements corresponded to dose rate from 100 cGy/min to 600 cGy/min. The 
sensitivity of MP512-EPI at a particular dose rate was averaged for four central pixels 
and average sensitivity was normalised to the maximum dose rate for both energies. 
 
Figure 4.8: The dose rate time-sequence of 6 MV photons for Varian Clinac IX. 
4.2.8. Dose per pulse (DPP) dependence  
Dose per pulse (DPP) is an integration of the instantaneous dose rate over the pulse width. 
Co-60 is a continuous beam that is equal to the instantaneous dose rate and the average 
dose rate. A LINAC delivers radiation in a pulse beam series with a high instantaneous 
dose rate. The silicon diode is sensitive to dose per pulse so there is some concern when 
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a silicon diode is used for measurements in a LINAC machine [65][216]. The DPP 
decreased as the SSD increased. The nominal energies of 6 MV x-ray beam (Varian 
Clinac iX) were used to study the dose per pulse dependence on the sensitivity of a silicon 
diode. The front of the detector array was perpendicular to the horizontal radiation beam 
(gantry 90°) at a 1.5 cm depth (dmax) and with a 10 cm solid water slab behind for full 
back scattering (Figure 4.9). The MP512-EPI was irradiated using a 10×10 cm2 beam and 
by varying the SSD from 100 cm to 370 cm. The frequency pulse timing for 6 MV photon 
beams for the Varian accelerator was 360 Hz, giving a dose per pulse ranging from 
2.78×10-4 to 0.21×10-4 Gy/pulse. The thimble ionisation chamber Farmer 0.6 cm3 
(NE2571) was used for comparison under the same conditions. Charges from the 
ionisation chamber were measured using a PTW UNIDOS electrometer with a supply 
voltage of -300 volts (V). The MP512-EPI sensitivity (pC/Gy) S was a ratio of the charge 
collected (pC) from an average of the four central pixels of MP512-EPI per unit absorbed 
dose (Gy) as measured by the ionisation  chamber at the same SSD (Equation 4.1). The 
dose per pulse response was calculated by normalising the sensitivity ratio at any SSD to 
the detector sensitivity at SSD 100 cm (2.78×10-4 Gy/pulse) (Equation 4.2) [218].  
 
NOO =  (>PQ JR"ISR)TTU(IR)TTU                                            (4.1) 
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WOO =  OTTUOYY                                             (4.2) 
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Figure 4.9:  A schematic of the gantry angle orientation for measuring 
dose per pulse.  
4.2.9. Output factor for small field size 
The output factors are defined as a dose for a particular field size ratio to the dose from 
the reference field size of 10×10 cm2 [50]. The output factors decrease as the field size 
decrease and decrease even faster in a small field due to lateral electron disequilibrium, 
source occlusion, and detector perturbation. The output factor measured by the detector 
in small radiation fields is a function of the averaging effect of the sensitive volume and 
the electronic density of the surrounding material [219]. The output factors were 
measured at a depth of 10 cm RMI 457 solid water phantom and fixed SSD at 90 cm 
(Figure 4.10). The detector array was irradiated on 6 and 10 MV photon beams with fixed 
100 MU and a dose rate of 600 MU/min. The detector array was irradiated using open 
square fields ranging from 10×10 cm2 down to 0.5×0.5 cm2. To avoid the dose averaging 
volume effect the response of the central pixel (0.5×0.5 mm2) at specific field size was 
used to calculate the output factors by comparing the OF measured with the MOSkin and 
gafchromic EBT3 film measurements under the same conditions. 
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Figure 4.10: The MP512-EPI in the output factors measurement setup.  
4.2.10. Angular response  
The MP512-EPI is a planar detector array whose active sensitivity consists of a 
monolithic substrate. This configuration is mainly concerned with the angular response 
when the beam is not perpendicular to the detector (Refer to Chapter 3)[220][221]. In this 
study, the angular response of MP512-EPI was under the same orientation discussed in 
Chapter 3 where irradiation was carried out by rotating the gantry from 0° to 180° at 
increments of 10° and finer increments of 1° at incidence beam angle of 90°±10° using a 
10×10 cm2 square field. The response at a particular angle was normalized to the detector 
response at an incidence beam angle of zero. The results were compared to the MP512-
Bulk in order to understand how substrate affects the angular response.  
4.2.11. Segment linearity  
Step and shoot IMRT is a series of low MU delivery where the maximum segment is 
approximately 15 segments per each field [48], therefore the innovation detector is used 
as a verification dosimeter and the measured linearity of segmental beam delivery should 
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be investigated. An MP512-EPI was placed at a depth of 1.5 cm of a water equivalent 
solid phantom and full backscatter, fixing the SSD at 100 cm. A series of 10×10 cm2 
beams were carried out at a dose rate of 600 MU/min. The constant dose of 50 MU was 
irradiated by varying the segments from 1 to 25; the MP512-EPI response for each 
segment was normalised to the one segment of 50 MU deliveries.  
4.2.12. Long-term reproducibility  
This experiment set out to estimate the long term sensitivity and stability of MP512-EPI 
over 12 months with the average dose of photons of 500 Gy. Irradiation was measured 
after pre-irradiation at 60 kGy and was repeated for one to twelve months. In this 
experiment an MP512-EPI was placed at a depth of 1.5 cm in a solid water phantom and 
delivered a fixed beam of 10×10 cm2 with 100 MU and at a dose rate of 600 MU/min; 
the SSD was fixed at 100 cm, and all the measurements used 6 MV photon beams. The 
response from an average of four central pixels was normalised to the primary irradiation 
time using the uncorrected calibration factor; standard deviation was calculated using five 
consecutive exposures.  
4.2.13. Measuring the cross plane profiles  
The cross plane profiles of MP512-EPI were measured in a solid water phantom at a depth 
of 10 cm. The central pixel of the detector array was aligned perpendicular to the central 
axis of the beam, and the set up position was tuned with a 0.5×0.5 cm2 beam. 6 MV 
photon beams irradiated a series of small fields collimated by the jaw from 1×1 cm2 to 
4×4 cm2 with a constant dose rate of 600 MU/min and a fixed 100 MU. In this study the 
MLC was completely retracted from the irradiation fields. The central beam profiles of 
MP512-EPI were evaluated with reference to gafchromic EBT3 films in terms of full 
width and half maximum (FWHM) or at a 50% isodose and penumbra region (20%-80% 
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isodose). The EBT3 films were cut into 7×7 cm2 sizes and performed under the same 
conditions. Each film was scanned by the Microtrex ScanMaker i800 flatbed scanner with 
48-bit depth of colour and a spatial resolution of 72 dpi (equivalent to a pixel size of 350 
µm). The difference in the FWHM between MP512-EPI and EBT3 films was calculated 
as shown by the equation below. 
 
∆[\G = >?PQBCD]BCD] ^100%                                         (4.3) 
 
4.3. Results 
4.3.1. I-V Characteristics 
Figure 4.11 shows the I-V characteristics of selected diodes of MP512-EPI in the function 
of logarithmic scale reverse current (pA) and reverse voltage (V). This characteristic was 
measured before irradiation and then compared to post irradiation for each pixel. With 
non-irradiation, the I-V curves show that the current has increased rapidly as the voltage 
increased until it reached approximately -10 V after which it continued to increase slowly. 
The I-V curves showed a breakdown voltage of approximately of -58 V. Increased 
radiation led to an increase in the leakage current of the diode but there was a large 
variation between the non-irradiated and an irradiated 2 Mrad (20 kGy). However, this 
increased dose of radiation after a 20 kGy did not effect the leakage current. I-V curves 
also exhibited a small variation for all selected diodes, whereas the MP512-EPI had 
excellent uniformity and a slight variation between each irradiated diode at the same 
accumulated dose (Figure 4.12). 
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(a) channel 16 (b) channel 28 
(c) channel 41 (d) channel 153 
(e) channel 155 (f) channel 163 
Figure 4. 11:  Leakage current measured in reverse direction on selected channels of 
MP512-EPI comparison between prior-irradiation and after irradiation. 
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(g) channel 224 (h) channel 288 
(i) channel 299 (j) channel 334 
(k) channel 351 (l) channel 363 
Figure 4. 11:  Leakage current measured in reverse direction on selected channels of 
MP512-EPI comparison between prior-irradiation and after irradiation. 
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(m) channel 441 (n) channel 454 
Figure 4.11:  Leakage current measured in the reverse direction on selected channels 
of MP512-EPI comparison before and after irradiation.   
 
(a) Prior-irradiation 
Figure 4.12: The results of I-V characteristic comparison of each channel for (a) Prior 
irradiation, and (b) After 20 kGy irradiation.  
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(b) After 20 kGy dose of irradiation 
Figure 4.12: The results of I-V characteristic comparison of each channel for (a) Prior 
irradiation, and (b) After 20 kGy irradiation.  
 
4.3.2. Radiation hardness 
Figure 4.13 shows the response of MP512-EPI and MP512-Bulk as a function of relative 
sensitivity and accumulated dose of radiation. The error bar represents the ±1SD of five 
repeated measurements (<2%). The sensitivity of MP512 dropped rapidly after irradiation 
with 10 kGy, while stability after irradiation with 20 kGy was then obtained. The 
detectors fabricated on a thin p-Si epitaxial layer with a high resistivity of 100 Ω cm 
(MP512-EPI) show a higher constant sensitivity than the detectors fabricated at a low 
resistivity of 10 Ω cm p-Si (MP512-Bulk). The response of MP512-EPI decreased less 
than 3% and was constant within 0.3% after a given dose of 40 kGy. The MP512-EPI 
demonstrated excellent sensitivity and stability after pre-irradiation with a sensitivity 
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degradation of 0.3%/10 kGy while the degradation response of MP512-Bulk was 5%/10 
kGy. 
 
Figure 4.13:  The relative sensitivity of MP512- Bulk and MP512- EPI 
as a function of the accumulated dose for Co- 60 gamma source, 
normalised to a zero dose response. 
4.3.3. Percentage depth dose (PDD) measurement  
Figure 4.14 shows a good agreement of percentage depth dose (PDD) for 6 and 10 MV 
photon beams between MP512-EPI and CC13, Markus chamber, and MP512-Bulk. The 
PDD curves measured by MP512-EPI were slightly lower than those measured with 
CC13 and MP512-Bulk. The maximum discrepancy between MP512 and IC for 6 MV 
beams was approximately 1.5% and 0.8% at a depth of 30 cm for MP512-EPI and MP512-
Bulk relative to Dmax. Similar variations occurred when 10 MV beams were measured 
relative to Dmax; here the maximum discrepancies were 1.3% and 1% for MP512-EPI 
and MP512-Bulk. These results are commensurate with their dose per pulse response and 
are easy to correct, and the discrepancy is within allowable error of ±2%.   
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(a) (b) 
Figure 4.14:  Percentage depth dose measurement of MP512 compared to the Markus 
and CC13 ionisation chambers for (a) 6 MV and (b) 10 MV photon beams.  
4.3.4. Dose linearity  
The response of MP512-EPI at doses ranging from 1 to 500 MU show an excellent 
linearity for the 6 MV and 10 MV photon energies, and the regression coefficient r2 is 
almost equal to 1 (Figure 4.15). The linearity of MP512-EPI in this study had the same 
trend as the MP512-Bulk, as presented in Aldosari et al study [170]. 
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Figure 4.15: The average response of four central pixels of MP512-
EPI as a function of the accumulated dose (MU). 
 
 
4.3.5. Dose rate (MU/min) dependence 
The change in MP512-EPI sensitivity as a function of the dose rate (MU/min) is shown 
in Figure 4.16; the error bar indicated the uncertainties after measuring the (1SD) five 
times. The maximum variation was within ±0.5% for the 6 MV photon and 6 MeV 
electron energies; this means the MP512-EPI response is independent of dose rate for the 
clinically relevant MU/min.  
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Figure 4.16: Variation of MP512-EPI response as a function 
of the dose rate ( MU/ min)  for 6 MV photon and 6 MeV 
electron beams.  
4.3.6. Dose per pulse (DPP) dependence 
Figure 4.17 shows the variation of detector sensitivity (pC/Gy) as a function of the dose 
per pulse of MP512-Bulk and MP512-EPI at 6 MV with an average uncertainty of five 
times the measurements was ± 2% (1SD). The sensitivity response decreased as the dose 
per pulse of both detectors decreased. The MP512-EPI fabricated at a high resistivity of 
a 100 Ω cm p-Si epitaxial layer had a reduced sensitivity of up to 8% while the MP512-
Bulk fabricated at a low resistivity 10 Ω cm p-Si had a reduced response of approximately 
3% at a dose per pulse change of 10 times (at a minimum dose per pulse of 2.11×10-4 
Gy/pulse or SSD 370 cm). However, this reduction in sensitivity is within ±2% for both 
detector arrays at a clinically relevant distance (SSD less than 150 cm). 
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Figure 4.17: Sensitivity response of MP512-Bulk and MP512-EPI 
detectors as a function of dose per pulse for 6 MV photon beam. 
These responses were normalised to a dose per pulse of 2. 8×10-4 
Gy/pulse at the source to a surface distance of 100 cm.  
4.3.7. Output factor for small field size 
Figure 4.18 shows the output factors measured by MP512-EPI and MP512-Bulk 
compared to the MOSkin and gafchromic EBT3 films for 6 and 10 MV photon beams. 
The results show an excellent agreement within ±2% and ±3% for all field sizes ranging 
from 10×10 cm2 down to 0.5×0.5 cm2 for 6 MV and 10 MV photon energies. This is 
partially due to the small area of pixels of 0.5×0.5 mm2 for MP512-EPI and a suitable 
optimised air gap above MP512-EPI. 
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(a) (b) 
Figure 4.18:  The output factors measured by MP512- EPI and normalised to a 
10×10cm2 field radiation compared to those measured by MP512- Bulk, MOSkin and 
EBT3 film for (a) 6 MV and (b) 10 MV photon beams. 
 
4.3.8. Angular response 
The angular response of MP512-EPI decreased as the incident beam angle decreased due 
to their intrinsic configuration and material; this resulted in a difference in attenuation 
and a scattering of photons and electrons that reached the active volume of the pixels 
while irradiating from different directions. Figure 4.19 and Figure 4.20 show that the 
relative angular response has normalised to the incident angle zero for MP512-EPI and 
MP512-Bulk as the incident beam angle increased from 0° to 180°. The angular response 
of both detectors was similar, with any difference being between ±2% (Figure 4.20). 
Maximum variation relative to incident beam angles of 17.55±0.32% and 16.11±0.40% 
were present at incident beam angles between 90° to 100° for 6 MV and 10 MV photon 
beams. The angular response depends on photon beam energy, as shown in Figure 4.19, 
as determined by the difference in the photon and electron scattering conditions. 
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Figure 4.19: A comparison of the average response of four 
central pixels between 6 and 10 MV photon beams for 
MP512-EPI. 
 
  
(a) (b) 
Figure 4.20:  A comparison of the average response of four central pixels between 
MP512-EPI and MP512-Bulk for (a) 6 MV and (b) 10 MV photon beams.  
4.3.9. Segment linearity 
Figure 4.21 shows the response of MP512-EPI as a function of the dose segments of a 
constant 50 MU dose where the response increased with increasing irradiation segments. 
With segments of 2 MU or larger, MP512-EPI responded within ±2%. Figure 4.22 shows 
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the signal (pC) from the central pixel acquired during segmental beam irradiation where 
MP512-EPI had excellent uniformity and a repeatable dose response even after delivery 
with a low MU and large segments. 
 
 
Figure 4.21:  The response of MP512- EPI as a function of a 
segmental monitor unit (MU) normalised to 1×50 MU.  
4.3.10. Long-term reproducibility 
Figure 4.23 shows the relative sensitivity of MP512-EPI as a function of time 
measurements where sensitivity remained stable after photon irradiation up to 500 Gy 
over a period of 12 months. The change in reproducible sensitivity was within ±0.9%, 
with two standard deviations of 0.03; this result indicates that MP512-EPI could be used 
without recalibration for one year.  
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(a) (b) 
  
(c) (d) 
 
 
(e)  
Figure 4.22:  The response of MP512- EPI from the central pixel during segmental 
beam irradiation as a function of acquisition time; (a) One segment with 50 MU each, 
( b)  Two segments with 25 MU each, ( c)  Five segments with 10 MU each, ( d)  Ten 
segments with 5 MU each, and (e) Twenty five segments with 2 MU each. 
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Figure 4.23:  The average response of four central pixels of 
MP512-EPI as a function of time (months)  normalised to the 
first acquisition after pre- irradiation of 60 kGy.  The standard 
deviation is smaller than the marked symbol. 
4.3.11. Measuring the cross plane profiles  
Figure 4.24 and Figure 4.25 shows half of the cross plane profile measured by MP512-
EPI and gafchromic EBT3 film for field sizes ranging from 1×1 cm2 to 4×4 cm2. These 
illustrations show more detailed resolutions. The cross plane profiles for 6 MV photons 
have excellent agreement between the MP512-EPI and EBT3 films within ±1% and 0.6 
mm for FWHM and the penumbra region. These results are similar to the MP512-Bulk 
presented in a previous study. The cross plane profiles for 10 MV photons show a slight 
overestimation of FWHM, with a different value for a 1×1 cm2 field of up to 1.5%, 
however the difference for the penumbra region is still within 0.6 mm; this percentage 
difference decreases as the field size increases. The FWHM, penumbra width and 
percentage differences are summarised in Table 4.1. 
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Table 4.1: The FWHM and penumbra width measured by MP512-EPI and gafchromic 
EBT3 films 
Field 
size 
(mm) 
6MV  10MV 
EBT3 MP512-EPI Differences  EBT3 MP512-EPI Differences 
FWHM 
(mm) 
Penumbra 
(mm) 
FWHM 
(mm) 
Penumbra 
(mm) 
FWHM 
(%) 
Penumbra 
(mm) 
 FWHM 
(mm) 
Penumbra 
(mm) 
FWHM 
(mm) 
Penumbra 
(mm) 
FWHM 
(%) 
Penumbra 
(mm) 
10 9.95 2.43 10.04 2.95 0.94 0.52  10.18 2.83 10.34 3.37 1.57 0.53 
20 19.95 2.85 30.02 3.35 0.33 0.50  19.86 3.43 20.13 3.72 1.40 0.29 
30 29.91 3.13 29.95 3.66 0.14 0.53  29.92 4.01 30.11 4.58 0.65 0.57 
40 39.94 3.23 39.99 3.84 0.15 0.60  40.06 4.30 40.20 4.87 0.36 0.57 
 
 
Figure 4.24: Cross plane profiles measured by MP512-EPI and EBT3 film for 6 MV 
photon beams; (a) field size 1×1 cm2, (b) 2×2 cm2, (c) 3×3 cm2 and (d) 4×4 cm2. 
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Figure 4.25:  Cross- plane profiles measured by MP512- EPI and gafchromic EBT3 
film for 10 MV photon beams; (a) field size 1×1 cm2, (b) 2×2 cm2, (c) 3×3 cm2 and 
(d) 4×4 cm2. 
4.4. Conclusions  
A 2D monolithic detector array MP512-EPI was developed and characterised by re-
grading the radiation hardness, long term stability, PDD, dose per pulse measurement, 
output factor, dose linearity, angular response, cross plane profiles and segment linearity 
using 6 MV and 10 MV photon beams and 6 MeV electron beams for the dose rate 
response. The MP512-EPI characteristics demonstrated the usefulness of detector arrays 
as a quality assurance tool for radiation therapy. The detector’s high spatial resolution of 
2 mm and small active area of 0.5×0.5 mm2 means it can be used in small field 
measurements without the effect of radiation perturbation from averaging volume 
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measurement. Moreover, silicon substrate resistivity and the thickness of an active silicon 
layer from which a charge is collected will determine the dosimetric response of MP512. 
A modified detector with epitaxial technology improved its long term stability and 
sensitivity with an accumulated dose of approximately 0.3%/10 kGy, unlike the MP512-
Bulk fabricated on bulk silicon (5%/10kGy). This is because the initial diffused length of 
electrons in 100 Ω cm epi layer is longer than the 35 µm thick epitaxial layer. Degradation 
of the diffused length does not inherently depend on the collected charge until the diffused 
length is less than 35 µm. In the MP512-Bulk, any deterioration of the diffused length 
creates a deficit in charge collection, so the trade off is a higher variations of dose per 
pulse for an MP512-EPI pre-irradiated with 60 kGy compared to a MP512-Bulk pre-
irradiated with 40 kGy. However, at a typical treatment distance corresponding SSD <150 
cm (fixing source to iso-centric, SAD setup) and for all beam angles, the sensitivity of 
MP512-EPI and MP512-Bulk in terms of their dose per pulse varies within ±2%, although 
MP512-EPI provides good long term stability over a 12 month period or photon 
irradiation up to 500 Gy; these good characteristics means this detector does not need 
frequent recalibration.  
The output factor measured by MP512-EPI with 0.5 and 1 mm thick air gaps 
above the detector surface for 6 and 10 MV photon beams, respectively, agreed with 
gafchromic EBT3 film and MOSkin within ±2% for 0.5×0.5 cm2 fields, unlike in the 
previous study where MP512-Bulk had a 1.2 mm thick air gap for 6 MV photon beams 
had an over response of approximately 4% for fields less than 1×1 cm2 [170]. This was 
partially due to 0.5×0.5 mm2 area of pixels and the optimised air gap above MP512. The 
predominant electron scatter in the silicon diodes cause increased sensitivity to a small 
field size compared to the reference field because the density relative to water was higher 
[222]. Overestimating the diode detector due to a small field size can be mitigated by 
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providing a wide enough air gap above the detector, the wide of this air gap depends 
mainly on the design of the diode detector [223].  
The packaging and intrinsic asymmetry of the 2D monolithic detector array 
MP512 affects its intrinsic angular dependence [220][221]. The angular response of 
MP512-EPI fabricated on an epitaxial layer with a high resistivity of varied by ±2% when 
compared to the low resistivity bulk subtract (MP512-Bulk); this means the angular 
response of MP512 is independent of its resistivity and substrate type bulk or epitaxial.. 
The angular correction factor must be applied where the detector is not perpendicular to 
the radiation beam in order to deliver accurate pre-treatment measurements (refer to 
Chapter 3). The MP512-EPI demonstrated excellent dose linearity for small mu range 
(1-10 MUs) and large dose range (10-500 MUs); it also responded very well to the dose 
segments, especially large segments and small MUs (25×2 MU) within ±2%. This result 
confirms that MP512-EPI is a suitable verification tool for step and shoots and dynamic 
IMRT. Conventional radiotherapy usually delivers dose rates from 100 to 600 MU/min, 
whereas advanced treatment machines such as True beam (Varian) which deliver beams 
using flattening filter free or Cyberknife, deliver dose rates of approximately 800 MU/min 
up to 2400 MU/min [24][224]. Although the dose rates range from 100 to 600 MU/min, 
the measurements were within ±1%, which cannot conclude that MP512-EPI can provide 
stable response at dose rates that are higher than 600MU/min. Further study of dose rates 
and doses per pulse is warranted, particularly for flattening filter free beams.  
A high resolution MP512-EPI (2 mm) was needed to measure small fields of 1×1 
cm2 with an acceptable value in FWHM and the penumbra region for clinical use [60], 
whereas this study only investigated the sizes of simple square fields. Further study is 
needed using MP512-EPI in order to evaluate a patient qualification for small intensity 
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modulated treatment fields. A clinical QA using MP512-EPI in homogeneous and 
inhomogeneous phantoms will be presented in Chapter 5.  
 
 
 
 
  
 
 
 
 
Chapter 5  
Clinical implementation of a 2D 
monolithic epitaxial detector array for a 
small intensity modulated field 
 
5.1. Introduction 
SBRT is a complex treatment that uses the IMRT and VMAT technique with a high dose 
per fraction and a steep dose gradient. Verifying the dose is the major process needed to 
guarantee an accurate dose delivery to the patient. Pre-treatment QA or end-to-end test is 
used to verify treatment delivery, as well as calculating the treatment planning dose, the 
data transmission system from TPS to the linear accelerator, and the actual dose delivery 
[225]. The absolute dose and dose distributions of treatment planning are verified by 
comparing them with the actual dose measurements using a 1D, 2D, or 3D dosimeter. 
Several commercial 2D arrays have recently been used as a QA tool to measure the 
phantom such as MapCHECK (SunNuclear, Melbourne, Florida-USA), Octavius 1000 
SRS (PTW-Freiburg-Germany) and MatriXX (IBA Dosimetry, Bartless, TN), but their 5 
mm and 10 mm spatial resolutions are too coarse to detect any errors in the TPS, or the 
delivery system for small irradiation fields [226][225][227][102]. This lack of 
information can lead to an inaccurate treatment delivery. The MP512-EPI is designed for 
patient specific QA in small field treatments with a high spatial resolution of 2 mm pixel 
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pitch; a dosimetry characteristic that has proved it can be used as a quality assurance tool; 
as discussed in Chapter 4.  
 Although the MP512-EPI is angular dependent has a maximum deviation with 
respect to a zero angle up to 18% at a gantry incidence angle of 90°, the angular correction 
factor works well with cross-beam profiles between MP512-EPI corrected and 
gafchromic EBT3 films for small static irradiation beams down to 1×1 cm2 fields within 
±2%, as discussed in Chapter 3. 
This chapter describes the clinical implementation of MP512-EPI as a patient 
specific quality assurance dosimeter for small intensity modulation fields of IMRT and 
VMAT delivery to a homogeneous and inhomogeneous phantom based on Pinnacle3 
version 14 treatment planning system (TPS). The planar dose reconstructions of MP512-
EPI have verified a comparison to EBT3 film dose measurement and TPS calculation 
dose.     
5.2. Materials and Methods  
5.2.1. Two-dimensional monolithic epitaxial detector array (MP512-
EPI) 
The 2D monolithic epitaxial detector array used for the measurements was the MP512-
EPI; it consists of 512 diode pixels over an area of 52×52 mm2 with a high spatial 
resolution of 2 mm pixel pitch, as discussed in Section 4.2.1. 
5.2.2. Data acquisition system (DAQ) and inclinometer 
The MP512- EPI data acquisition system ( DAQ)  is based on a 64- channel analog front-
end electrometer ASIC chip where each chip is interfaced to a quad analogue- to- digital 
converter (ADC). The ADC output is synchronised and the channel is de- randomised by 
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a field programmable gate array (FPGA) that also manages the synchronisation with the 
sync pulse of the LINAC to acquire the detector current discussed in Section 3. 2. 2.  In 
this study, the inclinometer attached to the gantry stand utilised the angular correction of 
MP512-EPI during VMAT arc delivery for any gantry angle increment (Figure 5.1).  
The ADIS16209 dual-axis digital inclinometer has 0.025° angular resolution and 
a very accurate measurement state within ±0.1° [228] .  The inclinometer can operate at 
both single-axis (±180°) and dual-axis (±90°) using a standard power supply voltage of 
3. 3 V.  The function block diagram of the inclinometer is shown in Figure 5.2.  The 
inclinometer data of gantry rotation during irradiation was synchronised with the detector 
acquisition (ADC output) signal and de-randomised by FPGA using the same sync pulse 
of the LINAC.  A schematic diagram of the DAQ system synchronised with the 
inclinometer is shown in Figure 5.3. Data acquisition is transferred via USB2.0 to the in-
house software interface called Magic Suite version AFE_MP- 512i.  This software can 
store the inclinometer function and also display the instantaneous detector response for 
each gantry angle and integral detector for all the delivery angles ( Figure 5.4) .  The 
acquisition data can be used for online and offline analysis and it can reset the parameter 
of the inclinometer in the actual experimental setup (Figure 5.5). 
To validate the inclinometer measurement, the gantry angle measured was 
compared with the gantry angle indication stored by Varian MLC controller software. 
Gantry information is recorded in binary format every 50 minutes, and then exported to 
the DynaLog files that also contain essential treatment parameters such as the gantry 
angle, collimator angle, couch angle, jaw settings, and MU delivery and MLC leaf 
positions [229]. 
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Figure 5.1: The CMRP phantom with the MP512-EPI inserted in the coronal 
plane and associated device, DAQ, and inclinometer. 
 
 
Figure 5.2: The function block diagram of ADIS16209 
inclinometer [228]. 
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Figure 5.3:  Schematic diagram of data acquisition system (DAQ) synchronised with 
the inclinometer. 
 
 
 
(a) (b) 
Figure 5.4: The software interface Magic Suite; (a) the inclinometer indicator and (b) 
the angle (degrees) as a function of time. 
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Figure 5.5: Inclinometer settings function  
5.2.3. CMRP cylindrical phantom and insertions 
The 30 cm diameter by 40 cm long CMRP cylindrical phantom was used to measure the 
clinical validation plans; it was designed and developed to fully verify an actual gantry 
beam delivery for IMRT and VMAT, where the phantom produced a PMMA density of 
1.15-1.19 g/cm3, as discussed in Section 3.2.3. This phantom has a 15.5×20.5×5 cm3 
central slot into which homogeneous and inhomogeneous holders can be inserted.  Both 
holders were designed and developed in-house to allow the MP512-EPI detector and films 
to be positioned at the isocentre of the CMRP phantom. 
5.2.3.1. Design and fabrication of the homogeneous insertion  
The homogeneous holder was made from PMMA with the same specifications as the 
CMRP cylindrical phantom; it is 5 cm thick and has a 1 cm central cavity for an MP512-
EPI and its packaging (Figure 5.6). The 18.5 cm length of the lower part of the holder 
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was designed to support the detector’s electronic boarding to stop detector from shifting 
as the boarding sags due to gravity during experiments. 
 
Figure 5.6: The homogeneous holder and MP512-EPI packaging. 
5.2.3.2. Design and fabrication of an inhomogeneous insertion  
Tissues with different densities pose a challenge in clinical calculation and optimisation 
because determining a steep dose gradient region and penumbra is complicated, as is 
delivering an accurate dose to the heterogeneous region such as the thorax with the lungs, 
heart, and bones. To use an MP512-EPI to diversify clinical treatment, a holder and 
insertions were designed and developed by CMRP. Both items were made from red cedar 
because its physical density of 0.38 g/cm3 is equivalent to human lungs [230]. The holders 
have upper and lower parts that are connected with two pinpoints of carbon fibre inside 
two holds on the larger holder (Figure 5.7a). The inhomogeneous insertion section was 
established in two 1 cm thick squares that enable gafchromic EBT3 film and MP512-EPI 
to be placed inside, as shown in Figure 5.8. The MP512-EPI detector without a PMMA 
cover was sandwiched between two inhomogeneous slaps and fixed to the holder, as 
shown in Figure 5.7b. These insertions were moulded into two types, a spherical shape 
with a large water equivalent size of 1 cm3 and 2 cm3 (density of 1 g/cm3) to represent a 
tumour in the lung, while the second insertion has no tumour representation (Figure 5.8). 
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(a) (b) 
Figure 5.7: The inhomogeneous holder; (a) without and (b) with MP512-EPI. 
 
 
 
(a) (b) 
Figure 5.8:  The inhomogeneous insertion; (a) The upper and lower part of the insert, 
and ( b)  schematic cross- section of the inhomogeneous insertion with a tumor inside 
(not to scale).  
5.2.4. Computed tomography (CT) scan 
Radiation therapy needs electron density data so that the treatment planning can be 
calculated precisely. CT image datasets provide patient anatomy and structure, including 
the CT number or Hounsfield units (HU) that can be converted to information on electron 
density. The CMRP cylindrical phantom with homogeneous and inhomogeneous 
insertions was carried out by computed tomography (CT) using SOMATOM (Siemens 
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Healthineers, Erlangen, Germany) at ICCC Wollongong hospital (Figure 5.9). Three 
small markers were placed on the phantom surface to correspond to the central detector 
reference. Two imaging datasets with and without a detector inside the phantom were 
carried out for each holder. Axial slices 2 mm and a 512×512 matrix resolution were 
acquired for the homogeneous and inhomogeneous holder insertions by following the CT 
scan protocol for radiation therapy [231][6]. Typical scanning extends over the length of 
the entire phantom by avoiding any electronic part of the detector. The CT images with 
and without detectors are shown in Figure 5.10 and Figure 5.11. The cylindrical phantom 
data sets were sent to the Pinnacle3 TPS. 
 
 
(a) (b) 
Figure 5.9: MP512-EPI and phantom setup for CT scan (b) the lead marker used for 
reference points.  
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(a) (b) 
Figure 5.10:  The CT images for the homogeneous holder ( a)  with MP512- EPI, and 
(b) without MP512-EPI. 
  
(a) (b) 
Figure 5.11:  CT images of the inhomogeneous holder; ( a)  without MP512- EPI and 
(b) with MP512-EPI and with a hidden tumour. 
5.2.5. Clinical planning and optimisation  
Pinnacle3 version 14 (Philips Radiation Oncology Systems, Fitchburg, WI, USA) was 
used as a treatment planning system to conduct clinical experiments. An adaptive 
convolution superposition was used to calculate 6 MV photon beams on a 2 mm3 dose 
grid resolution.  This algorithm is a fast model-based 3D dose calculation method 
developed by Mackie et al. and AhnesjÖ based on dose spread array (kernel) convolved 
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with energy fluence through the medium volume (TERMA; Total Energy released per 
unit Mass) that accounted for the polyenergetic spectrum [232][233]. The algorithm 
accounts for beam attenuation, primary and secondary scattered electrons changing in 
heterogeneous  medium, as well as the beam modifier and patient contour effects using a 
ray-tracing technique during the superposition [234]. To account for heterogeneities, the 
kernels are density-scaled during superposition by “collapsed cones” that using a single 
ray corresponding to the central axis of a cone model in space, the set of cone utilised a 
lattice of rays [235]. Several studies have been showed that collapsed cone convolution 
(CCC) using in Pinnacle provide a high accuracy calculation in the heterogeneity medium 
such as lung and bone by revealed insignificant differences between predicted dose 
distribution measured, and Monte Carlo simulated dose [236]–[238].  
5.2.5.1. Homogeneity plan 
The clinical IMRT and VMAT plans for a small brain tumour (GTV size 2.5-3 cm) were 
transferred to the CMRP homogeneous phantom CT datasets. The isocentre of the clinical 
plan was aligned with the isocentre of the detector, and each plan was recalculated without 
changing the clinical planning parameters. Both plans delivered a nominal 2 Gy per 
fraction to the target volume. Seven fixed gantries at 0°, 50°, 100°, 150°, 210°, 260° and 
310° were to generate the step and shoot IMRT plans. The plan was delivered with a total 
of 369 MU. The VMAT plan consisted of a full arc (360°) using a four-degree control 
point (CP) angular increment with a total of 90 CP and delivered 410 MU.  
5.2.5.2. Inhomogeneity plan 
A small 1 cm3 solid water equivalent within the inhomogeneous phantom was used to 
represent the GTV of a lung tumour for IMRT and VMAT delivery. The PTV was 
extended by 0.5 cm in every direction. A nominal 3.5 Gy per fraction was delivered to 
the target volume, and six fixed gantries of 0°, 50°, 120°, 180°, 240° and 310° were used 
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to generate the step and shoot IMRT plans. The plan was delivered with 757 MU. The 
VMAT plan consisted of a full arc (360°) using a four -degree control point (CP) angular 
increment with 90 CP and a dose delivery of 835 MU (2.32 MU/degree). A summary of 
the planning parameters for both phantoms is shown in Error! Reference source not 
found.. The dose distribution recalculated in a CMRP phantom is shown in Figure 5.12. 
The 3D dose volume was exported as a DICOM dose file, and MATLAB 2016b (Math 
Works Inc., Natick, MA) was used to extract the planar dose distributions that 
corresponded to the specified detector measured plane. The TPS dose distributions were 
compared to the MP512-EPI and EBT3 film dose measurement.  
  
(a) (b) 
Figure 5.12:  Pinnacle3 version 14 TPS screenshots of the dose distribution cross-
sections through the iso- centre of the CMRP cylindrical phantom for axial, sagittal 
and coronal plane; (a) IMRT plan and (b) VMAT plan. 
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Table 5.1: Treatment delivery parameters for homogeneous and inhomogeneous 
phantoms.  
 
Phantoms 
 Pinnacle3 Planning parameters 
Dose 
(Gy/Fx) 
IMRT  VMAT 
Gantry MU  Gantry CP MU 
Homogeneity 2 0°,50°,100°, 
150°,210°, 
260°, 310° 
369  360° 4° 410 
Inhomogeneity 3.5 0°,50°,120°, 
180°, 240°, 
310° 
757  360° 4° 835 
 
5.2.6. Gafchromic EBT3 film 
In this study, EBT3 film (Ashland Advanced Materials, Bridgewater, NJ) with batch 
numbers 04071601 and 05181502 were used as a reference dosimetry tool for comparison 
to MP512-EPI. The curves of these films were calibrated for each batch number, and then 
the films were cut into 7×7 cm2 size pieces to fit into the homogeneous and 
inhomogeneous holders (Figure 5.13). The films were scanned before and after being 
irradiated for 48 hours by the Microtrex ScanMaker i800 flatbed scanner and Epson 
Expression 10000 XL. Each film was aligned in the centre of the scanner and scanned six 
times with 48-bit colour depth of RGB colour channels and a spatial resolution of 72 dpi 
(equivalent to a pixel size of 0.35278 mm). The process of calibrating and analysing the 
films was discussed in Chapter 3, Section 3.3.3.  
Chapter 5: Clinical implementation of a MP512-EPI 
 
122 
  
(a) (b) 
Figure 5.13:  Gafchromic EBT3 film cutting pieces using for patient verification; ( a) 
Homogeneity holder and (b) Inhomogeneity holder.  
5.2.7. Verifying the clinical delivery  
All measurements were carried out with a Varian Clinac iX (Varian Medical System, Palo 
Alto, CA) at ICCC Wollongong hospital. The LINAC is equipped with a 120-leaf 
Millennium multi-leaf collimator system where the inner 80 leaves provide a leaf width 
of 0.5 cm and 1 cm for the remaining outer leaves. Before the detector was used as a 
dosimeter in clinical verification, MP512-EPI had performed equalisation and relative 
dose calibration as discussed in Section 3.3.1. The MP512-EPI was inserted into the 
homogeneous and inhomogeneous holder to deliver head and lung treatment, 
respectively. The detector array inside the holder was placed in the coronal plane position 
of the PMMA cylindrical phantom (Figure 5.1). The phantom was put onto the middle of 
the couch to avoid colliding with gantry while rotating around the phantom. To minimise 
couch attenuation error, the phantom was place in the same location relative to its location 
when the couch attenuation factor was measured. The centre of the detector was aligned 
to the isocentre of the radiation beam using a 5×5 mm2 field to reposition the vertical, 
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lateral and longitudinal axis to a setup uncertainty within ±1 mm. The inclinometer was 
attached to the gantry stand and aligned to zero to indicate a gantry angle of zero.  
The clinical plans were delivered with the actual beam angles for IMRT and 
VMAT, and the angular dependence correction factors were applied to MP512-EPI 
measurements (the details will discuss in Section 5.9). Each IMRT and VMAT plan was 
delivered three times to justify the reproducibility of the detector measurement. Each plan 
was also measured using gafchromic EBT3 film at the same orientation setup. The 
composite dose measurements for MP512-corrected and EBT3 films were compared to 
the calculated dose exported from RTP using gamma analysis and by following criteria 
of 2%/ 2mm and 3%/3mm. The overall process of clinical validation is shown in Figure 
5.14. 
 
Figure 5.14: A schematic diagram of the clinically validated process. 
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5.2.8. The correction factor  
5.2.8.1. Angular dependence correction factor 
The MP512-EPI was investigated to determine how the detector response could be 
affected by angular dependence and to provide the maximum relative discrepancy with 
respect to the incident beam angle zero of approximately 18.6% and 17.7% for 6 MV and 
10 MV photon beams (refer to Chapter 4 section 4.3.8). Since the angular dependence 
of MP512-EPI would affect the accuracy of the patient plan verification when using arc 
therapy modalities, its angular correction method was developed and has been proven that 
it can be used in small static fields due to good agreement (±2%) of the corrected dose to 
dose measured with gafchromic EBT3 films, as discussed in Chapter 3.  
 The angular correction factor of MP512-EPI was also calculated using the same 
method as MP512-Bulk (Chapter 3). The factor obtained as a function of the MP512-EPI 
responding measurement ratio to the EBT3 film dose measured at Ɵ and normalised to 
the zero incident beam angle (Ɵ = 0°). The dose correction of MP512-EPI was adopted 
as shown in Equation (3.1) (as present in Chapter 3).  
 
 GH:%IJJ%KL =  >?
@
′ (A)
M
@(A)                                             (3.1)  
 
where GH:′ (<) is the MP512 experimental measured response signal (counts) for the 
particular angle, and :(<) is the calibration tensor for the open 10×10 cm2 field. 
 
The angles measured during VMAT delivery with an inclinometer were used to correct 
the integral 2D-dose mapping in a particular plane. To correct the VMAT plan, the 
angular correction factors were applied to accumulated MP512-EPI responses at gantry 
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angle increments of 1°, 5° and 10°, respectively. The exported data files from Magic Suite 
software called VMAT_angle.aux and VMAT_Decoded.txt were used for the 
calculations in this study. The angles measured with an inclinometer (±180°) were 
converted to the same scale as the Varian IEC scale (360°). MATLAB 2016b (Math 
Works Inc., Natick, MA) was used to apply the angular correction factor to the detector 
measurement and convert the detector response to a relative dose (see Appendix B for 
MATLAB scripts). A schematic diagram of the angular correction factor applied to 
VMAT is shown in Figure 5.15. The reconstructed composite dose of MP512-EPI for 
VMAT and IMRT were compared to the EBT3 dose measurement and the TPS 2D-dose 
plane.  
 
 
Figure 5.15:  A schematic diagram of MP512- EPI dose reconstructed for VMAT 
delivery.  
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5.2.8.2. Couch attenuation effect  
The treatment couch can have an impact on the TPS calculation and the treatment 
delivery. Some reports showed the influence that a couch build up  has on skin reaction 
and underestimated of the target dose by ignoring this factor when calculating and 
optimising doses [239][240]. The angular correction factor discussed in section 5.9.1 was 
calculated when the detector was in a vertical position, so the couch attenuation effect 
was not included. To ensure that the MP512-EPI dose reconstruction calculation is 
accurate, couch attenuation on patient dose verification should be investigated. The 
Varian Exact image-guide (IGRT) couch (Varian Medical Systems, Palo Alto, CA) was 
used. This couch was manufactured with less artefacts and radio-translucent material for 
image guidance radiation therapy such as Cone beam computed tomography (CBCT), or 
Megavoltage computed tomography (MVCT) [241][242]. The couch consists of 2 mm 
thick carbon fibre (density of 0.7 g/cm3) wrapped around a 5.2 mm water equivalent thick 
homogeneous foam core (density of 0.1 g/cm3) at 6 MV photons [243]. The couch was 
manufactured from materials with different thicknesses, as shown in Figure 5.16. 
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(a) 
 
(b) 
Figure 5.16:  Photographs of the Varian Exact image- guide 
(IGRT) couch and construction cross-section [241]. 
 
The CMRP cylindrical phantom was used to measure couch attenuation and provide the 
equivalent depth for all the angles under investigation. The MP512-EPI was placed in the 
centre of the phantom, 15 cm deep. The detector array faced upwards to be perpendicular 
to the iso-centre of the radiation beam at a gantry angle of zero degrees (0°). Because the 
IGRT couch has different thicknesses and attenuation depends on the beam’s angle of 
incidence, the posterior oblique angle was measured. A 10×10 cm2 field of 6 MV photon 
beams was irradiated with the gantry at four different angles; 0°, posterior (180°), and 
posterior oblique (135° and 225°). To exclude the angular dependence of MP512-EPI, 
the measurements were repeated with the detector face down to the couch and irradiated 
with the gantry at 0°, 45°, 180° and 315°. All the gantry measurements were repeated 
Chapter 5: Clinical implementation of a MP512-EPI 
 
128 
three times at dose rates of 600MU/min, and 100 MU delivered. The setup is shown in 
Figure 5.17. Couch attenuation was the ratio of the detector response measured with the 
couch (GH512cM) and without the couch (GH512c/I) (Equation 5.1).  
 
FKKSeFKIS = ,1 − >?PQf>?PQf/58 ∗ 100                                   (5.1) 
 
  
(a) (b) 
Figure 5.17: The setup used for the couch attenuation effect; (a) MP512-EPI face up 
and (b) MP512-face down.  
5.2.9. Gamma analysis  
A gamma map analysis is a valid quantitative tool for evaluating a 2D planar dose-
agreement between the expected dose distribution of the treatment plan and the actual 
dose distribution measurement [244]. This method was introduced by Low et al. in 1998 
[245][246]. The two principal factors using for comparing the dose distribution of a 
Gamma index are dose deviation (DD) or dose tolerance (∆D), and distance-to-agreement 
(DTA). The point of interest is calculated within the acceptance of an ellipsoidal shape of 
DD and DTA (Figure 5.18) [247]. The gamma value (γ) is computed for all the points in 
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the area of interest by following Equation 5.2. The pass-fail criteria rely on the γ value, 
so if γ ≤1 the calculation passes, and if γ >1 the calculation fails.  
hi = jk ∆JDlmQ n k∆LoomQ                                              (5.2) 
Where ∆r is the distance between a point on the distribution A and B, ∆d is the difference 
between the dose on distribution A and B. In clinical practice, it is accepted gamma 
criteria of 3%/3 mm for evaluation of dose delivered in comparison with planned. Dose 
delivery is acceptable if the passing rate exceed 90% [248]. However, the small field 
provides a high dose gradient leading to the fact that more robust tolerances criteria 
should be considered. The MP512-EPI has a high resolution of 2 mm and to evaluate 
suitability of MP512-EPI for for small field dose verification; the 2%/2mm and 1%/1mm, 
gamma index were used to quantify confidence limit of MP512-EPI to be useful tool for 
small field measurement. The gamma evaluation criteria using in this study were 
1%/1mm, 2%/2mm and 3%/3mm with a threshold dose of 10% of the maximum.   
 
Figure 5.18: Schematic diagram of gamma evaluation [247]. 
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5.3. Results  
5.3.1. The couch attenuation effect 
The couch attenuation value for a 10×10 cm2 field size measured by MP512-EPI showed 
the average value to be within ±1.3% and a standard deviation of ±0.05 (1SD). Maximum 
attenuation was 1.4% at a posterior oblique angle (135° and 225°). These results showed 
that couch attenuation was within ±2% and had no effect on the MP512-EPI response. 
Couch attenuation depends on the angle of the incident beam, and the field size and 
photon energy [249][250]. For VMAT and IMRT, the treatments were delivered at a 
segment field less than 10×10 cm2 and irradiated with an amount of treatment angles 
around the patients. The detector responses had an insignificant effect on the partial couch 
attenuation portion so the correction couch attenuation factors were not used to correct 
the dose reconstruction of MP512-EPI. 
5.3.2. Inclinometer verification 
The accuracy of dose reconstruction with MP512-EPI depends on the accuracy of gantry 
angle sampling during treatment delivery. Figure 5.19 shows the deviation for each gantry 
measurement during beam delivery as a function of time (ms). The accuracy of the 
inclinometer used in conjunction with our fast DAQ system was within ±1.5° (0.05% ), 
unlike the particular data point extracted from the Dynalog files during full arc (360°) 
delivery of VMAT.  
Chapter 5: Clinical implementation of a MP512-EPI 
 
131 
 
Figure 5.19:  Comparison of the gantry angle measured by 
the inclinometer and extracted from Dynalog files over full 
arc (360°) delivery.  
5.3.3. Clinical verification 
5.3.2.1. Homogeneous phantom  
A comparison of an MP512-EPI dose reconstruction, a gafchromic EBT3 film dose 
measurement, and a planar TPS dose for IMRT and VMAT are shown in Table 5.1. These 
results showed an excellent gamma passing rate of more than 95% (2%/2mm criteria) and 
98% (3%/3mm criteria) for the IMRT and VMAT plans. However, a lower gamma 
passing rate of 60% for all cases with criteria of 1%/1mm emerged when the MP512-EPI 
dose reconstruction and EBT3 dose measurements were compared. The 1%1mm criteria 
had a better gamma passing rate of 80% compared to the MP512-EPI dose reconstruction 
and TPS dose calculation. Figure 5.20 shows the comparison of planar dose 
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reconstruction of MP512-EPI and EBT3 film dose measurement. For IMRT delivery, 
Figure 5.21 and Figure 5.22 show the x-axis and y-axis dose profiles through the isocentre 
(central axis) and indicated off-axis points reconstructed from MP512-EPI measurements 
with and without angular correction and EBT3 film. In all cases there was excellent 
agreement between the dose profiles measured using EBT3 film and those reconstructed 
from angular corrected MP512 measurements. Figure 5.23 and Figure 5.24 show the 
comparison of dose profiles measured using EBT3 film and those reconstructed from 
MP512-EPI measurements for the VMAT case. The gamma passing rate (2%/2mm) for 
the VMAT plan delivery improved slightly as smaller gantry angles were used for the 
MP512 dose reconstruction. The gamma pass rates were 95.04%, 95.23%, and 95.56% 
for gantry angles used for dose reconstruction at 10°, 5° and 1°, respectively. For example, 
at an off-axis of 2 cm, as shown in Figure 5.23(b) and (e), the agreement between the 
angular corrected MP512 and EBT3 film measurements can be improved using smaller 
angles because the dose can change rapidly over a small angular segment.  
5.3.2.2. Inhomogeneous phantom 
A comparison of MP512-EPI dose reconstruction, gafchromic EBT3 film dose 
measurement, and planar TPS dose for IMRT and VMAT for an inhomogeneous phantom 
are shown in Table 5.2, with similar results as those measured in homogeneity; they 
indicated an excellent gamma passing rate of more than 95% (2%/2mm criteria) and 98% 
(3%/3mm criteria) for IMRT and VMAT plans when MP512-EPI dose reconstruction 
was compared with EBT3 dose measurement and TPS dose calculation. MP512-EPI dose 
reconstruction compared to EBT3 dose measurements showed a lower percentage passing 
rate of 70% for 1%/1mm criteria but the pass rate was more than 85% when compared 
with the TPS dose calculation. Figure 5.25 shows a comparison of the planar dose 
reconstruction of MP512-EPI and EBT3 film dose measurement for the VMAT plan 
Chapter 5: Clinical implementation of a MP512-EPI 
 
133 
delivery. Figure 5.26 and Figure 5.27 shows the x-axis and y-axis dose profiles through 
the isocentre (central axis) which indicated that off-axis points were reconstructed from 
MP512 measurements with angular correction and EBT3 film. 
 
Table 5.1:  Summary of the gamma passing rate of IMRT and VMAT plan delivery to 
CMRP homogeneous phantom  
Cases 
Agreement Criteria 
1%/1mm 2%/2mm 3%/3mm 
MP512-EBT3 MP512-TPS MP512-EBT3 MP512-TPS MP512-EBT3 MP512-TPS 
IMRT 69.97 89.47 96.25 98.46 98.38 100 
VMAT-
1°sampling 
corrected 
56.21 82.70 95.56 98.77 99.79 100 
VMAT-
5°sampling 
corrected 
55.28 81.39 95.23 98.77 99.79 100 
VMAT-
10°sampling 
corrected 
53.73 80.13 95.04 98.77 99.79 100 
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(a) 
 
(b) 
Figure 5.20:  A comparison of planar dose reconstruction of MP512- EPI and 
gafchromic EBT3 film dose measurement for (a) IMRT and (b) VMAT plans delivery. 
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Figure 5.21: A comparison of Superior-Inferior dose profiles measured with gafchromic EBT3 
films and reconstructed from MP512-EPI measurements with and without angular correction, 
to deliver an IMRT plan to a homogeneous phantom as a function of distance from the centre; 
(a)  the beam profile at the centre, (b)  the off-axis profile above the central 2 cm, (c)  the off-
axis profile above the central 1 cm, (d) the off-axis profile below the central 1 cm, and (e) the 
off-axis profile below the central 2 cm. 
Chapter 5: Clinical implementation of a MP512-EPI 
 
136 
Figure 5.22:  A comparison of Left- Right dose  profiles measured with gafchromic 
EBT3 films and reconstructed from MP512 measurements with and without angular 
correction to deliver an IMRT plan to a homogeneous phantom as a function of distance 
(mm) from the centre; (a) the beam profile at the centre, (b) the off-axis profile 2cm 
right of centre, (c) the off-axis profile 1cm right of centre, (d) the off-axis profile 1cm 
left of centre, and (e) the off-axis profile left 2cm left of centre.  
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Figure 5.23:  A comparison of Superior- Inferior dose profiles measured with 
gafchromic EBT3 films and reconstructed from MP512 measurements with and 
without angular correction, to deliver a VMAT plan to a homogeneous phantom as a 
function of distance (mm) from the centre; (a) beam profile at the centre, (b) the off-
axis profile 2cm above the centre, (c) the off-axis profile 1cm above the centre, (d) the 
off-axis profile 1cm below centre, and (e) the off-axis profile 2cm below centre.  
Chapter 5: Clinical implementation of a MP512-EPI 
 
138 
Figure 5.24:  A comparison of Left- Right dose profiles measured with gafchromic 
EBT3 films and reconstructed from MP512 measurements with and without angular 
correction to deliver a VMAT plan to a homogeneous phantom as a function of distance 
(mm) from the centre; (a) beam profile at the centre, (b) the off-axis profile 2cm right 
of centre,  (c) the off-axis profile 1cm right of centre, (d) the off-axis profile 1cm left 
of centre, and (e) the off-axis profile 2cm left of centre.  
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Table 5.2:  Gamma passing rate of IMRT and VMAT for a CMRP inhomogeneous 
phantom 
Cases 
Agreement Criteria 
1%1mm 2%/2mm 3%/3mm 
MP512-EBT3 MP512-TPS MP512-EBT3 MP512-TPS MP512-EBT3 MP512-TPS 
IMRT 69.97 89.47 96.90 96.17 99.40 100 
VMAT-
1°sampling 
corrected 
73.53 83.33 97.06 99.17 99.12 100 
VMAT-
5°sampling 
corrected 
72.94 83.75 97.06 99.17 99.12 100 
VMAT-
10°sampling 
corrected 
72.65 79.58 96.76 98.33 99.12 100 
 
 
Figure 5.25:  A comparison of planar dose reconstruction of MP512- EPI and 
gafchromic EBT3 film dose measurement to deliver VMAT plans.   
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Figure 5.26:  A comparison of Superior- Inferior dose profiles measured with 
gafchromic EBT3 films and reconstructed from MP512 measurements with an angular 
correction for a VMAT plan delivered to an inhomogeneous phantom as a function of 
distance (mm) from the centre; (a) beam profile at the centre; (b) the off-axis profile 
1. 5cm right of centre,  ( c)  the off- axis profile 1cm right of centre, ( d)  the off- axis 
profile 1cm left of centre, and (e) the off-axis profile 1.5cm left of centre.  
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Figure 5.27:  A comparison of Left- Right dose profiles measured with gafchromic 
EBT3 films and reconstructed from MP512 measurements with angular correction for 
a VMAT plan delivered as a function of distance ( mm)  from the centre; ( a)  beam 
profile at the centre, (b) the off-axis profile 2cm right of centre, (c) the off-axis profile 
1cm right of centre, ( d)  the off- axis profile 1cm left of centre, and ( e)  the off- axis 
profile 2cm left of centre.  
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5.4. Conclusions 
To compare a clinical plan, the percentage passing rate of IMRT compared to gafchromic 
EBT3 film and RTP dose calculation was almost 95% and 100% when following the 
2%/2mm and 3%3mm gamma criteria for homogeneous and heterogeneous phantoms. 
With VMAT, the agreement between angular corrected MP512-EPI dose reconstruction 
and EBT3 film measurements can be improved using a smaller angular sampling interval 
because the dose can change rapidly over a small angular segment (Figure 5.23 and Figure 
5.26). The accuracy of dose reconstruction with MP512-EPI depends on the accuracy of 
gantry angle sampling during treatment delivery, but with VMAT plans, the four degree 
control points of TPS dose optimisation were not a fine enough sampling point to perform 
different percentage passing rates when the MP512-EPI dose reconstructions, EBT3 films 
dose measurements, and RTP dose calculation were compared. The homogeneous and 
heterogeneous phantom measurements showed a lower agreement between MP512-EPI 
dose reconstruction and EBT3 films dose measurement than the TPS dose calculation for 
a gamma passing rate of 1%/1mm criteria. The set-up error may influence this result 
because EBT3 films positioned in the holder could experience misalignment during setup 
due to the holder being configured and the small gap shown in Figure 5.13; moreover the 
small radiation field in the heterogeneous medium means that the accuracy of the dose 
calculation algorithms is more important. The accuracy of dose perturbations within the 
inhomogeneity and at the interface region between two different mediums depends on the 
secondary electron transport modelling used during optimisation and calculation. 
Pinnacle3 uses a convolution superposition algorithms so it tends to underestimate the 
dose to a low-density medium such as lung tissue [234][251], but the agreements between 
MP512-EPI dose reconstruction and TPS dose calculation were almost 98% at a tolerance 
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of 2%2mm, and maintained more than 99% at a tolerance of 3%/3mm, which could be 
acceptable for clinical practice. 
These results demonstrated the clinical feasibility and accuracy of  MP512-EPI as 
a real-time dosimetry QA tool with a high spatial resolution for small fields (less than 
5x×5 cm2) as used for SBRT. The QA procedure is practical and convenient for routine 
patient specific verification for small intensity modulated fields. Future work will be 
devoted to the development of a Quadro MP512-EPI detector comprised of four tiled 
MP512-EPI to allow for a sensitive area 10×10 cm2 while maintaining the same spatial 
and temporal resolution. 
  
 
 
 
 
Chapter 6  
 3D dose reconstruction using MP512- 
EPI 
6.1. Introduction  
Current patient specific verification using 2D dose distributions comparison between the 
treatment planning (TPS) dose calculation and dose measurement in the phantom is the 
primary choice in approach to QA in IMRT and VMAT delivery. However, the 2D 
gamma agreement has weak correlation to be clinically meaningful, so 3D dose 
distribution verification was introduced as a powerful QA tool for advanced treatment 
delivery because the results can be correlated with the clinical dose distribution histogram 
(DVH). In principle, the actual 3D dose can only be measured by polymer gel developed 
from radiation-sensitive materials. The other commercial 3D dose distribution 
measurement in a phantom such as DELTA4®, ArcCheck, and OCTAVIUS® 4D systems 
are known as a Quasi-3D dose reconstruction. DELTA4® and ArcCheck have a specific 
detector arrangement and reconstruct 3D dose measurements using the dose relative to 
the treatment planning dose calculation [139][144]. OCTAVIUS® 4D system is an 
independent QA tool that can calculate 3D dose distribution using the independent simple 
data input of a 2D planar detector array measure combination with a rotating phantom 
that rotates perpendicular to the irradiation beam delivery [227]. Although these devices 
have good results, 3D dose reconstruction based on coarse detector density (5 mm -10 
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mm) might not be suitable as the QA tool for small field dosimetry such as SRS and 
SBRT delivery.  
This chapter extends the study described in Chapter 5, which demonstrated the 
excellent agreement of 2D dose distribution measurement using the MP512-EPI 
comparison to gafchromic EBT3 films and TPS dose calculation. This chapter aims to 
introduce the use of MP512-EPI as an independent 3D dose distribution reconstruction 
QA device for small field dosimetry based on the dose calculation method proposed by 
Allgaier et al. [149]. The second purpose is to review and discuss the potential of dataset 
measured by MP512-EPI and used for clinical 3D dose reconstruction.  
6.2. Theoretical background of 3D dose reconstruction  
The critical aspect of modelling the dose distribution in a patient is the interpolation and 
correction of measured data. ArcCheck and DELTA4® using the 3D dose reconstruction 
that related to the TPS planning. ArcCheck combine with 3DVH software to reconstruct 
3D dose distribution using the algorithm call ArcCheck Planar Dose perturbation 
(ACPDP). Due to the detector of ArcCheck placed on the cylindrical surface, the dose 
inside the phantom is estimated by convolving TERMA and 3D_kernel using the 
measured dose at entry and exit detector. Each dose voxel inside the phantom 
renormalizes to the same dose voxel calculated from the TPS then use those ratio data to 
generate 3D dose distribution [252]. The 3D dose verification and its comparison with 
dose predicted by TPS also provided by DELTA4® system. DELTA4® generate dose along 
radiation rays path by renormalizing the TPS calculation to fit the measured dose at 
intersect bi-planar diode then use this data to reconstruct 3D dose inside the phantom 
[253]. Both of these systems reconstruct 3D dose distributions relying on the TPS dose 
calculation dose while Octavius 4D system uses independence algorithm to reconstruct 
3D dose.  
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The Octavius 4D system reconstructs 3D dose distribution using 2D planar detector 
(seven29, SRS1000 and 1500OC) in conjunction with a rotating able phantom 
(OCTAVIUS 4D phantom). To eliminate angular dependence, the detector plane is 
rotated and synchronised with the treatment gantry to keep the detector perpendicular to 
the radiation beam during delivery, as shown in Figure 6.1.  
  
(a) (b) 
Figure 6.1: OCTAVIUS® 4D system; (a) the component of OCTAVIUS® 4D system 
and (b) the phantom rotates synchronised with the treatment gantry [254]. 
 Allgaier et al. [149] investigated and demonstrated the simple algorithms of the 3D dose 
reconstruction based on PDDs data. The PDDs for different field sizes were measured at 
SSD 85 cm in a water phantom and implemented into the Verisoft software. The dose of 
each voxel along the ray line (Dr) at a distance r was calculated to correspond to the dose 
obtained from the current detector Ddet(0) at the current angle, as given by the Equation 
6.1 [149][148]. With the non-central axis detector, the Tissue phantom ratio (TPR) 
correction factors were applied according to Tailor et al. [255] for flattening filter beams 
and Georg et al. [256] for flattening filter free beams. The dose was calculated for all 
detectors and summarised for all the angular measurements. 
 
;V=  K;0= ?;J=?;+=                                               (6.1) 
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However, the patient densities are not as homogeneous as the phantom. The PDDs was 
converted to TPRs and the depth along the ray line in the patient CT was scaled to the 
depth in water. The patient dose (DCT) calculation algorithm was modified based on the 
above equation and given by Equation 6.2. 
 
MD  K D?;pq=D?;pU07= ∙ kFU07Fq m
Q
                                     (6.2) 
  
Where 9K and 9MD are the distance from the source to detector and current voxel;sMD=, 
respectively.  
6.3. Data measurement for commissioning and the factor 
involved in 3D dose reconstruction 
All the data measurements were carried out on a Varian Clinac iX (Palo Alto, CA) at the 
Illawarra Cancer centre (ICCC), Wollongong Hospital, Australia. These measurements 
were implemented using 6 MV photon beams because this energy is commonly used in 
intensity modulated techniques such as IMRT and VMAT. 
6.3.1. Percentage depth dose (PDD) measurement and off-axis ratio 
(OAR) 
The important data implementation for 3D dose reconstruction using MP512-EPI is the 
PDD dataset because PDDs depend on the beam quality, depth, field size and SSD. The 
beam data implemented to some TPSs or physical validation software for radiotherapy is 
generally based on small ionisations or diodes measured in a water phantom, but this 
technique is limited to point measurements and appropriated detector selections that will 
markedly increase the inaccurate data implementation. In this study, MP512-EPI was 
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used to measure and generate the dataset for each active pixel MP (ij,z,r). Theoretically, it 
is problematical to measure the PDD curves in the PMMA cylindrical phantom itself 
because there is no slot that can provide a different depth within the phantom except at 
the isocentre depth (zphy = 15 cm). To simplify the PDDs measurement within the original 
phantom, MP512-EPI was measured in a Gammex-RWI (Middleton, WI) solid water 
phantom slap size 30×30 cm2 and fixing the SSD at 85 cm, which corresponds to the SSD 
of a CMRP phantom. The PDDs were measured by varying the depth of the detector from 
0.5 cm to 30 cm (Figure 6.2) and the irradiating the detector at field sizes from 1×1cm2 
to 10×10 cm2. Although, the solid water phantom RMI has a density ;t  1.04 * ∙
wxQ) close to water equivalent (t = 1.00 * ∙ wxQ) the dose distribution within the 
solid water phantom is not completely matched with the water phantom [257]. Moreover, 
the MP512-EPI was sandwiched between 5 mm thick PMMA, so the depth measurement 
must be scaled to the appropriate water-equivalent depth (zeq) as shown in the Equation 
6.3, using the mass density in Table 6.1. 
 
s =  yz{70/ sR|tR| + s"it"i                                             (6.3) 
 
Where zsw and zpm is the depth in a solid water phantom and PMMA, and tR| and t"i is 
the mass density (* ∙ wxE) of the solid water material and PMMA, respectively. 
This measurement also provides the off-axis ratio (OAR) of each pixel (MP512ij,z,r) for 
depth z and field size r, where i is the active pixel in the x-direction, and j is the active 
pixel in the y-direction. The off-axis ratio ( }~:,p,J) is the ratio between a dose for 
particular points (:,p,J) and the dose at the central axis ((E,E),p,J) where the central 
pixel ij is 13,13; this calculation is given by Equation 6.4. 
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 }~:,p,J =  
@,,/(],]),,/                                              (6.4) 
 
Figure 6.2: Geometry used for PDDs measured 
by MP512- EPI at an SSD of 85 cm for 6 MV 
photon beams. 
6.3.2. Measuring the tissue maximum ratio (TMR)  
The tissue maximum ratio (TMR) is the ratio between the dose measured in the phantom 
at a particular depth (Dz) and the dose at maximum (Dmax) at the same distance (SAD) 
[37]. TMR is insensitive to the SSD set up and depends on the depth of measurement (z) 
and field size at the depth of measurement (rd). TMRs can generally be calculated by 
Equation 6.5 based on the PDDs data while ignoring  the peak backscatter factor (BSF), 
where z is the depth of measurement, rd is the field size at the isocentric, and ℎ is the 
photon energy [258][259].  
 
G~;p,J,ℎ= ≈  ?;,/,TTU,ℎ=++ k OOpOOp{m
Q                             (6.5) 
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According to Equation 6.5, PDDs with a smaller field are recommended to calculate the 
TMRs because measuring PDDs with a field size of less than 3×3 cm2 is difficult in 
practice because the detector must be moving, whereas TMRs can be measured with a 
stationary detector. TMRs for small fields are preferred for direct measurement which is 
why the TMR dataset in this study was measured in a solid water phantom using the 
MP512-EPI; these measurements were for 1×1 cm2, 2×2 cm2, 3×3 cm2, 4×4 cm2, 5×5 cm2 
and 10×10 cm2 fields. The MP512-EPI was placed at a source to axis distance (SAD) of 
100 cm and was provided with a full solid water phantom backscatter thickness of 10 cm, 
while the solid water slaps above the detector were placed from 0 to 30 cm, as shown in 
Figure 6.3. The TMRs that were scaled to a water-equivalent depth were compared to the 
data measured by Markus (ICCC dataset) in the water phantom for field sizes from 3×3 
cm2 to 10×10 cm2, whereas the TMRs for small fields of 1×1 cm2 and 2×2 cm2 were 
compared to TMRs measured by the CC01 ionisation chamber and stereotactic diode field 
detector (SFD), as provided by Li et al. and Cheng et al. [260], [261]. 
 
Figure 6.3:  Geometry used for TMR measured by MP512- EPI at SAD of 100 cm for 
6 MV photon beams.  
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6.3.3. Electron density of the CMRP phantom 
The PMMA cylindrical phantom was scanned with the SOMATOM (Siemens 
Healthineers, Erlangen, Germany) at ICCC Wollongong hospital. Details of the scan 
protocol are described in Chapter 5, section 5.2.4. The CT data provided the mass and 
electron density of tissues that were involved with the accuracy of the treatment 
calculation and optimisation. The CT number (NCT) or Hounsfield Units (HU) were 
calculated based on the linear attenuation coefficient within the material iFK;^, = 
relative to the attenuation of water  |FKJ;^, =; this dose calculation can be described 
as Equation 6.6 [262].  
 
MD   k{7z{70/z{70/ m ∗ 1000                                      (6.6) 
 
HU depended on the electron density and atomic number as well as the spectra energy 
used for the CT scan. 
Over the past decade most treatment planning algorithms, such as the pencil beam (PB), 
and the analytical anisotropic algorithm (AAA) and collapsed cone (CC) modelled the 
heterogeneous correction of each voxel using an equivalent path length (EPL) based on 
the mass density obtained from the CT value [263]. The CT calibration phantom with 
known mass densities that are relative to human tissue was scanned to calculate the NCT 
to the mass density calibration curve; a sample of the CT curve is shown in Figure 6.4. 
However, the EPL method overestimated the dose for bones and air, which is why J. Seco 
et al. introduced the electron density scaling method (eEPL) to correct the heterogeneous 
depth in the photon dose calculation [264]. The eEPL has been shown the excellent 
primary photon beams estimated within 1% for energies ranging from 4 to 20 MV; it is 
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also related to the mass density (tiL) and effective atomic number (klmiL) as given 
by Equation 6.7 and 6.8.  
t0 =  tiL × klmiL                                               (6.7) 
 
H =  ∑ (0iL y00y0z{70/                                               (6.8) 
Where the electron density of the medium is t0 , and the physical length of the medium 
is (0  . 
According to Equation 6.8 the inhomogeneous correction factor based on the PDDs data 
at particular field size (r) is calculated by Equation 6.9. 
 
 = ?0,/?k.ℎ,/m ∙ ,
OOp0OOp.ℎ 8
Q
                                   (6.9) 
 
Where sB? is the equivalent depth and s"ℎ is the physical depth.  
 
In this study, eEPL was used to scale the dose distribution and generate the lookup table 
for MP512-EPI measurements combined with the CMRP phantom. Table 6.1 shows the 
physical mass density and electron density of each phantom used in this study. 
 
 
Chapter 6: 3D dose reconstruction using MP512-EPI 
153 
 
Figure 6.4: The NCT to mass and electron density calibration curve 
normalised to water [264]. 
Table 6.1: Characteristic of phantom materials [264][265]. 
Phantom Mass density  
( ∙ ) 
Zeff 
(Photoelectric) 
(Z/A)eff Electron density 
relative to water 
Water 1.000 7.42 0.555 1.000 
Solid water phantom 
(GAMMEX-RMI457) 
1.042 8.06 0.536 1.006 
White water RW3 1.045 5.71 0.536 1.009 
Plastic water CIRS 1.013 7.92 0.545 0.995 
Polystyrene 1.060 5.69 0.538 1.028 
PMMA cylindrical 
phantom 
1.170 6.24 0.539 1.136 
 
6.3.4. Equivalent square field calculation 
The equivalent square radiation field is the field size that provides the same amount of 
radiation attenuation and scatter as the field size given with the same SSD. The equivalent 
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square is calculated to determine the appropriate PDDs and TMRs used in the dose 
distribution reconstruction. The equivalent square field (Aeq) can generally be computed 
using a simple equation and by following Day’s rule (if the field size has the same 
area/perimeter; A/P) for a rectangular field with the width of x and side of y, as shown in 
Equation 6.10 [266][259].  
 
}  Q!!  4 kl?m                                                (6.10) 
 
However, the IMRT and VMAT delivery that yielded the complex irregular fields must 
consider the scattering irradiation portion for the equivalent square field calculation. 
Several algorithms were used to calculate the irregular fields in the dose calculation 
software such as the ALFARD and Clarkson method [267], but this equation is 
complicated and time consuming. Equation 6.11 is based on the polar coordinate that 
proved to be a valid equation for comparing the equivalent field calculation to the 
experiment data [268][269]. Figure 6.5 shows the relationship between a circular field 
and a rectangular field, using the polar coordinates.  
 
}   QQ. k!m
 ¡km¢  k!Qm
 ¡km¢ k!Qm
 ¡km¢ k!QQm
 ¡km¢ ×
^X £Q¤ ¥¦ ln;cos <=¬­®
¡km¬­®¡km¢ ¯< n ¦ ln;cos <=
¬­®¡km¬­®¡km¢ ¯< n
¦ ln;cos <=¬­®¡km¬­®¡km¢ ¯< n ¦ ln;cos <=
¬­®¡km¬­®¡km¢ ¯< − ;1 −
K= ∑ ∬ Wℎ±(¯ ±ℎS² L!L!³´                                                                      (6.11) 
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Figure 6.5: The relative field size equivalent using the polar coordinates [268].  
6.3.5. Verifying the dose reconstruction for a small static field 
The 3D reconstruction method using MP512-EPI in combination with a CMRP phantom 
can be concluded, and is shown in Figure 6.6. The accuracy of dose reconstruction using 
the implemented data (PDDs, OARs, and TMRs) measured by MP512-EPI was tested on 
a static 3×3 cm2 open field at 6 MV photon beams. This size field was selected because 
it is suitable for an active detector area (5×5 cm2) that could ultimately be compared to 
FWHM and the penumbra. Moreover, a smaller field size could not be verified because 
the smallest field size data that could implemented to the TPS (Pinnacle V9.6) at CMRP 
was 3×3 cm2. The MP512-EPI was aligned at the isocentre of the CMRP phantom and 
the detector was irradiated with a 100 MU dose at 600 MU/min with the gantry at zero 
degrees. The cross beam profiles were reconstructed using the PDD and TMR dataset at 
physical depths of 1.5, 5, 10, 20, and 25 cm, which corresponded to the water-equivalent 
depth (electron densities corrected) of 1.704, 5.68, 11.36, 22.72 and 28.4, respectively. 
The reconstructed cross beam profiles were compared to the dose profiles obtained from 
The TPS. 
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Figure 6.6: Summary of the 3D dose reconstruction based on the algorithm by Allgaier 
et al. [149].   
6.4. Results 
6.4.1. PDDs curve and off-axis ratio (OAR) 
Figure 6.7 shows the PDD curves of the central axis pixels as a function of water-
equivalent depth for different size fields. The PDDs curve measured by MP512-EPI was 
scaled to the water-equivalent depth using the mass density presents in Equation 6.3 and 
the shape preserving interpolant function from MATLAB. The PDDs measurement using 
MP512-EPI also contained the off-axis ratio dataset, as shown in Figure 6.8 and Figure 
6.9. The PDD and OAR dataset will be installed as a matrix of field sizes and depths. 
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Figure 6.7:  Central- axis percentage depth dose ( PDD)  curves measured by MP512-
EPI at an SSD of 85 cm and normalised to a dose at Dmax for 6 MV photon beams 
ranging from 1×1 cm2 to 10×10 cm2. 
 
 
Figure 6.8:  The off- axis ratio ( MP13j, 10,r) measured by MP512- EPI for different size 
fields at a depth of 10 cm and SSD of 85 cm. 
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(a) 
 
 
(b) (c) 
Figure 6.9: The off-axis ratio of field size 3 × 3cm2 for 6 MV photon beams measured 
by MP512-EPI at SSD 85 cm; (a) 2D response map of the off-axis data for each pixel 
MP( ij)  at depth 1. 5 cm, ( b)  the off- axis present in the 3D matrix and ( c)  the off- axis 
ratio of MP(13,j) at different depths.  
6.4.2. Tissue maximum ratio (TMR) data 
Figure 6.10 shows a comparison of central isocentric TMR curves measured by MP512-
EPI and different detectors for various size fields. The difference in percentage relative 
to Dmax between MP512-EPI, the CC01 ionisation chamber, SFD, and the Markus 
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chamber are shown in Table 6.2. The TMRs measured by MP512-EPI showed the average 
relative error to Dmax was within ±1.5% in comparison to the reference detectors. The 
maximum under estimation was 1.09% for a 10×10 cm2 field at a water-equivalent depth 
of 30 cm.  
Table 6.2: The relative errors (Dmax) of the tissue maximum ration (TMR) measured by 
the MP512-EPI, Markus, CC01 and SFD.  
WED 
(cm) 
Field sizes (cm × cm) 
1×1 2×2 3×3 4×4 5×5 10×10 
MP-CC01 MP-CC01 MP-SFD MP-Markus MP-Markus MP-Markus MP-Markus 
1.5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
5 0.60 -0.10 -0.30 -0.86 0.01 0.05 -0.25 
10 -0.10 -0.40 0.00 -0.29 -0.27 -0.14 0.57 
15 0.00 -0.60 -0.50 0.51 -0.01 -0.72 0.05 
20 -0.50 -1.00 0.30 0.64 -0.38 -0.53 -0.69 
25 -0.20 -0.90 0.20 0.24 -0.05 -0.69 -1.08 
30 -0.60 -0.70 0.10 0.35 0.28 -0.30 -1.09 
 
 
Figure 6.10:  The tissue maximum ratio curves for different size fields as 
measured by MP512-EPI, Markus, CC01, and SFD.  
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6.4.3. Verifying the dose reconstruction for a small static field  
Figure 6.11 shows a comparison of the cross beam profiles of a reconstructed dose along 
the central axis (MP13,j) of a 3×3 cm2 open field for 6 MV photon beams based on PDD 
and TMR dataset, where the dose was obtained from TPS at different depths. The results 
showed an excellent agreement along the cross beam profiles. The dose agreements in the 
centre of the beam for all depths were almost within ±2%, except for the physical depth 
of 1.5 cm that had an error up to 2.3% for the dose reconstruction based on PDD data 
corrected. The FWHM and penumbra for both methods showed excellent agreement 
within 0.0875±0.62% and 0.0962±0.85 mm. The different agreement between TPS, PDD, 
and TMR corrected methods were summarised and shown in Table 6.3. 
 
Table 6.3: The different agreement of cross beam profiles between the reconstructed and 
TPS for different physical depths. 
Physical 
depth (cm) 
FWHM (%)  Penumbra (mm) 
PDD 
corrected 
TMR  
corrected 
 PDD  
corrected 
TMR 
corrected 
1.5 0.4547 -0.1414  -1.3670 0.7530 
5.0 0.7911 0.9420  -1.0960 1.1540 
10.0 0.1596 0.1596  -1.0760 1.0760 
20.0 -0.6554 0.6115  -0.6320 0.3650 
25.0 -1.2980 -0.1489  -0.4420 0.3030 
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(a) (b) 
  
(c) (d) 
 
 
(e)  
Figure 6.11: The cross beam profiles reconstructed along the central axis (MP13,j) of 
a 3×3 cm2 open field for 6 MV photon beams were compared to those obtained from 
TPS at a physical depth of (a) 1.5 cm, (b) 5 cm, (c) 10 cm, (d) 20 cm and (e) 25 cm.  
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6.5. Conclusions  
Verifying the 3D dose distribution involved many steps, such as the efficiency of the 
detector, design of the phantom, the data implemented and the reconstructed algorithms. 
This chapter is the primary step for reconstructing a 3D dose using MP512- EPI in 
conjunction with CMRP phantom, and based on the PDD and TMR calculation methods. 
In this study we found that reconstructing a 3D dose using the implemented data measured 
by MP512- EPI was very accurate compared to the TPS for a static 3×3 cm2 open beam. 
Reconstructing a dose using TMR data showed better agreement than PDD data, 
particularly at a physical depth of 1. 5 cm because the SSD effect may have influenced 
these results since we know the PDD depended on SSD. Although the PDD was measured 
at SSD 85 cm, the maximum depth was not 1.5 cm (approximate water-equivalent depth 
of 1. 44 cm) , and the depth close to the surface of the phantom and different scattering 
from the non- flat surface may be involved.  However, this study only showed the cross 
beams profiles of a 3×3 cm2 field.  The accuracy of the dose reconstruction for various 
static size fields, especially those smaller than 3×3 cm2, as well as the complex fields, 
should be verified.  A high spatial resolution of 2 mm of MP512 can provide a high dose 
reconstruction voxel up to 2×2×2 mm3 without using the linear interpolation method. This 
characteristic of MP512- EPI makes the device superior to a commercial detector array 
for reconstructing doses in small field treatment such as SRS and SBRT.  The method of 
reconstruction and implemented data demonstrated in this study could be further modified 
and developed for complicated patient dose verification.  However, the active area of 
MP512- EPI is only 5×5 cm2 so obtaining a small 3D dose volume and CMRP phantom 
size seems to be inappropriate.  Further study of the small rotating phantom will be 
developed for used in conjunction with MP512- EPI.  The accuracy of the rotatable 
phantom function must be investigated and the full dose measurement using the rotating 
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phantom and 3D dose reconstruction within the patient CT will be verified.  The dose 
agreement could be moved on from 2D gamma analysis to 3D gamma or DVH- based 
matric comparison. 
 
 
 
 
Chapter 7  
Conclusion and future work 
Intricate treatment delivery using a small field such as SRS and SBRT is being used more 
used extensively but the accuracy of dose distribution must be verified before or during 
treatment. However, the criticality of a small field means that an appropriate detector and 
dose algorithms to measure 2D and 3D dose distributions must be developed. This thesis 
has studied and investigated a high spatial 2D detector array called MagicPlate-512 that 
was developed as a verification tool for use in small fields. Two detectors were 
investigated in this thesis, the MP512-Bulk and the MP512-EPI. These devices were 
successfully characterised as fully dosimetric, so they were then used in conjunction with 
CMRP for pre-treatment verification of IMRT and VMAT. This chapter summarises the 
potential outcomes using the MP512-Bulk and MP512-EPI detectors, including a 
discussion of the advantages and limitations of these device systems. This chapter also 
presents future study and methods of developing these devices for small field dosimetry. 
  
7.1 The angular dependence study 
This study extended the dosimetric characterisation of MP512 presented by Abdullah et 
al. [170]. The MP512-Bulk is a monolithic 2D detector array based on a p-type silicon 
substrate; it has 512 sensitive pixels arranged to cover an area of 52×52 mm2 at 2 mm 
pitches. Each sensitive pixel area is 0.5×0.5 mm2. The detector was investigated in terms 
of the effect that field size and energy has on the angular dependence of MP512. An 
angular correction factor was also developed and verified. The design of MP512 with its 
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high z material and silicon bulk length of 52 mm limited its use in rotation beam delivery 
where the irradiation beam is not perpendicular to the MP512 plane. The relative angular 
response of the MP512-Bulk demonstrated its maximum deviation at an incident beam 
angle parallel to the detector plane of up to 18.5±0.5% and 15.5±0.5% for 6 MV and 10 
MV photon beams, respectively. The angular response of MP512 does not depend on the 
field size but it does depend on the photon energy. The angular correction method and 
correction factor with a reference field size of 10×10 cm2 showed excellent results. The 
corrected cross beam profiles compared to the dose measured by EBT3 yielded 
agreements to within 2% for all field sizes and all incident beam angles, except for a 1×1 
cm2 for 6 MV photon beams at an incident angle of 90°. The sophisticated electron 
scattering in the detector at a parallel beam angle for a small field of less than or equal to 
1×1 cm2 needs further investigation using the Monte Carlo. 
 
7.2 The dosimetric characteristics of MP512-EPI 
The MP512-EPI dosimeter was developed based on the high resistivity an epitaxial layer 
grown on the top of a low resistivity p+ substrate while keeping the arrangement and size 
of sensitive pixels the same as the MP512-Bulk. The MP512-EPI dosimeter and fast 
acquisition system based on FPGA has proven to be very useful as a QA device for small 
field dosimetry. The MP512-EPI dosimeter that was fabricated on a high resistivity 100 
Ω cm p-Si epitaxial layer was superior to the MP512-Bulk in terms of radiation hardness, 
while keeping it full dosimetric characteristics within ±2%, unlike the reference detectors 
such as the ionisation chamber and gafchromic EBT3 films. Moreover, the MP512-EPI 
provided excellent long-term reproducibility within ±0.9% for one year without 
recalibration. Although the MP512-EPI  response  had a reduction at a minimum dose per 
pulse of 2.11×10-4 Gy/pulse (SSD 370 cm) up to 8 %. At a typical dose per pulse or SAD 
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set up for IMRT and VMAT delivery its  response revealed it to be dose per pulse 
independent. The use of MP512-EPI in conjunction with the appropriate air gap provided 
accurate output factor measurements for field sizes down to 1×1 cm2. Increasing its 
thickness from 470 µm (MP512-Bulk) to 535 µm (MP512-EPI) and with a resistivity 
value of 100 Ω cm did not affect the relative angular response, which demonstrated the 
percentage difference between two detectors to be within ±2% for both energies. The dose 
per pulse dependence revealed the effect on PDD when measured by the MP512-EPI, 
where the depth was more than 20 cm, but the percentage difference relative to the Dmax 
comparison to IC measurement was within ±2%, and can be improve by correction with 
the dose per pulse factor.  
 
7.3. 2D and 3D dose reconstruction 
The MP512-EPI dosimeter was verified as a QA device for clinical IMRT and VMAT 
treatment delivery. The 2D dose distribution was measured using MP512-EPI in 
conjunction with a CMRP cylindrical phantom with different material insertions. The 
homogeneous and inhomogeneous insertions represented the brain and lung tissue, 
respectively. Small lesions (GTV) of less than 3 cm3 were used to plan with the Pinnacle 
V14. Gamma indexes of 1%/1mm, 2%/2mm and 3%/3mm were used as comparisons 
between the 2D dose distribution reconstruction of MP512-EPI, RTP dose calculation, 
and gafchromic EBT3 film dose measurement. The 2D dose distribution was computed 
using the angular correction method set out in Chapter 3. For the VMAT case, sample 
angles of 1°, 5°, and 10° were calculated and verified. The 2D dose distribution 
reconstructed by MP512-EPI demonstrated excellent agreement with the TPS dose 
calculation and EBT3 measurements. Due to the high spatial resolution (2 mm) of 
MP512-EPI, the percentage passing rate with a tolerance of 2%/2mm was almost 95% 
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for all plan deliveries. A more delicate sample angle of angular correction improved the 
dose agreement at the peripheral region to provide a low dose distribution, but the 2D 
dose distribution verification cannot present clinically relevant results.  
 The MP512-EPI dosimeter was also implemented as a 3D dose verification tool. 
The implemented data and 3D dose reconstruction algorithm were developed and the 
PDDs and TMRs measured by MP512-EPI in a solid water phantom demonstrated an 
excellent dataset using the 3D dose algorithm based on the method introduced by Allgaier 
et al. [149]. The reconstructed cross beam profiles of MP512-EPI agreed with the dose 
obtained from the Pinnacle V9.6 in terms of the central dose, FWHM, and the penumbra 
for all depths, but this study was only verified for a static 3×3 cm2 open field; a smaller 
field and a clinical IMRT or VMAT delivery should also be validated. 
 
7.4. Future work 
The design of MP512-EPI with its small active area limited its use for fields larger than 
52×52 mm2, so future work will be directed towards the development of a Quadro 
MP512-EPI detector with a four tiled MP512-EPI that allows for a sensitive area 10×10 
cm2 while maintaining the same spatial and temporal resolutions.  
Further development of the MP512-EPI and the acquisition system would be 
implemented for 3D dose distribution verification. The DVH matrix will be applied as a 
comparison method. A rotating phantom would be designed and developed to fit the 
MP512-EPI, it would have a suitable size and be combined with the rotation validation 
system. All the data discussed in Chapter 6 will play a big role in the specific domain 
development which we expect to use as a software application for the proposed a fast 3D 
dose reconstruction operating in real time measurements. In addition, the validation of 
3D dose reconstruction developed in this thesis using high spatial resolution 2D detectors 
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placed in rotation phantom and software for that will be investigated further by 
comparison of reconstructed doses with the TPS and some commercial quasi-3D dose 
verification devices such as ArcCheck and Delta4. Additionally obtained 3D dose will be 
compared with the actual 3D dose measurement using gel dosimetry.  
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Appendix A  
Autodesk drawing  
The detector holders for CMRP cylindrical phantom were designed for particular 
materials. The 3D design AutodeskTM AUTOCAD 2016 (California, USA) was used to 
create the drawings. 
A.1. MP512 holder for solid water phantom 
The PMMA frame was used in conjunction with the solid water phantom in the work 
described in Chapter 4. 
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A.2. Inhomogeneous holder for CMRP phantom 
A.2.1. Upper part 
The inhomogeneous holder was designed to hold the MP512 inside the CMRP cylindrical 
phantom. The redwood material represents lung tissue; it was used in the patient specific 
verification described in Chapter 5. 
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A.2.1. Lower part 
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Appendix B  
Matlab Scripts 
Matlab scripts were written using Matlab 2016 ( The MathsWorks Inc. )  to manage the 
MP512 data involved in Chapter 3 and Chapter 5.  
B.1. Mapping function script 
This script was used to map the MP512 data into matrix arrays.  
function [Map ] = mappingFunction( Input ) 
%% read 1x512 input data from Input512.xlsx file (file name can be changed) 
% Input contains a 1x512 matrix of MP512 
 
%% read 24x24 array from map.xlsx file (file name can be changed) 
Map = xlsread('map.xlsx');  
 
%% mapping  
for i = 1:1:24  
    for j = 1:1:24 
       if Map(i,j) == 0 
           Map(i,j) = 0; 
       else 
           %% transform 1x512 to 24x24  
           Map(i,j) = Input(1,Map(i,j));  
       end 
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    end 
end 
%%  replace NaN 
for i = 1:1:24  
    for j = 1:1:24 
       if isnan(Map(i,j)) 
            
           Map(i,j) = 0; 
       end 
    end 
end 
end 
B.1. Angular correction script 
The scripts were used to correct the angular dependence of MP512, as described in 
Chapter 3 and Chapter 5.  
B.1.1. Angular sampling script 
function [  samplingIndex, samplingData, convertedIndex ]  =  Sampling(  index, data, 
samplingSize) 
     
    if size(index,1) ~= size(data,1) 
        error('size of index and data is not compatible'); 
    end 
    if size(index,2) > 1 
        error('index has more than 1 column'); 
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    end 
    if size(data,2) ~= 512 
        error('data must be 512 columns') 
    end 
  
    %re-adjust index: for negative value do this (180 - x) + 180 
    fprintf('convert negative index: (180 - index) + 180\n') 
    fprintf('negative index: %d\n', sum(index<0)); 
  
    %converted Inclinometer index corresponding to LINAC index 
    convertedIndex = index; 
    for i = 1:size(convertedIndex,1) 
        if convertedIndex(i,1) < 0 
            convertedIndex(i,1) = (180 + convertedIndex(i,1)) + 180; 
        end 
    end 
    %find number output row 
    outputRow = 360 / samplingSize; 
    lower = 0; 
    upper = samplingSize; 
    clear samplingIndex; 
    clear samplingData; 
    for i = 1:outputRow 
        samplingIndex(i,1) = lower; 
        samplingIndex(i,2) = upper; 
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        samplingData( i,: )  =  sum( data( convertedIndex >=  lower & convertedIndex < 
upper,:)); 
         
        lower = upper; 
        upper = upper + samplingSize; 
    end  
end 
B.1.2. Application of angular correction factor applying  
dataFileName = 'InhomoVMAT/Inhomo_VMAT3_Decoded.txt'; %folder/filename 
indexFileName = 'InhomoVMAT/Inhomo_VMAT3_angles.aux'; 
load('sumCF_6X_10de.mat');  
 
% load('CF_6X_ctrPoint.mat');  
load('ERMap_m.mat') 
 
%% import data 
data = importDecodedData512(dataFileName); 
index = importIndexAngle(indexFileName); 
 
%% adjust data 
 
data(1, :) = []; %cut first raw due to unstable reading of inclinometer where gantry start 
movement, have to check 
data(:, 171)= 0; %replace zero to channel that error reading this number can be changed 
depend on raw data show 
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data = (data.*100)./65535; % where 65535 = 2^16 -1 (16 bit) and data is a percentage 
response of data bit reading 
% index(1, :) = [];  %cut first raw due to unstable reading of inclinometer where gantry 
strat movement 
 
%% find baseline 
 
BS = 10; % first part: before beam start this number can be changed 
BP = 35000; %BP = second part after beam stop this number can be changed  
baseline = cutBaseline(data, BS, BP); 
data = data - baseline; %cut baseline each raw 
%% sampling angle and cut baseline 
samplingSize = 10; % this value can be change 
[  samplingIndex, samplingData, convertedIndex ]  =  Sampling(  index, data, 
samplingSize); 
 
%% Begin matrix angular correction  
 
[ correctedData2, mapData2]  =  ApplyCorrectionFactor( samplingData, 
sumCF_6X_10de,2); 
mapData2(isnan(mapData2)) = 0; 
mapData2 = mapData2./ERMap_man; %ER = equivalization factor (20x20 cm2, d10)  
mapData2 = mapData2 .* 0.00038; % Converted MP512 response to dose(cGy) using 
FC(10x10cm2 ,d1.5cm) 
[mapData2]= MP_fixNan(mapData2); 
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B.2. Gamma analysis 
The 2D gamma index was used to compare the dose distribution of MP512 reconstruction, 
EBT3 measurements and TPS calculations. This gamma index was calculated based on 
Low‘s equation.  
%Run script 
MP = In_VMAT2_1de_predict; %add MP512 name 
MP2 = MP2:23,2:23); %wing pixel was cut 
  
%newMP = fillDead(MP2,k); 
  
film = VMAT1_D; %add Film name 
flim2 = medfilt2(film); 
flim2(1,1) = film(1,1); 
flim2(1,137) = film(1,137); 
flim2(137,1) = film(137,1); 
flim2(137,137) = film(137,137); 
  
[Vq_MP, Vq_wflim] = AdjustScale(film, MP2, 2,0.35278,11,1); 
[ GammaMap numpass avg numWithinField]  = 
GammaCompare(Vq_wflim./mean(Vq_wflim(:)), Vq_MP./mean(Vq_MP(:)),41, 41,0.5, 
0.03, 0.3, 0.1,10);  
  
fprintf('-------result-------\n'); 
fprintf('Gamma pass-rate:%4g\n',numpass*100); 
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fprintf('Average gamma :%4g\n',avg);  
subplot( 1,3,1) , imagesc( film) , subplot( 1,3,2) ,imagesc( MP) , subplot( 1,3,3) , 
imagesc(GammaMap); 
subplot( 1,3,1) , contour( film) , subplot( 1,3,2) ,contour( MP) , subplot( 1,3,3) , 
contour(GammaMap); 
%imagesc(GammaMap); 
%Adjust scale 
 
function [Vq_MP, Vq_film] = AdjustScale(film, MP, Mpx,Fpx,exSize,exPx) 
  
%{ 
%INPUT parameters and detial  
film = IMRT1_fD;        % original film data 
MP = comImRT1_PDnet;    % original MP5121 data 
Fpx=0.35278;            % pixel size spacing of film data 
Mpx=2;                  % pixel size spacing of MP512 data 
exSize = 20;            % output image size (i.e 20X20 mm)  
exPx = 1;             % pixel size spacing of output image(i.e0.5mm) 
%OUPUT  
Vq_MP                   % converted MP images 
Vq_film                 % converted film images  
 
For example:  
[Vq_MP, Vq_film] = AdjustScale(film2, newMP, 2,0.35278,20,1); 
%film2 is film with median filter (3X3)  
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%} 
% read image size  
fsize = size(film,1); 
msize = size(MP,1); 
% Create Mesh grid  
[Mxgrid,Mygrid] = meshgrid(-1*Mpx*msize/2+(Mpx/2):Mpx:+Mpx*msize/2-(Mpx/2)); 
[Fxgrid,Fygrid] = meshgrid(-1*Fpx*fsize/2+(Fpx/2):Fpx:+Fpx*fsize/2-(Fpx/2)); 
[Nxgrid,Nygrid] = meshgrid(-1*exSize+(exPx/2):exPx:+exPx*exSize-(exPx/2)); 
% 2D interp  
Vq_film = interp2(Fxgrid,Fygrid,film, Nxgrid, Nygrid); 
Vq_MP = interp2(Mxgrid, Mygrid, MP, Nxgrid, Nygrid); 
  
 
% GammaCompare 
% GammaMapsub will carry the calculated gamma values for the truncated 
% images. GammaMap2 will be the Gamma values for the full image. 
GammaMapsub = NaN; 
GammaMap = zeros(size(Image1)); 
% Find the threshold limits for truncation 
[validmask_y validmask_x] = find(Mask); 
min_x = min(validmask_x)-rad; 
max_x = max(validmask_x)+rad; 
min_y = min(validmask_y)-rad; 
max_y = max(validmask_y)+rad; 
if min_x < 1 
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    min_x = 1; 
end 
if min_y < 1 
    min_y = 1; 
end 
if max_x > size(Image1,2) 
    max_x = size(Image1,2); 
end 
if max_y > size(Image1,1) 
    max_y = size(Image1,1); 
end 
% Truncate the images to avoid needless calculations 
Im1 = Image1(min_y:max_y,min_x:max_x); 
Im2 = Image2(min_y:max_y,min_x:max_x); 
% Shift the image by varying amounts. Determine the minimum gamma value 
% for all shifts 
for i=-rad:rad 
    for j=-rad:rad 
        % circshift function wraps elements from top to bottom as necessary 
        % The entire image is shifted at once 
        Im2_shift = circshift(Im2,[i j]); 
        dist = sqrt((res_y*i)^2 + (res_x*j)^2); 
        DoseDiff = Im2_shift - Im1; 
        % Compute the gamma map for this particular shift value 
        Gamma_temp = sqrt((dist./DTA_tol).^2 + (DoseDiff./Dose_tol).^2); 
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        % Accumulate the map of the minimum values of gamma at each point 
        GammaMapsub = min(GammaMapsub,Gamma_temp); 
    end 
end 
% Put the truncated gamma map back into its proper location within the full 
% gamma map 
GammaMap(min_y:max_y,min_x:max_x) = GammaMapsub; 
% Remove any edge effects from the circular shifting by multiplying by the mask values. 
This will negate any calculated gamma values around the edges of the distribution where 
this effect would arise 
GammaMap = GammaMap .* Mask; 
% Ensure that NaN values outside the mask do not affect the calculation 
GammaMap(~Mask) = 0.0; 
 
% Compute statistics 
numWithinField = nnz(Mask); 
numpass = nnz(GammaMap<1 & Mask)./numWithinField; 
avg = sum(GammaMap(:))./numWithinField; 
 
